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1 General introduction 
1.1 Protein-ligand interactions 
Protein-ligand interactions are essential for all biological processes. These interactions 
comprise biological recognition at the molecular level. When the ligand binds to the protein, 
it can regulate binding of other molecules, either by directly disrupting the interaction, 
competition of binding, or indirectly causing conformational changes. Therefore, 
understanding the detailed interactions between the binding partners is important to gain 
insight into the corresponding biological processes. This thesis focuses on two proteins: 12 
kDa FK-506 binding protein (FKBP12) and plastocyanin (Pc). FKBP12 is used as a model 
protein for the development of a paramagnetic NMR-based methodology for studying 
general protein-small molecule interactions. The transient complexes formed by three 
different Pcs and small charged peptides, are created as models to elucidate the dynamic 
nature of encounter complexes and to provide fundamental understanding of transient 
protein-protein interactions. 
 FK-506 binding protein (FKBP) 
FKBP is a protein family with cis-trans peptidyl-prolyl isomerase activity and belongs to the 
immunophilin family. FKBPs have been identified in many eukaryotes and function as 
protein folding chaperones for proteins containing proline residues. In this family, FKBP12 
is a ubiquitous cytosolic protein implicated in several physiological processes. It is known in 
humans for binding the immunosuppressant molecules FK506 (tacrolimus)
1,2
 and rapamycin 
(sirolimus),
3
 which are used in treating patients after organ transplant and patients suffering 
from autoimmune disorders. The FKBP12-FK506 complex inhibits a serine/threonine 
phosphatase, calcineurin,
4
 thus blocking the T-lymphocyte signal transduction pathway.
5,6
  
The structures of FKBP12 in the free form, with ligands or other proteins, have been solved 
by NMR spectroscopy
7–14
 and X-ray crystallography.
15–29
 The overall structure is made up of 
five -strands, an -helix, and three loops.
15
 The structure indicates a unique ligand binding 
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pocket, which can be subdivided into two sites.
30
 Site 1 is the binding location for the 
pipecolinic acid ligands, whereas site 2 lies about 7 Å away. Selected ligands with a range of 
affinities for sites 1 or 2 have been reported, some of which have been linked to generate 




Figure 1.1: (Left) Surface representation of the two binding sites of FKBP12 with site-specific 
ligands. Residues in yellow and red are in site 1 and site 2, respectively. Residues in orange are 
shared between the two sites. For the ligands, atoms in red, blue and green are oxygens, nitrogens 






Plastocyanin (Pc) is a blue copper protein which is involved in the electron transport process 
in photosynthesis. It transports electrons between cytochrome f of the b6f complex and P700
+
 
of photosystem I (PSI) in plants, green algae and cyanobacteria.
31–34
 Pcs from different 
species have been extensively studied and their structures are available from various plants 
and bacteria.
35–49
 The overall structures of Pc are highly conserved from cyanobacteria to 
higher plants,
42
 ranging from 97 to 105 amino acid residues, but large differences are present 
in terms of surface charge distributions. The typical structure of Pc consists of a -sandwich 
consisting of seven -strands and an irregular strand which contains a small helix in some 
Pcs. In poplar Pc, for example, the copper ion is chelated strongly by 3 residues, namely the 
S
 
of C84, the N

 atoms of H37 and H87 and weakly with the S

 of M92 (Figure 1.2).
50
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Figure 1.2: Structure of poplar Pc (PDB 
entry 1TKW).
47
 Pc is shown as a grey ribbon, 
with the Cu ion as a blue sphere. The four 
residues (H37, C84, H87 and M92) that serve 
as the copper ligands are shown in sticks. 
 
 
The function of Pc relies on two sites: a 
hydrophobic patch surrounding the 
solvent-accessible histidine copper ligand, 
and an electrostatically charged, remote 
surface area, whose nature varies from 
one organism to another. This charged 
area is mainly acidic in plants and green algae, whereas it ranges from acidic to basic in 
cyanobacteria. In higher plants, the hydrophobic patch surrounding the exposed His87 ligand 
and the distant acidic patch are potential binding sites for redox partners of Pc.
41,51–54
 In the 
fern Dryopteris crassirhizoma Pc, on the contrary, the acidic region surrounds the 
hydrophobic patch.
43
 Although the acidic patches are not conserved in bacteria, the 
hydrophobic patch is always present. The hydrophobic patches and the acidic patches play a 
key role in the dynamics of the complex.
51
 
1.2 Fragment-based drug discovery 
Fragment-based drug discovery (FBDD) is a powerful method for discovering high-affinity 
ligands for target proteins. The term “fragment” is used for small organic molecules with a 
molecular weight of <300 Da.
55
 Fragment-based screening has several advantages over 
conventional high-throughput screening (HTS). First, due to the small size of fragments, the 
number of compounds that need to be screened is dramatically reduced to cover a greater 
chemical diversity space. Second, although fragment hits are weakly binding, they make 
high-quality interactions with the target to bind with sufficient affinity for detection, which 
has been interpreted as high ligand efficiency.
56
  
 In FBDD, detection of weak binding is of particularly interest, which leads to the 
development of various biophysical tools. Overview of various techniques applied in FBDD 
can be found elsewhere.
57–59
 The following content describes three of the most commonly 
used techniques to characterize ligand binding. An overview of existing protein-ligand NMR 




X-ray crystallography ins an information-rich technique that provides both hit validation and 
structural information in one step. It is often accomplished by analyzing protein crystals 
soaked in a cocktail of fragments.
60
 This technique is a versatile tool to visualize the 
complex structures at the atomic level, although it is not possible to measure an affinity. 
However, many cases have shown failures in obtaining good quality crystals due to problems 
of ligand soaking, multiple binding modes, weak binding, or disruption of the crystal lattice 
caused by protein motions. It is also a huge investment of resource to obtain the simple 
yes/no answer in primary screening. 
Surface plasmon resonance 
Surface plasmon resonance (SPR) is a technique based on optical sensors. It provides 
binding measurements to characterize the kinetic properties of the biomolecular complex. In 
SPR, the target protein is immobilized on a sensor chip with a thin layer of gold on the 
surface, which is then exposed to the analyte in the flow channel.
61
 Binding of the ligands 
results in changes of the refractive index on the surface of the sensor. This change is 
proportional to the number of bound molecules. The rate constants of ligand association (kon) 
and ligand dissociation (koff) are estimated by regression of the association and dissociation 
gradients at different ligand concentrations. The ratio of kof f /kon is the binding constant (KD). 
Therefore, SPR can quantitatively analyze the binding events.
62
  
Isothermal titration calorimetry  
Recently, thermodynamics involved in ligand binding has gained much interest in optimizing 
the structures of drug candidates.
63,64
 Isothermal titration calorimetry (ITC) is one of the few 
techniques which measure both the binding affinity and the thermodynamic terms that 
contribute to the affinity: the binding enthalpy (H) and the binding entropy (S). It has no 
requirement for chemical modification, labeling, immobilization or limit on the size of 
interacting species. The binding curve allows extraction of the thermodynamic parameters, 
the stoichiometry and KD. This technique has been used to provide a comparison of energy 
terms in the development of complete series of drugs.
63
 To achieve high affinity, both H 
and S are required to contribute favorably to binding. Therefore, the thermodynamic data 
can provide valuable information to complement existing tools to facilitate lead discovery 
and optimization.
64,65   
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1.3 NMR techniques for protein-ligand interactions 
NMR has been recognized as a powerful tool to characterize macromolecular structures and 
dynamics. It is also utilized extensively in screening ligand binding to protein targets in the 
early stage of fragment-based drug discovery.
66–70
 One of its key advantages is that it can 
detect and quantify weak interactions (KD M-mM) without prior knowledge of protein 
structures. In addition, NMR can be applied to obtain structural information for both the 
protein target and the ligand with atomic resolution for subsequent optimization of weak 
binding hits into high affinity drug candidates. 
Here, a summary of NMR techniques used for protein-ligand interactions is presented. They 
are subdivided into ligand- and protein-observed techniques. In the protein-observed 
techniques, the influences of ligand binding on the spectra of the target are detected, whereas 
in the ligand-observed techniques, changes induced in the ligand’s NMR resonances upon 
binding are observed. Recently, a variety of techniques using paramagnetic NMR and 
combining NMR and computational approaches are gaining interests. These techniques are 
also described here. 
Protein-observed NMR 
Binding of ligands to targets leads to changes in the chemical shifts, which are most 




C-labeled protein. Through a 
series of target 2D-HSQC spectra with different ligand concentrations, the dissociation 
constant KD can be derived. If the assignments of the target are available, the location of the 
binding site may be easily derived. This strategy is called chemical shift perturbation (CSP), 
also known as SAR (Structure-Activity Relationship) by NMR,
30
 chemical shift mapping or 
complexation-induced change in chemical shift (CIS), and has been successful applied in 
numerous cases for screening and optimizing lead compounds. However, HSQC-based 
methods are presently limited to macromolecular complexes with a molecular weight below 
30 or 100 kDa (in combination with TROSY).
71,72
 Another limitation is the requirement for 
large amounts of isotopically labelled protein, which can only be obtained if an effective 
expression system in an isotope-labelled medium is available. Despite this, side-chain 
specific isotope labelling has significantly increased the scope of protein systems that are 
amenable for SAR by NMR,
73,74
 and the cost-effective 
13
C labelling has made screening of 
100,000 compounds practical.
75
 To obtain information of ligand binding at atomic resolution, 
intermolecular NOEs can be observed using isotope filtered/edited NOESY experiments. 
Chapter 1 
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This works best for tight-binding ligands. Transferred NOE experiments can be used for 
weak binding ligands. 
Ligand-observed NMR 
Another category of techniques is based on the changes in the ligand NMR signals in the 
presence of the target. These methods are often used for proteins with Mw 15–100 kDa. 
Given that the ligand is in fast exchange on the NMR time scale, the observed signals are the 
weighted average of the free and bound ligand. Most techniques used for primary screening 
detect a response in the form of a reduction (disappearance) or increase (appearance) of 
signal amplitude due to changes in relaxation rates or magnetization transfer. 
Competition/displacement experiments can also provide information of the binding site and 
the relative affinity if the location and affinity of the first ligand is known. Paramagnetic 
labelling on the ligand or the protein can also be used to obtain information of the ligand 
binding by monitoring changes in the relaxation or chemical shifts of nuclei located at 
different regions of the molecule. An overview of the techniques is shown in Table 1.1. 
Saturation transfer difference (STD) was initially designed to identify small-molecule 
ligands that bind to a receptor protein from a mixture of compounds.
76
 The spectrum of the 
receptor is saturated by selective irradiation that does not influence the ligand resonances. 
Spin diffusion in the receptor leads to saturation of its spectrum and causes saturation 
transfer by NOE to the bound ligand. If the ligand is in fast exchange, signal reduction of the 
free ligand can be detected. This method has also been applied to identify the ligand binding 
epitope
77
 and the structure of a bound ligand.
78,79
 
With the combination of STD and highly deuterated proteins with selectively protonated 
amino acids (Ile, Leu, Val, and Met), one can also identify ligand binding sites. This is used 
in SOS-NMR (structural information using Overhauser effects and selective labelling).
80
 It 
requires an unlabeled protein as the positive control and a perdeuterated protein as the 
negative control.  
WaterLOGSY (water-ligand observed via gradient spectroscopy)
81–83
 is based on the 
intermolecular magnetization transfer and spin diffusion of the excited bulk water. Small 
molecules that interact with the ‘bound’ water on the protein (binders) behave differently 
from those that interact with the bulk water (non-binders), resulting in different signs in 
NMR signals. WaterLOGSY has been widely applied in primary screening. 
Target immobilized NMR screening (TINS) uses a solid support to immobilize the target and 
therefore slows down the tumbling rate of the immobilized target, causing much faster 
                                                             General introduction 
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relaxation relative to the free molecules in the solution phase. TINS uses difference in the 
spectrum of the fragments in the presence of the target to detect binding, and of a reference 
protein to cancel out non-specific binding. It was first demonstrated with FKBP12,
84
 and has 
been successfully applied on membrane proteins DsbB
85
 and adenosine A2A receptor.
86,87
 
INPHARMA (interligand NOEs for pharmacophore mapping)
88
 detects protein-mediated 
ligand-ligand interactions in competition binding. The restraints come from protein-mediated 
inter-ligand nuclear Overhauser effects (NOEs) observed between two competitive ligands. 
If the structure of the ligand–protein complex is known for one ligand, the complex structure 
for the other ligand can be estimated based on the intermolecular NOEs.  
Paramagnetic NMR  
Paramagnetic effects originate from unpaired electrons, which can affect the magnetic 
properties of nuclei in the vicinity. The theory of paramagnetic effects is explained in 
Section 1.4. These long-range effects are strongly distance and, in some cases, orientation 
dependent, and are subsequently observable in NMR spectra as pseudocontact shifts (PCS), 
paramagnetic relaxation enhancement (PRE) and/or residual dipolar coupling (RDC).
89–91
 
Therefore, paramagnetic NMR can provide valuable information for elucidation of protein 
structure, conformational dynamics, protein-protein interactions and protein-ligand 
interactions. Here the existing paramagnetic NMR-based approaches for protein-ligand 
complexes are described. 
SLAPSTIC (spin labels attached to protein side chains as a tool to identify interacting 
compounds) uses spin-labels, such as 2,2,6,6-tetramethyl-piperidine-1-oxyl (TEMPO),  
attached on the lysine residues of the target protein to detect ligand binding from a mixture 
of compounds.
92
 The bound ligand shows signal reduction in T1relaxation experiments. 
This approach can be used for primary screening. A similar approach has been applied in 
screening a second ligand that binds close to an already identified primary ligand attached 
with a TEMPO spin label.
93
 Such approaches have been demonstrated to find inhibitors for 
Bcl-xL
93
 and Bcr-Abl kinase.
94
 The use of paramagnetic ions instead of spin labels for ligand 
screening has also been demonstrated by substitution of diamagnetic Zn
2+
 with paramagnetic 
Co
2+
 in the matrix metalloproteinase MMP-12.
95
  
To further determine the structure of the protein-ligand complex using paramagnetic effects, 
several studies have appeared in recent years. A combination of PCS and RDC with respect 
to a single fusion C-terminus lanthanide-binding peptide tag (LBT) was applied to assist 
structure determination of a carbohydrate-protein complex.
96
 Later, the use of PCS was 
Chapter 1 
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applied to determine the pose of a ligand bound to a metalloprotein.
97
 This requires an 
enzyme with a native metal chelating site near the binding pocket, and the use of very strong 
lanthanides. PRE assisted ligand docking with a spin-label peptide bound specifically to a 
protein was also reported.
98
 Recently, a two-point anchored N-terminus lanthanide binding 
peptide (LBP) was applied for both ligand screening and determination of protein-peptide 
complexes.
99
 In this approach, ligand screening was achieved by observing paramagnetic 
line broadening for both the target protein and its bound ligand in 1D-
1
H NMR, and the 
ligand binding modes were derived by paramagnetic pseudocontact shifts (PCS). 
Combination of NMR and computational approaches 
The advantages of computation over experimental approaches are the fast speed and the 
possibility of studying challenging complexes that are difficult to study experimentally. 
However, computational approaches do not always provide accurate prediction. By 
integrating the experimental information, computational studies can provide more valuable 
biological insight. Various approaches combining NMR data and computation have been 
developed to extract the information of ligand binding.
100–102
 
Typically, if no significant conformational changes occurs on the protein upon ligand 
binding, the ring current effect generated by aromatic rings in ligands is the most important 
factor of the observed CSPs on the protein.
103
 Detailed calculations of ligand-induced CSPs 
were demonstrated useful to determine ligand binding modes.
104–106
 However, the 
quantitative CSP methods are limited to aromatic ligands, due to the requirement of ring 
current shifts produced by the ligand.
104
 Qualitative CSPs can also be used to both guide and 
filter the calculations, reducing the grid space and minimized energy in the process.
107
 
Protein-ligand NOE matching approach
108







HSQC-NOESY spectra for evaluating ligand binding poses. Only the 
1
H NMR assignments 
of the bound ligand are essential. No protein assignments are required but can be used if the 
information is available. Predicted filtered NMR spectra are used and, in combination of 
ligand pose evaluation, refined to match with the experimental spectra. This method required 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.4 Theory of paramagnetic effects 
Due to its isotropic and anisotropic effects, paramagnetic NMR can be a versatile tool to 
extract position-specific distance and angular information with respect to the paramagnetic 
center. Subsequently, the information can be used to determine and refine the structures of 
protein-ligand and protein-protein complexes, facilitate resonance assignments, and to study 
the sparsely-populated states and the dynamics.
89,90,109–112
 The three most commonly used 
paramagnetic effects are paramagnetic relaxation enhancement (PRE), pseudocontact shift 
(PCS) and residual dipolar coupling (RDC). The principles of paramagnetic effects applied 
in this thesis, PRE and PCS, are explained below. Detailed theories of paramagnetic effects, 
including RDC, can be found in literature reviews and books.
89,113–119
 
Paramagnetic relaxation enhancement (PRE) 
Paramagnetic centers invariably cause line broadening in the NMR spectrum owing to 
paramagnetic enhancements of the transverse relaxation rate, R2. This effect is called 
paramagnetic relaxation enhancement (PRE). It shows a distance dependency of r
−6
. The 
relation between the nucleus-to-electron distance (rIM) and relaxation rate enhancement 
(R2
para











































                       (1.1) 
Where µ0 is the permeability of free space, ge is the electronic g-factor, B is the Bohr 
magneton, S is the total electron spin quantum number, I is the proton gyromagnetic ratio, 
I/2π is the Larmor frequency of the proton, and c is the correlation time.  
R2
para 
can be retrieved by comparing the peak intensities in the paramagnetic and 














                                                (1.2) 
where Ipara and Idia are the peak heights under paramagnetic and diamagnetic conditions, 
respectively, and t is the INEPT time in a HSQC experiment, the time during which 
transverse relaxation was active. 
PREs fall off with the sixth power of the distance, yielding a limited useful distance range. 
On the other hand, they offer the possibility to study minor conformational species of 





Pseudocontact shifts (PCS) 
Pseudocontact shifts (PCS) are defined as the difference in chemical shifts between the 
paramagnetic and diamagnetic states. The PCS gives information on the distance and angle 
between a nucleus and the paramagnetic center according to Equation 1.3:
113
 
                     (1.3) 
where r, , and are the polar coordinates of the nucleus with respect to the principle axes 
of the -tensor and ax and rh are the axial and rhombic components of the -tensor, 
respectively. The r
−3
 distance dependency is much weaker than the r
−6
 distance dependency 
of PRE. PCS can therefore be measured for nuclear spins that are far from the paramagnetic 





Figure 1.3: Principles of PRE and PCS. (A) PRE depends on the distance between electron and 
nuclear spin, and is observed as intensity difference between the paramagnetic and diamagnetic states. 
(B) PCS is observed as chemical shift differences between the paramagnetic and diamagnetic states. 
For PRE and PCS the intensity ratios or chemical shift differences of NMR resonances between a 





















1.5 Generation of paramagnetic effects on biomolecules 
The use of paramagnetic effects in metalloproteins has been pioneered by Bertini et.al.
114,116
 
Later it was expanded from metalloproteins to non-metalloproteins by external paramagnetic 
tags. Common approaches to introduce paramagnetic effects on the target protein are 
presented: 
Direct metal substitution 
Lanthanides (Ln) do not exist in natural biological systems. For metalloproteins containing 





 in terms of ionic radius and oxophilicity allows direct metal substitution, providing a 






-binding proteins were also 




In recent years, a variety of site-directed lanthanide-binding tags (LBTs), spin-label 
compounds and lanthanide binding peptides (LBPs) have been developed to provide great 
opportunities for applying paramagnetic NMR on non-metallic proteins. 
LBPs that mimic metal binding sites of metalloproteins can be inserted by standard 
molecular biology techniques, at either terminus or in the loop regions of non-
metalloproteins, to serve as paramagnetic center once they are chelated to the appropriate 
metal.
130–135




Another way to incorporate Ln is to use organic compounds as LBTs. The attachment of 
LBTs through cysteine thiol modifications is advantageous since it affords a rational means 
of generating Ln-tagged proteins with desired orientations between the Ln ion and the target 
proteins for NMR application.
133
 However, site-specific incorporation of cysteines and 
removal of other solvent-accessible cysteines can sometimes results in problems in folding 
and purification. These problems can be eliminated by using metal-binding unnatural amino 
acids.
137
 The amino acids can be incorporated site-specifically by a modified expression 
system.
138
 Despite its relatively weaker binding affinity to lanthanides compared with other 
LBTs and LBPs, this approach has no limitation on the amino acid sequence, and therefore 






Nitroxide spin labels are the simplest and most widely used paramagnetic tags for PRE.
89
 
These nitroxides contain an unpaired electron in a sterically protected environment, making 
them stable radicals under physiological conditions.
140
 In most cases, they are usually 
attached to a surface cysteine residue, and therefore are mobile groups. This has to be taken 
into account when deriving PRE restraints.
141
 Recently, an amino acid with a stable radical 
and a rigid conformation, 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid 
(TOAC) has been introduced into peptides by using conventional solid phase synthesis.
142
 
Due to its relatively bulky structure, placing TOAC outside the recognition motif is 




1.6 Thesis outline 
The aim of this thesis is to study protein-small molecule and protein-peptide interactions by 
various NMR approaches, including NOE, PCS and PRE. Particular interests are emphasized 
on paramagnetic NMR in the following topics: (1) implementation of a general methodology 
of paramagnetic NMR to elucidate ligand binding modes; and (2) dynamics of transient 
protein-peptide encounter complexes. 
Chapter 2 describes the initial ligand studies for FKBP12. In order to characterize the 
behavior of the ligands and the chemical shift perturbations on the protein target, a set of 
small-molecule ligands selected from a TINS competition screen and known FKBP12 






N]-HSQC NMR. It was found that 
the chemical structure and the binding affinity of the ligand could have dramatic effects on 
their behavior in the 1D-
1
H diamagnetic and paramagnetic NMR spectra.  
Chapter 3 discusses the NOE-based structure of a small-molecule ligand bound to FKBP12. 
Multi-dimensional NMR was applied to complete the assignments of the protein in the free 
and bound form with the ligand. The ligand was first identified in TINS screening and later 
validated with chemical shift perturbations (CSPs). However, CSPs alone were not sufficient 
to elaborate the binding site, as perturbations were found in both site 1 and site 2 of FKBP12. 
Therefore, the actual binding site was determined by intermolecular NOE restraints from 
isotope filtered/edited NOESY experiments. Despite possible dynamics present in both the 




In Chapter 4, the same protein-small molecule structure was determined independently by a 
paramagnetic NMR approach, mainly using ligand PCS. The paramagnetic effect was 
implemented by using a lanthanide-binding tag, CLaNP-5.
144
 The structural calculations 
were carried out in two individual ways: with either the predicted or the optimized tensors. A 
comparison between these two PCS-derived structures and the NOE-derived structure is 
presented. The advantage and disadvantage of this methodology compared with other NMR 
approaches is addressed. 
In Chapter 5, the interactions between tetralysine peptides and plastocyanins from different 
species poplar tree (Populus nigra), Japanese fern (Dryopteris crassirhizoma), and a 
cyanobacterium (Phormidium laminosum)were investigated by PRE NMR and theoretical 
Monte Carlo simulations. Tetralysine peptides have been shown to interrupt the binding 
between Pc and cytochrome f and to cause subtle structural changes on the copper site of 
Pc.
44,145–147
 In this study, lysine peptides that contain TOAC spin-labels
143
 were applied to 
investigate the dynamics of the transient Pc-peptide complexes.  






This chapter describes a pilot study of qualitative characterization of ligand binding to 
FKBP12 using 1D-
1
H NMR in order to reveal their suitability for a follow-on paramagnetic 
NMR study. We include examples of difficulties that can be encountered during the process 
of structural characterizations for hits identified from 
1
H-NMR based screening. A variety of 
FKBP12-binding small molecules, selected from the literature or identified from a TINS 
screen, were characterized for their binding to FKBP12. As a result of combination of their 
binding affinities, chemical structures and differences in relaxation between the para- and 
diamagnetic states, these small molecules show different behavior in the NMR spectra 
between the free and bound, as well as the para- and diamagnetic forms. Through this 
analysis, we have established the requirements for ligands suitable for structure 
determination of the ligand-protein complex using paramagnetic NMR spectroscopy. The 
results may serve as guidelines for choosing suitable ligands and optimizing experimental 
conditions for paramagnetic NMR studies. 






NMR spectroscopy has been widely used in characterizing structures of organic molecules. 
Because of the high gyromagnetic ratio and abundance of protons present in organic 
molecules, many fragment-based screening techniques have been developed based on 
analyzing 1D-
1
H spectra of the compounds screened.
68,148–150
 These screening techniques, 
however, are mostly applicable for primary screening but not for structural determination of 
the ligand-protein complex. Some of them have been developed to provide limited 
information on ligand binding modes.
77
  
Paramagnetic NMR spectroscopy has been applied in studying protein-protein interactions, 
but rarely used in protein-ligand interactions. It is useful to use paramagnetic NMR due to its 
wide range of choices for the paramagnetic source and predictable long-distance effects on 
the systems of interest.
89,111,117
 In order to extend the utility of proton chemical shifts of the 
ligands to elaborate detailed protein-ligand interactions by using paramagnetic NMR 
spectroscopy, it is required to examine the behavior of the ligands in 
1
H-NMR upon binding 
to a protein. To date, there have been three cases studying protein-ligand structure 
exclusively with paramagnetic NMR restraints.
96,97,99
 Therefore, the application of 
paramagnetic NMR in protein-ligand studies may still be in its infancy.  
In this study, we focused mainly on simple 1D-
1
H NMR measurements of the protein-ligand 
complexes, either with or without the paramagnetic source. The 12 kDa FK-506 binding 
protein (FKBP12), a well-characterized protein with many known small-molecule ligands, 
was chosen as the model protein.
30
 To suppress the resonances of the protein in the spectra, a 
T2 relaxation filter was applied using the Carr–Purcell–Meiboom–Gill (CPMG) pulse 
sequence. For the paramagnetic NMR study, a lanthanide-binding tag CLaNP-5 (Caged 
Lanthanide NMR Probe 5)
144
 was attached to the protein to introduce paramagnetic effects to 
the protein-ligand complex. In total, fifteen ligands with diverse chemical structures were 
selected: three ligands reported in structure-activity relationship (SAR) studies,
30,151
 four 
ligands from docking studies
152
 of FKBP12, and eight ligands were FKBP12 hits identified 
from a TINS (Target-immobilized NMR screening)
84
 screen.  
Here we focus on two subjects frequently discussed in NMR: line broadening and chemical 
shift changes. First, tumbling time increases when the molecular size increases. Small 
molecules usually have sharp lines due to their fast tumbling time. When the ligand is bound 
to the protein, it behaves more similar to the protein. Therefore the NMR resonances of the 
ligand are broadened in the bound form. With the T2 relaxation filter, the intensity of the 
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resonances from the species that have shorter relaxation time, such as the protein and the 
bound ligand, would be dramatically reduced, resulting in a cleaner spectrum dominated by 
the species which have longer relaxation time, such as the free ligand. This simple concept 
has been applied in many NMR screening techniques, including TINS.
84
 
Second, ligand binding to its target protein induces chemical shift changes in both the 
protein and ligand with varying magnitudes that are dependent on the local chemical 
environment. Chemical environment of the ligand nuclei changes upon binding, which is 
reflected from the corresponding changes in the chemical shifts of the ligand nuclei. In the 
fast exchange regime in terms of NMR time scale, the observed chemical shifts are the 
weighted average of chemical shifts from the free and bound ligand. For slow-exchange 
species, the bound and free populations show separate signals. For intermediate-exchange 
species, the resonances can be very broad and sometimes difficult to observe in the spectra.  
The positions and linewidths of the ligand 
1
H resonances were qualitatively examined in 1D-
1
H NMR spectra, in the presence of either the wild type or, in some cases, CLaNP-5 tagged 
FKBP12. The ligands were found to exhibit varied or unchanged positions and linewidths in 
1D 
1
H-NMR spectra, not only between their free and bound form, but also between the para- 
and diamagnetic environment. Possible factors that could contribute to the different behavior 
of the ligands were discussed. Finally, we conclude the requirements for a suitable ligand for 
the paramagnetic NMR study.  
2.2 Materials and Methods 
Ligand preparation 
The known FKBP12 ligands from SAR studiesZB6, ZB10 and ZB88were synthesized 
according to the synthetic schemes described in the literature.
30,151
 The other ligands were 
purchased from the suppliers listed in Table 2.1. 
The ligands were dissolved in H2O buffer, D2O buffer or d6-ethanol with a final 









C]-HMBC spectra acquired on a 100 mM solution 






Table 2.1: Details of supplier information for the ligands used in this study. 
ZB code Supplier Catalog number CAS 
ZB1 Sigma-Aldrich 155101 1137-68-4 
ZB2 Sigma-Aldrich 642711 1137-67-3 
ZB3 Sigma-Aldrich 226769 670-96-2 
ZB84 Sigma-Aldrich D87759 91-44-1 
ZB293 Maybridge S13756 -- 
ZB390 InterBioScreen STOCK1N-10205 -- 
ZB429 Sigma-Aldrich 54169-9 -- 
ZB1035 Labotest LT00367766 -- 
ZB1051 Chemical Block A1180/0054672 -- 
ZB1104 Sigma-Aldrich S292249 -- 
ZB1406 InterBioScreen STOCK1N-60294 -- 
ZB1489 Maybridge JFD02405 -- 
 
Protein expression and purification 
Recombinant human FKBP12 wild type and the double cysteine variant K34C/K35C, all of 
which contain an additional LEHHHHHH tag at the C-terminus were purified from 
Escherichia coli strain BL21(DE3) containing the overexpression plasmid pET20b with 
FKBP12 insert. The bacterial culture was incubated at 37 
o
C until OD 0.6-0.8, and then gene 
expression was induced by adding IPTG to a final concentration 1 mM. Incubation was 
continued at 18
 
°C overnight. After centrifugation, the pellets were resuspended in 5 mL/g 
pellet sucrose buffer (50 mM Tris, 20% sucrose, 1 mM EDTA, pH 7.5), centrifuged at 7,000 
× g for 30 min at 4 °C, re-suspended in 5 mL/g pellet of 5 mM MgSO4 and incubated on ice 
for 10 min. Cells were then centrifuged at 4,500 × g for 20 min, the supernatant was 
discarded and the pellet was resuspended in 1.5 mL/g pellet lysis buffer (50 mM sodium 
phosphate, 5 mM imidazole, 500 mM NaCl, pH 7.5) and frozen. For lysis, cell suspensions 
were incubated with PMSF, DNase and lysozyme at room temperature for 1 h and lysis was 
achieved using a French Press (SLM Instruments Inc.). The crude lysate was cleared by 
ultracentrifugation at 35,000 × g for 45 min at 4 °C followed by filtration through a 0.22 m 
syringe filter. FKBP12 was purified to homogeneity using a 5 mL His-Trap column (GE 
Healthcare) with a gradient of 5-500 mM imidazole, followed by a Superdex G75 gel 
filtration column (GE Healthcare). Protein concentrations were determined by UV-Vis 






). The purity was confirmed by SDS-PAGE and 
Coomassie blue staining. The yield was in general 80 mgL
-1 
for wild type FKBP12 and 15 
mgL
-1 
for the double cysteine mutants. 
CLaNP-5 attachment 
To a solution of FKBP12 double cysteine mutant in 25 mM sodium phosphate, 100 mM 
NaCl, pH 7.5, 10 mM dithiothreitol was added and the reaction mixture was incubated on ice 
for 1 h to reduce cystines. After removing DTT with a PD-10 column (GE Healthcare), 3-10 
molar equivalents of Ln
3+
-CLaNP-5 were added to a 20 M solution of the reduced FKBP12 
and incubated on ice for 1 h. The mixture was purified using a PD-10 column followed by a 
24 mL Superdex 75 gel filtration column (GE Healthcare) to separate the probe attached 
monomeric protein from dimers and excess probe. Protein concentrations were determined 








 for CLaNP-5). 
The fractions of dimers were estimated to be 10%-25% based on the intensities observed on 
SDS-PAGE analysis. The yields of pure tagged proteins after purification were 20%-40%.  
NMR measurements 
All protein NMR samples contained 15 mM Tris-HCl, 25 mM NaCl, pH 7.7 and >95% D2O. 
The concentration of wild type FKBP12 and Ln-CLaNP-5 attached FKBP12 was 10 to 100 
M for titrations. Spectra were recorded at 290 K on a Bruker Avance DMX-600 
spectrometer equipped with a TCI-Z-GRAD cryoprobe. 1D-
1
H spectra of the protein-ligand 
complexes were recorded at 600 MHz with a spectral width of 16 ppm and 6 k complex 
points, resulting in a digital resolution of 1.56 Hz before zero filling. The length of the 
transverse relaxation filter was semi-optimized based on the visibility of the resonances of 
each free ligand, and therefore varied per ligand, ranging from 0.5-200 ms. Data were 
processed and analyzed in TopSpin (Bruker). 
2.3 Results 
To find clear paramagnetic pseudocontact shifts (PCSs) of the ligands, we aimed to look for 
ligands that have clear, measurable changes on 
1
H chemical shifts upon binding to their 
target protein. FKBP12, a well-characterized 12-kDa protein with many known small-
molecule ligands, was selected as the model. In order to assess the effect of ligand binding 
on 1D-
1
H NMR spectra of the protein-ligand complexes, fifteen compounds were selected 
for the initial tests. Figure 2.1 shows an overview of the compounds studied in this chapter. 
The first group consists of three ligands selected from SAR studies,
30,151
 in which ZB6 and 
ZB88 are FKBP12 site-1 ligands and ZB10 a site-2 ligand. The second group consists of four 
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FKBP12 ligands selected from a docking study.
152
 Two common characteristics are present 
in ZB1, ZB2 and ZB3: an arylimidazole skeleton which contains only aromatic protons 
(apart from the imido protons), and similar affinity for FKBP12. ZB84 is structurally 
different from the other three compounds in this group. The third group includes nine 
compounds identified as FKBP12 hits from an NMR screen of a collection of commercially 
available fragment-like molecules. The collection shows a large variation in structures, some 
of which have only aliphatic protons and some others have both aromatic and aliphatic 
protons. 
 
Figure 2.1: Overview of FKBP12-binding compounds discussed in this chapter. The available KD 
values are shown in brackets. KD values of ZB1, ZB2, ZB3, ZB293 and ZB1035 were determined by 





 were taken from references.  
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Presence of isomers, slow to intermediate exchange, and scalar coupling 
Our first attempt was to determine the structure of a known complex of FKBP12 and a 
bound ligand using paramagnetic NMR, and to compare with the structure of the same 
complex reported in literature. ZB6 was chosen as the starting point for our initial study 
because of the available SAR by NMR information for the complex of FKBP12 and ZB6, 
exhibiting a KD of 2 M.
30
  Characterization of the ligand binding started with the titration of 
ZB6 against wt FKBP12. However, the proton resonances of ZB6 did not show clear 
chemical shift changes or line-broadening upon binding to FKBP12 (Figure 2.2). The only 
resonances that showed slight line-broadening during the titration were the resonances 
belonging to the methoxy groups (Figure 2.2, protons 1, 2 and 3). Besides, careful inspection 
of the spectra of free ZB6 suggested that at least two isoforms of ZB6 were present in the 
solution. Neither of the two forms showed clear shifts during the titration. Therefore, ZB6 
may already exhibit slow exchange on the NMR time scale. The resonances of the bound 
ligand were not found in the spectra due to the use of the relaxation filter.  
Figure 2.2: 1D-
1
H NMR spectra of ZB6 titrated into wt FKBP12. The 
proton assignments correspond to the numbers on the ligand structure, 
with KD in brackets (left).  Asterisks indicate the protein/buffer resonances. 
Signal intensities were scaled non-linearly for ease of viewing the shapes 
of the resonances. The concentration of the protein was 10 M and free 
ZB6 150 M. The fraction of bound ligand was 6.5% at the end point of 




We then set out to assess the binding behavior of ZB88, an analog of ZB6, using CLaNP5-
tagged FKBP12. CLaNP5 is a two-armed lanthanide binding tag which can be attached to 
the protein via disulfide bond linkage.
144
 The cysteines required for CLaNP5 tag attachment 
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were introduced at residues 34 and 35, resulting in a K34C/K35C variant of FKBP12. 
Thulium (Tm) was used as the paramagnetic lanthanide, and lutetium (Lu) as the 
diamagnetic control in CLaNP5. ZB88 has been shown to bind to FKBP12 in a 
computational SAR study.
151




N]-HSQC spectra of FKBP12 
showed visible shifts upon binding of ZB88 with KD 60 M (data not shown). 
When ZB88 was added to the CLaNP5-tagged FKBP12, the proton resonances of ZB88 
showed very different linewidths in the presence of paramagnetic protein compared to the 
diamagnetic protein. First, in the 1D-
1
H NMR spectra of free ZB88, two forms were 
identified (Figure 2.3, top panel), similar to the situation of ZB6. Second, the major form of 
ZB88 binds FKBP12 and experiences severe paramagnetic line broadening, resulting in only 
one resonance of ZB88 indentified from the paramagnetic spectra (H-8), whereas the rest 
were broadened beyond detection. A possible reason for this is that binding of ZB88 must be 
in the intermediate exchange regime on the NMR time scale. The resonances of the minor 












Figure 2.3 : 1D-
1
H NMR spectra of ZB88 in the free form (top trace), 
and in the presence of diamagnetic FKBP12 (34/35-Lu, middle trace) 
and paramagnetic FKBP12 (34/35-Tm, bottom trace). The proton 
assignments correspond to the numbers on the ligand structure, with KD 
in brackets (left). Signal intensities were scaled non-linearly for ease of 
viewing the shapes of the resonances. Asterisks indicate the 
protein/buffer resonances. [FKBP12]=75 M, [ZB88]=2000 M, 
resulting in a ligand : protein ratio of 26.7 and a bound ligand fraction 
of 3.6%. The T2 filter was 50 ms. 
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H-1(i) and H-2(i) showed shifts and the others no shifts. All three visible resonances are 
methyl groups, showing the highest peak intensity among other protons. Third, the 
intensities of the resonances which have strong scalar couplings, such as the protons of the 
proline ring, were dramatically reduced in the spectra. Given only one ligand PCS was 
available from the major isoforms, severe line-broadening due to intermediate exchange, and 
the presence of isomers, it was not practical to proceed with structural calculations.  
The two species of ZB88 were thought to be two of the three possible conformational 
isomers in equilibrium (Figure 2.4). The major species is thought to be the conformation 
with the trans form for both the two ketone groups and the proline group (Figure 2.4, 
conformational isomer 1) because it is more energetically favored. It seems not possible to 
isolate isomers 1 and 3. Isomer 2 can appear due to the cis-trans prolyl isomerase function of 
FKBP. The combination of intermediate exchange, complex scalar coupling and ligand 
isomers present in equilibrium in solution has made it difficult to use this ligand for the 
paramagnetic study. Due to its limited solubility in water, the ligand concentration could not 
be higher. 
 
Figure 2.4: Proposed conformational equilibrium in ZB88. 
 
Symmetric structure 
We then tested another FKBP12 ligand, ZB10, that is known to bind at the so-called ‘site 2’ 
of FKBP12. The ligand was added to the CLaNP5-attached FKBP12 at a protein to ligand 
ratio of 1 to 1. The binding affinity of ZB10 against wild type FKBP12 (KD 0.8 mM) was 




N]-HSQC in the presence of saturating concentration of ZB88 (data not shown). Eight 
protons of ZB10 are visible in the NMR spectrum and appear as four doublets due to 
degeneracy of NMR signals resulting from the symmetric structure (Figure 2.5, top trace). 
Therefore, only four ligand PCSs could be obtained (Figure 2.5, middle and bottom traces). 
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Each PCS corresponds to the average of the degenerate proton pair. The available ligand 
PCS data can still be used for structural calculations, but the number of available restraints 










Figure 2.5: 1D-1H NMR spectra of ZB10 free form and in the 
presence of FKBP12 (K34C/K35C) tagged with CLaNP-5 (Lu, 
Tm). The proton assignments correspond to the numbers on the 
ligand structure, with KD in brackets (left). The PCSs are 
indicated by connecting lines. Signal intensities were scaled non-
linearly for ease of viewing the shapes of the resonances. Asterisks indicate the protein resonances. 
The protein and ligand concentrations were 23 M and 30 M, resulting in 2.7% of bound ligand and 
3.5% of bound protein. The T2 filter length was 200 ms. 
 
In a previous study, ZB10 was identified as the site 2 ligand of FKBP12 in the presence of 
saturating concentration of ZB6.
30
 Binding of the same ligands have not been tested in the 
opposite way (saturate with ZB10 and then add ZB6). Here, ZB10 was added into the 
CLaNP5-tagged FKBP12 before the addition of ZB88. Surprisingly, ZB88 does not bind 
FKBP12 when ZB10 was already present (Figure 2.6). It should be noted that in this 
condition FKBP12 was not yet saturated by ZB10 (27% of FKBP12 and 2% of ZB10 were 
bound, based on KD of 0.8 mM). The PCSs from ZB10 were still visible upon addition of 
ZB88, while the chemical shifts of the resonances of ZB88 in the para- and diamagnetic 
samples appeared to be identical. This indicated that ZB10 is not only a FKBP12 site 2 
binder, but also a site 1 binder and therefore competes with ZB88 for the same binding site. 
Thus the KD of ZB10 determined in the presence of ZB88 (0.8 mM) might not be applicable 
in this situation. 





H NMR spectra of ZB88 titrated into wt FKBP12 in 
the presence of ZB10. The proton assignments correspond to the 
numbers on the ligand structure, with KD in brackets (left). The label 
“3(ZB10)” represents the protons 3 from ZB10. Signal intensities were 
scaled non-linearly for ease of viewing the shapes of the resonances. 
Resonances labeled with (i) represent the protons from ZB88 isomers. 
The concentration of FKBP12 and ZB10 was 23 M and 300 M, 
resulting in 27% bound protein and 2.1% bound ligand. No PCS could 
be observed for ZB88 in the concentration range from 150-600 M. The spectra above contain 600 
M ZB88. The T2 filter length was 100 ms. 
 
Symmetric structure and intermediate exchange 
ZB1, ZB2, ZB3, ZB84 were ligands selected from a docking study on FKBP12.
152
 The 
common feature of ZB1, ZB2 and ZB3 is the arylimidazole scaffold. The binding affinities 
and chemical shifts of the resonances in 
1
H NMR spectra are also similar. ZB84 contains a 
coumarin scaffold and its binding affinity is different from the other three ligands in the 
group. Four out of six of the proton resonances of ZB2 can be identified in the spectra 
although the linewidths were very broad due to aggregation of the ligand at high 
concentration (Figure 2.7). This was also observed in the broader linewidths at the ligand to 
protein ratio of 20 than at the ratio of 10. The severe line broadening in some resonances 
could be due to intermediate exchange, as in the case of ZB88. The spectra of ZB1 (Figure 
A1, three out of six resonances were broadened beyond detection) and ZB3 (Figure A2, one 
resonance was broadened beyond detection and one resonance was very broad) are provided 







H NMR spectra of ZB2 titrated into wt FKBP12. The 
proton assignments correspond to the numbers on the ligand structure, 
with KD in brackets (left). Signal intensities were scaled non-linearly for 
ease of viewing the shapes of the resonances. Asterisks indicate the 
protein resonances. The initial concentration of the protein was 100 M and the concentration of free 
ZB2 was 2 mM. The fraction of bound ligand was 4.8% at the end point of the titration. The T2 filter 
length was 50 ms. The broad resonances in the free ligand spectra was caused by aggregation of ZB2 




On the contrary, the resonances of ZB84 were completely broadened beyond detection 
(Figure 2.8). Two resonances (protons 4 and 7) were likely to be visible, but unfortunately 
due to peak overlapping with the buffer (proton 7) and the protein (proton 4) resonances, 
none of the resonances were clearly distinguishable. It could be that the relaxation filter was 
too long (50 ms) in this case, or the bound fraction of the ligand (1.9%) needs to be reduced. 
This example also points out the limitation of 1D 
1






























H NMR spectra of ZB84 titrated into wt FKBP12. 
The proton assignments correspond to the numbers on the ligand 
structure, with KD in brackets (left).  Signal intensities were scaled 
non-linearly for ease of viewing the shapes of the resonances. 
Asterisks indicate the protein and solvent resonances. Concentration 
of free FKBP12 and free ZB84 was 50 M and 2.5 mM. The bound 
ligand fraction was 1.9% at the end point of the titration. The T2 filter length was 50 ms. 
 
Table 2.2 shows a summary of the above mentioned four ligands studied with wild type 
FKBP12. Although these ligands have similar KD values as ZB88, they do not exhibit 
complicated scalar coupling. Some of the resonances of ligand were still broadened beyond 
detection in their bound form, indicating intermediate exchange. 
Table 2.2: Summary of FKBP12 ligands selected from docking studies. 
 
(a)






Ligands selected from FKBP12 TINS screen 
As none of the above mentioned ligands displayed ideal characteristics, we decided to 
investigate the hits identified from TINS screen. In total eight hits were tested. Two of them 
are shown as examples below, in which one ligand proved to be very suitable while another 
ligand exhibits challenges different from the previously discussed. The spectra of the other 
ligands are provided in Appendix A, Figures A3-A8. 
ZB293 has both aromatic and aliphatic protons and a well-resolved 1D-
1
H NMR spectrum 
with simple scalar couplings. The ligand was tested with FKBP12 and the chemical shift 
changes of the resonances of the ligand upon binding to FKBP12 were clearly visible (Figure 
2.10), indicating fast exchange in NMR timescale. Besides, the structure of ZB293 is 
asymmetrical, which does not contribute to NMR degeneracy. The only degeneracy is the 
methyl groups in the free form, which were resolved in the protein bound state. This can be 




H NMR spectra of ZB293 titrated into wt FKBP12. The 
proton assignments correspond to the numbers on the ligand structure, with KD 
in brackets (left). Signal intensities were scaled non-linearly for ease of 
viewing the shapes of the resonances. Asterisks indicate the protein resonances. 
Free protein and free ligand concentration was 100 and 1000 M. The fraction 
of bound ligand was 3.5% at the end point of the titration. The T2 filter length  
                                    was 40 ms. 
NMR-identical isomers  
In synthesis procedures, drugs having one or more centers of chirality were often obtained as 
isomeric mixtures of both diastereomers and/or enantiomers. Below is an example 
encountered during our study related to this issue. 
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ZB1035 was an FKBP12 hit identified from TINS screen whose binding was verified by 




N]-HSQC spectra of FKBP12 upon 
titration of the compound. Although the compound has two chiral carbons, it showed 
promisingly high ligand efficiency (binding energy/non-hydrogen atoms,
56
 0.314 kcal/mol) 
and was potentially interesting as a starting point for lead optimization. However, the 
chemical shifts of the ligand itself were not examined closely. When free in solution, 
ZB1035 shows a single form in the 
1
H-NMR spectrum (Figure 2.11, top panel). When the 
ligand is bound to FKBP12, most of the ligand resonances split into 2 sets of resonances. 
Both sets of resonances showed two separate sets of chemical shifts that gradually merged 
into one single set at increasing ligand concentration. This observation indicates that (1) 
there are two isoforms present in the ligand, and (2) it is possible for both forms of the ligand 
to bind FKBP, but the individual affinities can be difficult to determine by simple NMR 
experiments. The population of these two species in the compound mixture is unknown. The 













H NMR spectra of ZB1035 titrated into wt FKBP12. 
The proton assignments correspond to the numbers on the ligand structure, 
with KD in brackets (left). Many resonances in the bound form have split 
into two. For example, protons 2, 4, 7 and 8 consist of two sets of peaks, 
which gradually merge into one with increasing ligand concentration. 
Signal intensities were scaled non-linearly for ease of viewing the shapes of the resonances. The 
unlabeled resonance at 1.08 ppm is from the buffer.  The initial protein concentration and free 
ZB1035 concentration was 48 M and 1920 M, resulting in a total of 2.0% bound ligand at the end 





Inspection of the structure of ZB1035 indicates that this compound can have even four 
different isomers in the free form (Figure 2.12), including enantiomers which are NMR-
identical, and diastereomers which might be distinguishable given a correct structural model. 




(2.65 Hz) in the NMR spectra and 
comparing with the models obtained from PRODRG server
153
 (Figure 2.12B), it is likely that 
isomers a and b are present in the mixture. Although this analysis reduces the number of 
isomers from four to two, no information concerning the ratio of a and b is available. As this 
situation is complicated and there was not enough of the compound for further structural 
analysis, the study of this compound was discontinued. To obtain an enantiomerically pure 
compound, a chiral separation of the racemic mixture can be used, or a chiral paramagnetic 
reagent
154
 can be used to determine the ratio of the enantiomers.  
 
Figure 2.12: (A) Possible isomers that are present in ZB1035. From left to right are the enantiomers. 
From top to bottom are the diastereomers. (B) Newman projections of ZB1035 isomers a and c. 
Models used for calculation of dihedral angles were generated from PRODRG server.
153
 Coupling 









  limited practical information concerning the applicability and 
limitations is available and therefore this area still requires further development.  
We have performed a series of studies to characterize the effect of ligand binding to FKBP12 
on the1D-
1
H NMR spectrum of the ligand. The ultimate goal was to observe clear changes in 
ligand chemical shifts from simple 1D-
1
H NMR spectra upon binding to the target protein. 
To achieve this, it was concluded that the requirements for a suitable ligand to study are: (1) 
has an asymmetric structure, (2) contains well-resolved proton resonances with minimal  
degenerated protons, (3) no stereoisomers or enantiomers present in the compound, (4) the 
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scalar couplings shall not obscure assigning the resonances in the dia- and paramagnetic 
spectra, (5) binding at the regime of fast exchange in NMR time scale, and (6) has clear 
changes in chemical shifts upon binding to its target. ZB293 satisfies all the above 
requirements and therefore is the best candidate for further paramagnetic NMR studies 
among all the ligands investigated here. In Chapter 3 and 4 the interaction of ZB293 with 
FKBP12 will be studied in detail. 
Structurally symmetric fragments, such as ZB10, are still possible to be studied, but would 
present some difficulties due to reduced number of restraints. Ligands that show slow 
exchange are possible to study if the resonances of the bound ligand can be identified and 
assigned from the spectra.
99
 Ligands that show severe line broadening due to scalar coupling 
or intermediate exchange, such as ZB88 and ZB84, would be difficult to measure ligand 
PCSs. Ligands that contain isomers, such ZB6, ZB88 and ZB1035, should be best isolated to 
a single form prior to such NMR studies.  
Besides the consideration on the ligand structure, there are also other requirements to 
optimize the set-up of 1D-
1
H NMR experiments: 
1. The length of the relaxation filter should be long enough to eliminate most of the protein 
resonances while reducing as little as possible the intensity of the ligand resonances. The 
relaxation filter length used here is between 0.5-200 ms. In theory, it is possible to 
optimize the length of T2 filter by simulating the relaxation decay of the protein and the 
ligand. However, it proved to be difficult as every proton on the ligand has different 
relaxation time and every ligand exhibits different affinity to the target. Therefore, the 
range of T2 filter length provided here is only a guideline. The optimal T2 filter length 
still can be protein- and ligand-dependent.  
2. Avoid peak overlap with the resonances from the buffer or solvent. Most of the protein 
signals have been dramatically reduced because of the relaxation filter and the use of 
deuterated buffer conditions. Nevertheless, there can still be some residual signals, 
particularly in the aliphatic region. 
3. Sufficient fractions of bound ligand in fast exchange are required. It is essential to 
maintain a small fraction bound of a ligand in fast exchange in order to observe sharp 
lines (with preferably low protein concentration). This varies for each compound, 
depending on the chemical structure and binding affinity.  
A new NMR methodology, called pure-shift NMR,
156–158
 may be able to address the problem 
of multiple, strong J couplings. This technique eliminates multiplets and increases the 
resolution of 
1
H-NMR, although the sensitivity might be sacrificed. For compounds with 
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H-NMR can increase 
the number of observable chemical shift changes in the resonances between the free and the 




This chapter presents the determination of ligand binding pose by the traditional NOE 
approach. Chemical shift perturbations (CSPs) were used to determine KD and initially also 
to determine the binding site. However, CSPs monitor both direct and indirect effects, as 
observed in the complex. Therefore isotope filtered/edited NOESY measurements were used 
to determine the ligand binding mode. To characterize the interaction, full assignments on 
the protein and the ligand were performed. Many intermolecular NOEs were identified from 
the NOESY spectra and subsequently applied for structural calculation. The resulting 
structure is used as a reference structure to compare with the structure of the same complex 
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Structure information of protein-ligand complexes is highly valuable in the early stages of 
structure-based drug design (SBDD) and fragment-based drug discovery (FBDD), where X-
ray crystallography plays an important role to provide structure information. In many cases, 
however, hit compounds that interact weakly with their targets may not readily crystallize, 
due to a variety of reasons. Due to its high sensitivity in detecting weak interactions, NMR 
has proved to be a very useful tool when X-ray crystallography cannot be applied. 
Ligand-induced chemical shift perturbations (CSPs) are commonly used to monitor ligand 
binding and, for rigid proteins, to determine ligand binding sites. However, CSPs caused by 
direct contact with ligand and indirect conformational changes cannot be distinguished by 
simply mapping CSPs on the protein structure.   
NOEs develop due to through-space interactions rather than through-bond interactions. The 
intensity of an NOE is proportional to the inverse of the sixth power of the distance that 
separates the two dipolar-coupled spins within 5 Å, and so NOEs are sensitive probes of 
short-range through-space intramolecular and intermolecular interactions. In standard 
isotope-edited NOESY spectra, intermolecular NOEs are indistinguishable from 
intramolecular protein NOEs. Acquiring 2D and 3D edited/filtered NOESY
159,160





N-labeled protein saturated with unlabeled ligand can overcome this 









N atoms (ligand) while suppressing all other 
cross-peaks by isotope filtering and editing.
161
 Crosspeaks from the filtered NOESY 
spectrum can therefore be unambiguously assigned to protons on the small-molecule ligand. 
The aim of the work presented here is to characterize the structure of a small molecule ligand 
bound to a 12 kDa FK-506 binding protein (FKBP12) using CSP and intermolecular NOE 
restraints. FKBP12 is a peptidyl-prolyl isomerase which belongs to the family of 
immunophilins and is a drug target for the immuno-suppressants rapamycin and FK506. 
There have been many structural studies on this protein.
9,10,15,20,162,163
 The ligand in this study 
is a fragment that was identified as a hit against FKBP12 from a screen of a fragment library 
using Target-Immobilized NMR Screening (TINS).
84
 Using high-resolution NMR 
spectroscopy, we determined the binding mode of the bound ligand. The determined ligand 
binding mode serves as a reference structure for Chapter 4, in which a paramagnetic NMR 
approach was applied to determine the binding mode of the same ligand. 
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3.2 Materials and Methods 
Ligand preparation 
The ligand 1, [2-(4,4-dimethyl-5,5-dihydro-1,3-oxazol-2-yl)phenyl]methanol, was purchased 
from MayBridge (catalog number S13756). Assignment of the ligand resonances was 








C-HMBC spectra acquired on a 100 mM solution 
of  the ligand  in D2O. 







C-labeled FKBP12 was purified from Escherichia coli 







The proteins were essentially expressed and purified as described in Chapter 2.  
NMR measurements 
All protein NMR samples contained 15 mM Tris-HCl, 25 mM NaCl, pH 7.7, 6% D2O for 
15
N-labeled protein and >95% D2O for non-isotope-labeled protein. The concentration of 







N]-HSQC, HNCA, HNCACB, HN(CO)CA, 
HN(CO)CACB, HNCO, (H)CCH-TOCSY, HN(CA)CO and HBHA(CBCACO)NH spectra 
were recorded at 290 K on a Bruker Avance DMX-600 spectrometer equipped with a TCI-Z-






























N-filtered NOESY, and a ratio of 3:1 used in 2D NOESY, 2D DQF-COSY, and 2D 







N} cryogenic probe. Data were processed in TopSpin (Bruker) and then 
spectra were analyzed in Sparky.
164
 Dr. Frank Löhr (Goethe University Frankfurt, Germany) 
is acknowledged for the NMR measurements on the 950 MHz spectrometer. 
Calculations of dissociation constants and bound ligand fractions 





spectrum upon titration with the ligand.
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N backbone resonances, the weighted average chemical shift values were 













                                                    (3.1) 




H chemical shift of an amide group, 
respectively.  
The dissociation constant (KD) was determined using a two-parameter non-linear regression 




























                                                     (3.2) 
where R is the total [ligand] to [protein] ratio, avg is the average CSP (equation 3.1) at a 
given R, 0 is the CSP at 100% bound protein, P0 is the starting concentration of the protein, 
L0 is the stock concentration of ligand and KD is the dissociation constant.
166
 The fraction of 
bound ligand was calculated using the dissociation constant. 
NOE-based structure calculations 
Intermolecular NOE crosspeaks were identified in 2D and 3D NOESY spectra with NOE 
mixing times of 50-70 ms and then converted into distances using the CYANA
167
 calibration 
function. Intermolecular restraints were introduced as ambiguous restraints if degenerate 
protons were involved or the protein resonance could not be unambiguously assigned. 











) and the backbone was kept fixed throughout 
the process. Starting structures for the complex were generated by placing the ligand in 
random orientations with respect to FKBP12. Then the NOE distance restraints were applied 
to generate ligand orientations which satisfied the intermolecular restraints. Side chain atoms 
within 8 Å of the ligand were allowed to rotate during subsequent energy minimization. The 
XPLOR-NIH script is available in Appendix B. 
3.3 Results and Discussion 
Characterization of the ligand-protein interaction 
The ligand 1 (Figure 3.1A) was identified from a TINS screen
84
 of a library of commercially 
available, low molecular weight “drug fragments” for binding to FKBP12. To confirm the 
binding of 1 to FKBP12 and obtain structural insight into the binding site, we titrated the 








N]-HSQC spectra with 
increasing ligand concentration. Figure 3.1B shows the titration curves for the ten residues 
most effected from which the equilibrium dissociation constant, KD, could be extracted. 
CSPs occurred throughout the protein, including in two previously defined ligand binding 
sites, referred to as site-1 and site-2.
30
 Five of these residues are site-1 residues and the other 
five residues belong to site-2. In Figure 3.1C the CSPs have been mapped onto the crystal 
structure of FKBP12 (PDB entry 2PPN
29
) and color coded according to their magnitude. 
While CSPs can be caused by direct changes in the electronic environment of spins close to 
the ligand, many other factors can contribute. For example, it has been shown that, upon 
ligand binding to FKBP12, perturbations of both main-chain and side-chain dynamics can 
occur at sites distal to the binding interface.
168
 Since such changes in dynamic behavior may 
also lead to CSPs, it was not possible to define the ligand binding site by CSP mapping alone. 
Therefore we sought an alternative method to elucidate the structure of the complex. 

























Figure 3.1: (A) Chemical structure of ligand 1. (B) Chemical shift changes of FKBP12 resonances as 
a function of increasing [L]/[P]. The top 10 residues which showed largest perturbations are shown. 
Residues in the site-1 and site-2 regions are shown in black and red, respectively. The dissociation 
constant of 1 was obtained by fitting simultaneously to a 1:1 binding model (equation 3.2, solid lines). 





). The positions of site 1 and site 2 are indicated. Color representation: red, avg > 0.15 ppm; 
orange, 0.15 > avg > 0.10 ppm; yellow, 0.10 > avg > 0.03 ppm; blue, avg ≤ 0.03 ppm; dark grey, 




Assignment of the chemical shifts of free FKBP12
7
 and FKBP12 bound to ascomycin
12
 have 
been reported and these were used as the starting points. The complete assignments were 
verified as following: Backbone assignments (HN, CO, C and C) of ligand-free protein 
were obtained from standard triple resonance spectra and transferred to the bound state by 








C]-HSQC spectra upon ligand addition. 
Subsequently, the aliphatic side chains were assigned from a (H)CCH-TOCSY spectrum and 










NOEs develop due to through-space dipole-dipole interactions, thus containing information 
on the distances between atoms separated by 5Å or less in space.  The intensity of an NOE is 
proportional to the inverse of the sixth power of the distance between the two nuclei, but not 
always a precise reflection of the distance. The structure of the FKBP12-1 complex was 
initially determined using standard intermolecular NOE based methods. Intermolecular 
































N-filtered NOESY and 
2D NOESY spectra. Figure 3.2 and 3.3 show regions of NOESY spectra containing 
intermolecular NOEs between the ligand and backbone amides (Figure 3.2) and side chains 
(Figure 3.3) of the protein. In total, 66 intermolecular NOE crosspeaks were identified in 
these NMR spectra. 







H cross-sections from NOESY-
15







N-TROSY (B, D) of FKBP12-1 
complex, displaying intermolecular NOE cross-





N labeled FKBP12 and 
1
H nuclei of the 
unlabeled ligand 1. (A, B) I56 at ( = 
(111.83, 7.334) ppm and (C, D) W59 at ( 
= (120.36, 7.498) ppm. Chemical shifts of 
























There are two possible orientations of the five-membered oxazole ring relative to the six-
membered aromatic ring. Between these two orientations, the five-membered ring flips by 
180
o
. The difference in intensities of intramolecular NOEs between protons 4/1, 4/2 and 4/3 
(proton numbers as indicated on the structure in Figure 3.1A) in the presence of FKBP12 
suggests that the presented conformation is the prefered bound conformation in solution. A 
possible explanation is that the hydroxyl group from the aromatic ring may form a hydrogen 
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NOESY. Chemical shifts of the ligand 
1
H nuclei are indicated on the right.  
 
 
NOE-based structure calculations 
Among the 66 intermolecular NOE crosspeaks, 43 restraints were used for structural 
calculations (Table 3.1). The NOEs that were weak (20 peaks) or with uncertain assignments 
(3 peaks) were excluded. Superposition of various FKBP12 structures from the PDB (1FKR, 
1FKS, 1FKT, 1D6O, 2PPN) indicated that the loops surrounding the hydrophobic pocket are 
variable and hence might undergo significant dynamic behavior in solution. Therefore, to 
cover the range of conformations of the loops, multiple structures were used as input for 
structure calculations.  
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Table 3.1: List of intermolecular NOE restraints and their corresponding distances (in Å) calculated 
from the final NOE structure. (A) Restraints from flexible residues. (B) Restraints from rigid residues. 
(C) Restraints that were excluded due to weak intensities or uncertain assignments.  
(A) NOE restraints from flexible residues  (B) NOE restraints from rigid residues  
no. residue # protein ligand r(exp) r(calc)   no. residue # protein ligand r(exp) r(calc) 
1 37 H1 H-5 3.4 4.1  29 26 H H-4 2.7 5.1 
2 37 H2 H-5 3.4 3.3  30 36 H H-5 2.9 3.3 
3 55 H H-1 3.4 2.6  31 36 H H-5 3.5 3.9 
4 55 H H-2,H-3 3 3.6  32 46 H H-2 3.5 4.9 
5 55 H H-8 3.4 6.5  33 46 H H-4 3.1 3.2 
6 55 H H-1 3.3 4.5  34 46 H H-2 2.6 3.4 
7 55 H1 H-1 2.8 3.7  35 59 H2 H-3 3.4 3.7 
8 55 H1 H-2,H-3 2.4 3  36 59 H2 H-2 3.7 6.4 
9 55 H2 H-2,H-3 3.3 5.3  37 59 HN H-1 3.5 6.4 
10 56 H1 H-1 3.3 3.8  38 59 HN H-2,H-3 3.5 6.3 
11 56 H1 H-2,H-3 3.3 3.5  39 59 H2 H-3 3.7 3.2 
12 56 H2 H-1 3.5 2.3  40 59 H3 H-3 3.4 4 
13 56 H2 H-2,H-3 3.3 4.7  41 59 H3 H-2 3.7 6.4 
14 56 H2 H-8 3.2 5  42 99 H H-4 3.3 5.8 
15 56 HN H-1 2.8 2.4  43 99 H H-2 3.4 6.2 
16 56 HN H-2,H-3 3 3.5  (C) Excluded NOE restraints 
17 56 HN H-8 3.4 6.4  no. residue # protein ligand r(exp) remark 
18 82 H H-8 3.5 4.3  44 37 H1 H-4 3.8 weak 
19 82 H H-8 2.5 2.7  45 55 H1 H-4 3.9 weak 
20 87 H2 H-7 3.4 5.3  46 55 H2 H-1a 4.2 weak 
21 90 H1 H-2,H-3 3.4 9.7  47 55 HN H-2,H-3 4.1 weak 
22 90 H1 H-7 2.9 4.4  48 56 H11 H-4 3.5 weak 
23 90 H1 H-6 2.7 2.5  49 56 H12 H-1 3.6 weak 
24 90 H2 H-2,H-3 3.5 9.8  50 56 H2 H-1a 3.9 weak 
25 90 H2 H-7 2.6 3.7  51 56 H2 H-1b 3.9 weak 
26 90 H2 H-6 2.7 2.4  52 56 H2 H-4 3.9 weak 
27 91 H1 H-7 2.9 3.4  53 57 HN H-2,H-3 3.8 weak 
28 91 H1 H-8 2.8 4.5  54 59 H2 H-2 3.9 weak 
       55 60 HN H-2,H-3 3.8 weak 
       56 90 H H-7 3.7 weak 
       57 90 H H-8 4.1 weak 
       58 90 H1 H-4 3.6 weak 
       59 90 H11 H-7 4.2 weak 
       60 90 H2 H-4 3.8 weak 
       61 91 H1 H-2,H-3 3.4 weak 
       62 91 H11 H-7 3.9 weak 
       63 91 H12 H-7 3.7 weak 
       64 82 H H-1a 3.4 uncertain 
       65 99 H H-4 3.7 uncertain 
       66 99 H H-1a 3.4 uncertain 
 
The position and orientation of the ligand is similar in all structures (overlay and individuals 
in Figure 3.4), suggesting that the conformation of the loops does not strongly influence the 
protein-ligand interaction. 33 out of 43 input NOEs were satisfied, resulting in a well-




Figure 3.4: NOE-based structures calculated with selected PDB files. The side chains showing 
possible hydrogen bonding to ligand 1 are colored in yellow. The side chains of other residues 
showing intermolecular NOEs to the ligand are colored grey. (A) Overlay of the lowest energy 
(A) 
      
   
   
   
   
    (B) 1D6O (C) 1FKR-14 
(D) 1FKR-16 (E) 1FKS 
(F) 1FKT (G) 2PPN 
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structures of the complex of 1 (in green sticks) with 6 previously determined structures of FKBP12 
(1D6O, 1FKR models 14 and 16, 1FKS, 1FKT and 2PPN) as determined by intermolecular NOE 
restraints. The RMSD of all ligand atoms relative to the mean is 1.1 ± 0.4 Å. Each individual 




However, some large violations of NOEs remain (Table 3.1 and Figure 3.5). The NOEs 
indicate 1 has contacts with residues located in site 1. The ligand interacts with the 
hydrophobic pocket formed by F36, F46, V55, I56, W59, I90, I91 and F99. The violations 
could be due to the motion of the flexible loop at residues 50-56 and 78-95 which are on 
opposite sides of the hydrophobic pocket.
163,168,171–173 
As no single ligand orientation can 
satisfy all the restraints, it is possible that the dynamic behavior of the protein gives rise to 
time-averaged NOEs. Consistent with this idea, the backbone
163
 and side chains
173
 of 
FKBP12 were also shown previously to undergo chemical exchange on the s-ms timescale. 
Alternatively, it is also possible that multiple ligand orientations are present. Therefore, the 
NOE structure presented here is only an approximation of the actual ligand binding mode. 
Analysis of the structures indicates possible hydrogen bonds present between (1) the ligand 
hydroxyl and Y82-hydroxyl, (2) the ligand hydroxyl and D37-Oand (3) the ligand nitrogen 
and Y82-hydroxyl. Previous studies have suggested that the side chains of  D37
20,25
  and 
Y82
15
 are involved in hydrogen bonding with rapamycin and FK-506, two high affinity 
ligands of FKBP12. Our NOE-based structure model shares a similar hydrogen bonding 
framework with the previous studies. 
 
Figure 3.5: Correlation of experimental 
and back-calculated distances from 
NOE. Red symbols, restraints from 
rigid residues; black symbols, restraints 
from flexible residues. Horizontal error 
bars represent ±1 Å. Vertical error bars 
represent 1× standard deviation for the 
calculated structures. Horizontal dashed 



































We have successfully determined the binding pose of ligand 1 bound to FKBP12 by 
intermolecular NOE restraints. Not all NOEs were satisfied in the final structure, indicating a 
certain extent of dynamics. Nevertheless, the final structure is convergent among different 
PDB structures and all the NOE crosspeaks indicate that ligand 1 binds at site 1. This final 
structure is used in Chapter 4 as a reference for an orthogonal comparison for the PCS-






Determining the three dimensional structure of a small molecule-protein complex with weak 
affinity can be a significant challenge. We present a paramagnetic NMR method to 
determine intermolecular structure restraints based on pseudocontact shifts (PCSs). Since the 
ligand must be in fast exchange between free and bound state and the fraction bound can be 
as low as a few percent, the method is ideal for ligands with high micromolar to millimolar 
dissociation constants. Paramagnetic tags are attached, one at a time, in a well-defined way 
via two arms at several sites on the protein surface. The ligand PCSs were measured from 
simple 1D 
1
H spectra and used as docking restraints. An independent confirmation of the 
complex structure was carried out using intermolecular NOEs (Chapter 3). The results show 
that structures derived from these two approaches are similar. The best results are obtained if 
the magnetic susceptibility tensors of the tags are known, but it is demonstrated that with 
two-armed probes, magnetic susceptibility tensor can be predicted with sufficient accuracy 
to provide a low-resolution model of the ligand orientation and the location of the binding 
site in the absence of isotope labeled protein. This approach can facilitate fragment-based 
drug discovery in obtaining structural information on the initial fragment hits. 
 
This work has been published as part of 
 
J.-Y. Guan, P. H. J. Keizers, W.-M. Liu, F. Löhr, E. Heeneman, S. P. Skinner, H. Schwalbe, 
M. Ubbink and G. Siegal. Small molecule binding sites on proteins established by 
paramagnetic NMR spectroscopy.  J. Am. Chem. Soc., 2013, 135 (15), pp 5859–5868 
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The availability of three dimensional (3D) structures of protein-ligand complexes 
significantly improves the efficiency of refining hits towards leads in the early stages of drug 
discovery.
174
 Typically, structure-driven hit optimization programs rely on crystallographic 
data. In fragment-based drug discovery (FBDD), however, weakly binding ligands 
(fragments) are often not observed in crystals, for a variety of reasons. NMR spectroscopy is 
a powerful alternative for deriving structural information, particular for weakly interacting 
complexes. The classical NMR approach is based on the observation of intermolecular 
NOEs and is suitable for most proteins smaller than 40 kDa. Although robust, the method 
can be time consuming and requires uniformly isotopically labeled protein. The method is 
strictly limited to proteins that can be functionally expressed under these conditions. 
Selective isotope labeling schemes have been employed in combination with deuteration to 
enable NMR analysis of much larger proteins. Complexation-induced chemical shift 
perturbation (CSP) data have been used as ambiguous interaction constraints to calculate 
structures of protein–ligand complexes.
175
 However, this method monitors both direct and 
remote effects, and therefore the .binding site is not always well defined. We sought a 
method that could in principle be applied to proteins where no, or only limited, isotope 
labeling can be performed. 
Paramagnetic NMR is known to be a powerful tool to study biological systems due to its 
versatile effects, including pseudocontact shifts (PCSs), paramagnetic relaxation 
enhancement (PRE) and residual dipolar coupling (RDC).
89–91
 Paramagnetic NMR has been 
applied extensively to characterize protein-protein interactions, but very little in protein-
small molecule interactions. Pioneer studies used the PRE caused by a paramagnetic metal 
ion
95
 or spin label
92,93




A combination of PCS and RDC was applied to assist structure determination of a 
carbohydrate-protein complex where the paramagnetic center was introduced by creating a 
fusion protein with a C-terminal lanthanide-binding peptide tag (LBT).
96
 PRE assisted ligand 
docking with a spin-labeled peptide bound specifically to a protein was also reported.
98
 
Recently, paramagnetic effects stemming from a two-point anchored N-terminal LBT were 
used to determine the structure of protein-peptide complexes.
99
 PCSs have also been applied 
to determine the structure of a small molecule ligand in rapid exchange with a protein in 
which a lanthanide was bound in a natural metal binding site.
97
 In this study the ligand 
bound very closely to the lanthanide, enabling the use of large ligand-to-protein ratios. This 
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latter example is the only case where PCSs have been used to elucidate the structure of a 
protein-ligand complexes containing a small fragment (Mw <300 Da).  
We demonstrate here an alternative way to determine the location and orientation of a 
weakly bound fragment with PCS restraints from a ligand in rapid exchange with a protein. 
A rigid, double-armed lanthanide-binding tag, CLaNP-5,
144,176
 was attached at three different 
sites, one at a time, on the protein surface via disulfide bond linkage. Using this tag, the 
magnitude and orientation of the -tensors can be predicted. Further, the paramagnetic 
effects can be tuned by using different lanthanides in the tag. We selected a 12 kDa FK-506 
binding protein (FKBP12) as a model protein to investigate the potential of the methodology. 
FKBP12 is a peptidyl-prolyl isomerase which belongs to the family of immunophilins and is 
a drug target for the immuno-suppressants rapamycin and FK506. There have been many 
structural studies on this protein.
9,10,15,20,162,163
 The ligand in this study is a fragment that was 
identified as a hit against FKBP12 from a screen of a fragment library using Target-
Immobilized NMR Screening (TINS).
84
 In this work, we compare the PCS-based docking 
result with the structure determined by intermolecular NOEs (Chapter 3). The structure 
calculations were performed using parameters from both predicted and experimentally 
determined paramagnetic -tensors. The result shows that, even without resonance 
assignments of the protein, it is possible to determine the ligand binding site and 
approximate orientation. The method can assist lead optimization in fragment-based drug 
discovery when high resolution structural information is not available. 
4.2 Materials and Methods 
Ligand preparation 
Assignments and preparation of the ligand 1 (Figure 3.1A) was carried out as described in 
Chapter 3. 
Protein expression and purification 
Uniformly 
15
N-labeled FKBP12 double cysteine mutants (K34C/K35C, K44C/K47C, 
C22V/E61C/Q65C), all of which contain an additional LEHHHHHH tag at the C-terminus 
were purified from Escherichia coli strain BL21(DE3) containing the overexpression 
plasmid pET20b with FKBP12 insert. The expression and purification are described in 
Chapters 2 and 3. The yield was in general 15-23 mgL
-1 





The details of CLaNP-5 attachment to FKBP12 variants are described in Chapter 2. 
NMR measurements 
All protein NMR samples contained 15 mM Tris-HCl, 25 mM NaCl, pH 7.7, 6% D2O for 
15
N-labeled protein and >95% D2O for non-isotope-labeled protein. The concentration of 
Ln
3+
-CLaNP-5 attached FKBP12 was 17 to 39 M. The ligand to protein ratios were 1.3:1 
for all Ln
3+






N]-HSQC spectra were 
recorded at 290 K on a Bruker Avance DMX-600 spectrometer equipped with a TCI-Z-
GRAD cryoprobe. 1D-
1
H spectra of the complex CLaNP5-FKBP12 and ligand 1 were 
recorded with a spectral width of 16 ppm and 6 k complex points, resulting in a digital 
resolution of 1.56 Hz before zero filling. Carr–Purcell–Meiboom–Gill (CPMG) pulse 
sequence was used with a total echo time of 60 ms comprising 60 pulses, for suppression of 




Magnetic susceptibility tensor optimization and PCS-based structure calculations 
PCSs are defined as the difference in ppm between the corresponding resonance in the 
paramagnetic sample and the diamagnetic sample. The PCS gives information on the 
distance and angle between a nucleus and the paramagnetic center according to Equation 
1.3.
113
 Errors were calculated by randomly excluding 10% of the data with Monte Carlo 
analysis implemented in Numbat.
177
 
The fits of observed versus back-calculated protein PCSs and docking were performed in the 
XPLOR-NIH
178
 program containing the PARArestraints module.
179
 The predictions of the 
initial -tensor positions and orientations were carried out as previously described.
144
 The 
structure model, parameter and topology files of the ligand were generated from PRODRG 
server.
153
 Bound ligand PCS values were used as the experimental restraints for PCS docking. 
PCSs of ligand methyl protons were used for methyl carbon positions instead of methyl 
proton positions. The protein backbone atoms and the pseudo-residues defining the metal 
coordinates were fixed in the docking process. The three datasets of the different tag 
positions on FKBP12 were used simultaneously. Ligand PCSs from all three tagging sites 
were used in the docking procedure with equal weighting. Each docking calculation 
comprised 100 steps, started with restrained rigid body docking for 20 steps (0.01 pico-
seconds increments, 300 increment evaluations/step). The lowest energy structure was 
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subsequently subjected to restrained Langevin dynamics for 80 steps (0.001 pico-seconds 
increments, 2000 increment evaluations/step), which allowed the ligand and the residues 
within 8 Å from the ligand to be flexible. 200 independent docking calculations were 
performed using the solution structure of FKBP12 (PDB entry 1FKR, model 14)
9
 and the 
predicted -tensor parameters and position of the lanthanide ion. The same calculations 
with experimentally determined -tensor parameters and positions were performed for 
comparison. The agreement between the experimental PCSs and back-calculated PCSs was 





















                                           ( 4.1) 
 where expiPCS  and 
calc
iPCS are the observed and calculated PCSs. The XPLOR-NIH script 
is available in Appendix B. 
PCSdock prediction 
The PDB structure containing all three -tensors (calculated or predicted) was imported 
into PCSdock using Scientific Python.
181
 Ligand PCS data were imported, along with the 
axial and rhombic magnitudes of the -tensors. A cubic grid of user-defined size (30 Å was 
used) and 1 Å spacing was placed around the protein using the centre of mass as its origin. 
Predicted PCS values for the points on the grid were calculated for each paramagnetic -
tensor. The experimental ligand PCS values for an atom j were then compared to the 




























                                      (4.2) 
where N is the number of paramagnetic -tensors, predkiPCS ,  is the PCS calculated for the 
grid point i relative to the paramagnetic -tensors k, expkjPCS ,  is the experimental PCS used 
for the atom j relative to the paramagnetic -tensors k. If the Qi,j for any atom of the ligand 
was lower than a user-defined level, the grid point i was accepted. If the Qi,j was larger for 
all atoms of the ligand, that grid point was discarded. The PCSdock script is kindly provided 





Selection of CLaNP-5 tagging sites 
In order to determine the protein-ligand complex, we also utilized paramagnetic NMR and 
generated three FKBP12 mutant proteins tagged with the synthetic lanthanide tag CLaNP-5. 
The lanthanide tag, CLaNP-5, is designed to covalently link to the protein surface via two 
disulfide bridges.
144,176
 Therefore, the presence of surface accessible cysteine pairs is 
essential. Several criteria need to be considered for selecting the mutation sites: (1) The 
cysteines should be far enough from the putative ligand binding site to avoid interference 
with binding, yet close enough to yield appreciable paramagnetic effects; 15-30 Å is a 
reasonable estimation based on the location of the binding site and the total size of FKBP12. 
25 Å is an estimation of the effective range for Yb
3+
-chelated CLaNP-5. In this study, the 
distances between the putative ligand binding site and the three lanthanide tags are in the 
range of 15-25 Å. It is possible to use other lanthanides to adjust the effective range for 
different protein sizes.
117
 (2) The two C atoms from the cysteines should be 6-10 Å apart, 
with their side chains pointing away from the protein surface and roughly in the same 
direction. Cysteines buried inside the protein cannot react with CLaNP-5. The locations of 
cysteine mutation sites (K34C/K35C, K44C/K47C and E61C/Q65C) were selected to satisfy 
the above requirements. As a consequence of the anisotropy of the magnetic susceptibility, 
the ligand PCSs can be close to zero regardless of the distance if the ligand is located close 
to the region in which the PCS changes its sign. Nevertheless, measuring PCSs in this 
situation for a different tag position will provide information. This is one of the advantages 
of synthetic tags compared with the methods using lanthanide-binding peptides
182,183
 or 
metal displacement, in which usually only one tag position is available. 
Ligand PCS measurement 













C]-HMBC spectra (Chapter 3). The binding affinity of the 




N]-HSQC titrations, and was found to be 
1.80 (±0.05) mM. (Chapter 3). To eliminate interference from the protein resonances, 1D-
1
H 
NMR spectra of the ligand in the presence of Ln
3+
-CLaNP-5-FKBP12 were recorded using a 
T2 relaxation delay of 60 ms. Ligand PCSs were measured from singly tagged protein with 
Yb
3+
-CLaNP-5 in the paramagnetic sample and Lu
3+
-CLaNP-5 in the diamagnetic sample. In 
total, 3 different pairs of protein samples, each containing the CLaNP-5 attached at a 
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different site, were used. Initially 1 was titrated into Yb
3+
-CLaNP-5-FKBP12 to determine 
the optimal molar ratio of protein to ligand. The ligand and protein concentrations were 36 
and 28 M (34C/35C), 24 and 17 M (44C/47C), and 47 and 39 M (61C/65C). Under these 
conditions 0.9-1.9 % of the ligand is bound. A protein to ligand ratio 1:1.3 was used for all 




-CLaNP-5, because this ratio represented 
the best compromise between size of the PCSs, the line broadening and spectral resolution. 
Figure 4.1 shows the spectra from which the ligand PCSs were determined for the 34C/35C 





















Figure 4.1: (A) Overlay of 1D-
1
H NMR spectra of ligand 1 in the presence of 28 M FKBP12 
(34C/35C) attached to paramagnetic Yb
3+
-CLaNP-5 with increasing ligand/protein molar ratios, 
which are indicated in the spectra. Proton assignments of 1 are indicated by corresponding numbers 
on the structure. The chemical shift of proton 4 overlapped with the water resonance and is not 
shown here. The resonances of the methyl groups numbered 2 and 3 are degenerate in the free form 
but are resolvable in the bound form. (B) The observed ligand PCS is the difference between the 
resonance positions for the paramagnetic (Yb
3+
) and diamagnetic (Lu
3+
) samples. The dashed and 
solid lines indicate the positions of the diamagnetic and paramagnetic ligand resonances, respectively. 





The observed ligand PCS values are small (less than 10 Hz) due to the small fraction of 
bound ligand (1.5%). However, they can be measured precisely because of the sharp signals 
of the ligand.  The PCSs are summarized in Figure 4.2. A control measurement of the ligand 
in the presence of the free probe in the absence of protein showed no paramagnetic effects 
(data not shown). This indicates that the observed ligand PCSs derive exclusively from the 
bound state of the ligand. A total of 21 PCS values were obtained from the three pairs of 
para- and diamagnetic spectra. 
 
 
Figure 4.2: Observed 
1
H PCS values (in Hz, for spectra acquired at 600 MHz) of ligand 1 from three 
different locations of the paramagnetic center. The relative positions of the paramagnetic centers are 
indicated and the associated PCS values are color coded. Blue, PCSs from 34C/35C; black, PCSs 
from 44C/47C; red, PCSs from 61C/65C. 
 
PCS-based structure calculation with predicted -tensors 
For ligands in fast-exchange on the NMR time-scale (i.e.  < koff), the observed PCSs are 
weighted averages of the free and bound states. Therefore, the PCS values for the bound 
state can be derived if the fraction of ligand bound is known. Using the known concentration 
of ligand and protein, as well as the experimentally determined KD, the observed PCSs were 
converted to the PCSs in the bound state (Table 4.1). 
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Table 4.1: Ligand pseudocontact shifts converted to 100% bound (ppm) according to calculated 
bound fractions (indicated at bottom of the table). The observed values are given in Figure 4.2. 
Uncertainties (parentheses) are estimated as ± 2× standard deviation of the positions of the para- and 
diamagnetic resonances based on the following formulae: 22
diapara    
Spin K34C/K35C K44C/K47C C22V/E61C/Q65C 
H-1 -0.28 (0.06) 0.23 (0.08) 0.32 (0.04) 
H-2 -0.29 (0.02) 0.40 (0.02) 0.31 (0.06) 
H-3 -0.33 (0.02) 0.40 (0.02) 0.26 (0.04) 
H-5 -0.63 (0.12) 0.42 (0.18) 0.11 (0.10) 
H-6 -1.04 (0.38) 0.16 (0.34) 0.13 (0.18) 
H-7 -0.77 (0.24) 0.07 (0.32) 0.14 (0.18) 
H-8 -0.34 (0.12) 0.17 (0.13) 0.14 (0.01) 
[Protein] (M) 28 17 39 
[Ligand] (M) 36 24 47 
Bound fraction (%) 1.5 0.9 1.9 
 
Previous work in which CLaNP-5 was bound to a rigid protein suggested that lanthanide 
position and the -tensor orientation can be predicted using a simple set of rules.
144
 This 
characteristic is important for proteins that cannot be isotopically labeled, so we first 
determined the structure of the complex of 1 bound to FKBP12 using the predicted -
tensor orientations. As with the NOE-based structure determination, several structures of 
FKBP12 from the PDB were used as input. PDB file 1FKR model 14 is shown as an 
example. In the docking procedure, the ligand was allowed to move, and the protein was 
fixed, except for side chains within 8 Å of the ligand, which were allowed to rotate. The 
complex formed by FKBP12 and ligand 1 was energy minimized guided by the energy terms 
for the pseudocontact shifts and Lennard-Jones potential. The five lowest energy structures 
were selected, based on the total energy and overlaid with the structure derived from NOE 
restraints (Figure 4.3). Two orientations are found with low PCS energy, which differ by a 
rotation of ~90 degrees (Figure 4.3, A and B), and the lowest energy cluster (Figure 4.3A) is 
closest to the orientation observed in the NOE structure. The average RMSD relative to the 
NOE structure is 4.7 ± 0.9 Å. In the other orientation, which has on average 10% higher PCS 
energy, the aromatic ring of 1 points outwards from the binding site (RMSD relative to NOE 





Figure 4.3: Best five PCS structures calculated using the predicted -tensors (ligands in 
magenta) superimposed on the averaged NOE structure (ligands in green). Two clusters with 
similar PCS energy are present with the ligand rotated by ~90 degrees. (A) The lowest 
energy cluster has an orientation parallel to the NOE structure. (B) The second cluster has 
the aromatic ring pointing out from the binding site. 
 
By applying the predicted -tensor parameters for PCS-based structure calculations, the 
approximate location of the ligand binding site could be established. Both clusters of 
calculated orientations showed good agreement between the predicted and experimental 
ligand PCSs (Figure 4.4, A and B), as indicated by the quality factor (equation 4.1). This 
suggests that, using CLaNP-5 with predicted -tensorparameters, it is possible to detect 
the ligand binding site and obtain a low resolution structure for further ligand optimization. 
For this approach, prediction of the -tensor position and orientation does not require any 
PCSs or other NMR data on the protein, although the 3D structure of the protein is required.  
-Tensor calculations 
PCS values depend on the position of the nuclear spin relative to the magnetic susceptibility 
anisotropy tensor of the lanthanide ion, as described by equation 1.3. The -tensors are 
defined by eight parameters (the axial and rhombic components, the x, y, z coordinates of the 
metal, and the orientation of the -tensor relative to the molecular frame, defined as three 
Euler anglesTherefore, they can be determined from a minimum of eight PCSs measured 
from the nuclear spins with known resonance assignment. The PCS values of protein amide 









N]-HSQC assignments of the wild type 
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Figure 4.4: Correlation between experimental and back-calculated ligand PCSs for the top five 
structures of 1 bound to FKBP12 as determined from predicted and experimentally determined -
tensor positions. (A) Correlation of the best structures obtained with predicted -tensors, lowest 
energy cluster, as shown in Figure 5A and (B) second lowest energy cluster, as shown in Figure 5B. 
(C) Best five structures with experimentally determined -tensors. (D) Back-calculated ligand PCS 
values for NOE-based structures using predicted -tensor positions. (E) Back-calculated ligand PCS 
values for NOE-based structures using experimentally determined -tensor positions. Vertical error 
bars represent 2× standard deviation of the variation in the sets of structures for the back-calculated 
PCSs. Horizontal error bars represent the estimated experimental error. 
 
Although there are ambiguous assignments in the spectra of the mutants, more than 70% of 
the residues could readily be assigned and therefore the -tensor magnitude and orientation 
could be determined for each of the three mutants. The calculated parameters are 





spectra of the three mutants and the correlations between the experimental and back-
calculated protein PCSs are shown in Figure 4.5. Compared with FKBP12 variants 
K34C/K35C and K44C/K47C, C22V/E61C/Q65C exhibits somewhat smaller tensor 
magnitudes (Table 4.2) and a slightly poorer fit (Figure 4.5), which is an indication that the 




the values of the axial and rhombic components from three tagging sites are comparable to 
previously reported values,
144,184–188
 and therefore the values for C22V/E61C/Q65C were 
considered reasonable.   
 
Table 4.2: -Tensor parameters of Yb
3+




PCS-based structure calculation with experimentally determined -tensors 
The docking of ligand 1 to FKBP12 was repeated using the experimentally determined 
tensor orientations. The orientations of the best five structures form a single cluster that is 
close to the NOE-derived structure (Figure 4.6). The correlation of experimental and back-
calculated ligand PCSs is presented in Figure 4.4C. The average RMSD between the cluster 
members is 1.6 ± 0.5 Å and to the averaged NOE structure 2.8 ± 0.4 Å. With the 
experimental -tensor parameters, the quality factor has slightly increased to 0.117. Given 
the error estimates shown in Figure 4.4, we conclude that the calculated structures fit the 
data and that the differences of the Q values between the clusters derived from the predicted 
and experimental -tensors are not significant. The position of the ligand found with the 
optimized -tensors is closer to the NOE-based position, suggesting that the optimization 
increases the accuracy of the solution. The PCSs were also back-calculated from the NOE-
based structures, using both the predicted -tensors (Figure 4.4D) and the experimentally 
determined -tensors (Figure 4.4E). It is clear that the NOE-derived ligand position fits the 
PCS data worse than the calculated position, indicating that the two positions differ 
significantly from the experimental point of view. The NOE-based structure is used here as 
the standard for validation of the PCS based structure, but, as mentioned in Chapter 3, the 
NOE-based solution is also an approximation due to the dynamics in the binding site. 










) 3.4 ± 0.4 3.3 ± 0.3 2.7 ± 0.2 
Q (eqn. 4.1) 0.023 0.021 0.035 
Restraints 75 73 72 
a)
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N]-HSQC overlay of CLaNP5 attached FKBP-12 mutants with Yb (red) and 
Lu (black). Solid lines show examples of PCS from selected corresponding residues. (Right) 
Correlation between experimental PCS and back-calculated PCS from FKBP-12 mutants attached to 




Figure 4.6: Superposition of the 
averaged NOE structure (in green) of 
the FKBP12-1 complex and the best 
five structures (in orange) calculated 
using ligand PCSs and the three 
experimentally determined -tensors. 
The protein backbone is represented 
as a grey ribbon except for the 
residues D37 and Y82 (in yellow). 
The average RMSD of the ligand 
from PCS calculations relative to the NOE calculation is 2.8 ± 0.4 Å. 
A ‘ghost’ site found by PCS due to degeneracy of -tensors 
A commonly encountered problem in paramagnetic NMR is the observation of multiple 
structure solutions due to the degeneracy of -tensor frames.
189–191
 Here, we encountered a 
similar situation. In the calculations, another cluster of ligands was found at a site entirely 
different from the one shown in Figure 4.6 and which was neither identified by any 
intermolecular NOE, nor reported in the literature. Using the predicted -tensor parameters, 
this position was not identified. The position is located near a loop consisting of amino acids 
S39 to F46, opposite to the binding site mentioned above (Figure 4.7). At this ‘ghost’ site, 
the ligand has no van der Waal’s contacts with the protein and is exposed on the protein 
surface and therefore it does not appear to be physically realistic. This non-physical position 
is apparently an artifact which originates from the degenerate nature of the -tensors. By 
removing solutions that have zero van der Waal’s energy, it is possible to eliminate this 
artifact. 
Figure 4.7: Second ligand position is defined by 
experimentally determined tensors. The two 
clusters calculated using the experimentally 
determined tensors are shown in orange and the 
averaged NOE position is shown in green. The 
metal positions and tensor orientations are 
shown in sticks, with the z-axis in cyan. 
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In order to visualize the degeneracy in a set of three tags, a script named PCSdock was 
written to produce a grid around the protein and calculate the PCS values of the pre-defined 
tags for each grid point. The algorithm then compares the experimental PCSs with the three 
calculated ones and calculates a Q value (equation 4.2). If the Q value for any atom of the 
ligand is below a threshold, that grid point is selected, otherwise it is discarded. Thus, 
PCSdock gives a fast, though crude, representation of where the ligand could be located on 
the basis of the PCSs. While the procedure is likely to overestimate the number of possible 
locations, it can be a useful tool for establishing degeneracy. Applied to FKBP12 with the 
three tags and the experimentally observed PCSs, the calculation clearly shows two possible, 
spatially distinct areas (Figure 4.8A). Each of the two low energy clusters from the 
calculation using experimentally determined -tensors fits into one of the areas defined by 
the PCSdock calculation. Interestingly, this ‘ghost’ site was not found when calculated using 
the predicted -tensors (Figure 4.8B). 
 
 
Figure 4.8: Grid points produced by PCSdock (Q = 0.15). The metal positions are shown in spheres 
(magenta, predicted positions; orange, experimentally determined positions), and -tensor 
orientations are shown in sticks, with the z-axis in cyan. Ligands in green are the NOE-based position. 
(A) The two ligands in orange show the two locations determined by the experimental -tensors. 
Two clusters were determined by PCSdock (orange dots): one close to the actual binding site, the 
other at the ‘ghost’ position. Distances between the metal positions determined by pure prediction 
and by experimental PCS are indicated. (B) Ligand in magenta shows the position determined using 






We have demonstrated a general method to obtain structural information on complexes of 
weakly binding, small molecule ligands and proteins. The method seems most applicable to 
proteins that cannot be isotopically labeled, for which X-ray crystallography fails and for 
which many ligands need characterization. Although powerful, the method has certain 
limitations. On the target side, proteins with many surface-exposed cysteine residues are not 
appropriate as it would be quite challenging to attach the CLaNP-5 tag at one unique 
position. There are also restrictions on the ligands such that those with symmetric structures, 
with many scalar couplings or that exhibit intermediate exchange on the NMR time scale can 
cause difficulties in analyzing the data. Ligands that have symmetric structures tend to show 
degeneracy in NMR spectra, resulting in a reduced number of restraints that are themselves 
degenerate. Ligands with many scalar couplings, such as a saturated hydrocarbon ring, have 
1
H spectra that can be difficult to resolve and the PCSs may be difficult or impossible to 
measure. Similarly, ligands in intermediate-exchange are difficult to study in NMR due to 
NMR line broadening leading to resonance overlap or less visible resonances. It should be 
noted that such ligands will present a challenge to any paramagnetic NMR approach, not just 
those based on the use of a lanthanide tag. 
If the goal is to precisely define the binding site of the ligand on the protein, it is essential to 
obtain a sufficient number of meaningful restraints. Due to their small volume, fragments 
can only generate restraints covering a limited part of -tensor space, easily leading to 
degenerate solutions. We addressed this issue by attaching CLaNP-5 at several sites 
throughout the protein surface. Three tag positions were used to generate a total of 21 PCS 
restraints for structure calculations. It is also possible to use CLaNP-5 with different 
lanthanides at a single tagging site, an approach used in previous studies for which multiple 
-tensor positions were not available.
97,99
 However, the tensor orientations of different 
lanthanides are similar in the same tag, so the PCSs merely scale with the magnitude of the 
anisotropy, reducing the information content of the extra restraints. In this case, a combined 
application of CLaNP-5 and CLaNP-7
188
 would be possible using the same tag position, 
because the -tensor orientations differ between these two CLaNP molecules. We expected 
that the three tagging sites would lead to a unique solution for the binding site. Unfortunately, 
degeneracy remained, leading to a physically unrealistic binding site in addition to the 
correct site. While the relevant site could be readily distinguished from the irrelevant one, 
some caution must nevertheless be exercised when interpreting the results. The presence of 
Structure determination of a protein-ligand complex by paramagnetic NMR 
66 
this ‘ghost’ site suggests that, depending on the actual situation, more than three mutants 
might be required to fully break all degeneracy. Additionally, it is important to consider the 
(potential) dynamic behavior of sites within the protein when selecting positions to generate 
the dual cysteine mutations. Motion of the attachment site within the protein can influence 
both the position of the paramagnetic center and magnitude of the -tensor.
176,185
 For 
example, the large difference between the predicted and experimental position of the 
lanthanide for FKBP12 (K34C/K35C) and the orientation of its tensor (Figure 4.4A and 
Figure 4.5) is likely related to its location on an ill-defined protein loop, which makes the 
prediction less reliable and bears the risk that the tag slightly affects the average structure of 
the loop. 
A number of NMR approaches have been proposed to determine the structure of protein-
small molecule complexes. The approach based on intermolecular NOEs, which is robust 
and provides structural detail, is most frequently used. The method emphasizes short-range 
restraints (<5 Å or <8 Å depending on the isotopic labeling scheme) and requires resonance 
assignments of the protein. With the assistance of computational modeling, the NOE method 
can be relatively fast, as demonstrated in the system of matrix metalloproteinases (MMPs) 
and its tight-binding ligands.
192
 A particular limitation of the method is the requirement for 
isotope-labeled protein, typically necessitating expression in E. coli. In contrast, methods 
that exclusively observe the NMR spectrum of the ligand can, in principle, be applied to 
protein derived from nearly any source. Epitope mapping, a method that quantitates the 
amplitude of ligand resonances in a saturation transfer difference spectrum (STD),
76,77
 can 
provide information on how the small molecule binds to the protein. In theory, this 
information could be used for constraining molecular docking efforts. However, significant 
artefacts can be introduced by the inherent differences in transverse relaxation rates of ligand 
resonances. Therefore, the most significant advantage of the paramagnetic methods is that 
structural information relative to a fixed point on the protein can be reliably obtained from 
the ligand spectra. Previous paramagnetic NMR methodologies for determining protein-
ligand structures have been limited to metalloproteins with an intrinsic metal binding site
97
 
or have used a lanthanide tag that can only be placed at the N-terminus of a protein.
99
 In 
contrast, the CLaNP-5 tag can be used on non-metalloproteins and can be placed at a variety 
of sites on the protein, provided they are sufficiently rigid. It should be noted that in our 
hands, the effect of the tag on the stability of the protein is variable. In some cases, but 
certainly not all, the protein more easily precipitates, perhaps due to the partly hydrophobic 




use the most stable ones. The tag is attached via disulphide bridges, which means that the 
probe can be lost. The rate of dissociation is variable (days-weeks), so it is advised to 




Figure 4.9: Sanson-Flamsteed projections of the predicted and experimental tensors. The 
orientations of the experimental tensors were translated to the axes of the Cartesian coordinates for 
an easier comparison with the predicted tensors. Blue, green and red colors represent z, y and x axes. 
The errors in the experimental tensors were calculated by randomly excluding 10% of the data. The 
orientations of the predicted tensors were modeled based on the protein structure. The intervals 
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The principle of the proposed technique is based on determination of the ligand position with 
respect to the paramagnetic -tensor. In order to predict the -tensor positions, the protein 
structure must be available. The results presented in this study have demonstrated that, with 
the predicted -tensor parameters, it is possible to identify the ligand binding site. It is not 
necessary to have protein resonance assignments in order to predict the -tensor position 
and therefore the approach can be applied to proteins that cannot be readily isotopically 
labeled. In principle, the approach can also be applied to proteins for which experimental 
structure information is not available, providing reliable structure prediction methods (such 
as homology modeling
193,194
) are applicable. For drug discovery, the potential binding site 
can be identified, which can accelerate optimization of hits to achieve higher affinity and 
greater biological activity even when the structure of the target is not available. 
4.5 Conclusions 
We have successfully determined the site and orientation of a small molecule ligand binding 
to a protein using ligand PCS and validated the results with an NOE structure. The use of the 
CLaNP-5 tag to induce the paramagnetic effects makes this approach suitable for non-
metalloproteins. The results show that this strategy can identify the ligand binding site better 
than chemical shift perturbations. Comparison of the PCS structures from predicted and 
experimentally determined tensors demonstrates that the predicted tensor positions are 
sufficient for coarse definition of the binding site and it is therefore not necessary to 
experimentally optimize the tensor position. This PCS-based approach can be useful in early 
stages of fragment-based drug discovery to identify binding sites for proteins that are 








Protein complex formation involves an encounter state in which the proteins are associated 
in a non-specific manner and often stabilized by electrostatic interactions between charged 
surface patches. Such patches are thought to bind in many different orientations with similar 
affinity. To obtain experimental evidence for the dynamics in encounter complexes, a model 
was created using the electron transfer protein plastocyanin and short charged peptides. 
Three plastocyanins with distinct surface charge distributions were studied. The 
experimental results from chemical shift perturbations, paramagnetic relaxation 
enhancement (PRE) NMR and theoretical results from Monte Carlo simulations indicate the 
presence of multiple binding orientations that interconvert quickly and are dominated by 
long-range charge interactions. The PRE data also suggest the presence of highly transient 




This chapter is based on: 
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Peptide Complexes Characterized by NMR Spectroscopy. Submitted to ChemBioChem. 
An ensemble of rapidly interconverting orientations 
in electrostatic protein-peptide complexes 





According to the current models, formation of a specific protein complex is preceded by that 
of an encounter complex.
195
 It is believed that in this state the partners assume multiple 
orientations to enhance the probability of finding the specific binding site.
196
 Often, in the 
encounter complex electrostatic interactions dominate whereas the specific (final) state is 
stabilized by various short-range interactions. The assumed presence of multiple orientations 
in the encounter state is based on the theoretical notion of charged surface patches. Like 
velcro,
197
 such patches can bind in many orientations with similar energy and thus all are 
assumed to be populated. The presence of multiple orientations and the dynamic exchange 
between them in the charge-driven encounter state is, however, not easy to demonstrate 
experimentally.  
The aim of this study was to create a pure, charge-driven encounter state, and demonstrate 
the existence of a rapidly exchanging set of binding orientations. We chose to study the 
complex of plastocyanin (Pc) and short charged peptides (Lys4), assuming that the 
interaction would be dominated by the strong positive charges of the peptides. The peptides 
are an artificial binding partner, so plastocyanin will not have an optimized binding site and 
a specific complex is unlikely to be formed. 
Pc is a type-I blue copper protein involved in the electron transport process in oxygenic 
photosynthesis, functioning as an electron carrier between cytochrome f (Cyt f) of the b6f 
complex and P700
+
 of photosystem I (PSI). Structures are available for Pc from various 
plants and bacteria.
36,41–43,45,53,54,198
 The C-terminal histidine that is a copper ligand is the 
electron entrance, located at the so-called ‘northern’ side of the protein, placed in a 
hydrophobic patch. Pc is acidic in higher plants
41,51,53,54,198
 and green algae,
199–201
 possessing 
two highly conserved negatively charged surface regions (acidic patches) formed by amino 
acids at positions 42–44 and 59–61 at the so-called ‘eastern’ side. The typical example of 
Populus nigra Pc (PoPc) is shown in Figure 5.1A. Compared to typical plant Pcs, the 
structure of Pc from the fern Dryopteris crassirhizoma (DPc) conserves the same global 
structure (Figure 5.1B), but a large acidic arc extends to the north side surface near the 
hydrophobic patch, resulting in very distinct electrostatic properties.
43
 In cyanobacteria, Pc 
can also be almost neutral
42,202
 such as Phormidium laminosum
42
 (Figure 5.1C), or basic, 
such as Nostoc sp. PCC 7119.
203–205
  
Charged peptides have proved useful to study interacting sites in proteins and the 
corresponding structural changes in electron transfer proteins, including Pc, Cyt f and Cyt 
c.
44,146,147,206–209
 Experimental evidence showed that positively charged polylysine peptides 
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interact with the clustered acidic residues on Pc and competitively inhibit electron transfer 
from Cyt c or Cyt f to Pc.
147,207
 The resulting competitive inhibition was explained by 
neutralization of charges by the formation of the Pc-peptide complexes.
147
 The experimental 
evidence has also shown that binding of polylysine peptides to Pc can subtly perturb the 
active site geometry and the redox potential.
44,147
 Little information is, however, available on 
the binding interface and the underlying degree of dynamics in the interaction. 
Paramagnetic relaxation enhancement (PRE) NMR spectroscopy has been used as a sensitive 
tool to detect lowly-populated intermediates in biomolecular complexes.
112,121
 The large 
magnetic moment of the unpaired electron from the paramagnetic center causes relaxation of 
a nucleus in the vicinity, and this effect falls off very rapidly, being proportional to the 
inverse sixth power of the distance between the electron and the nucleus. TOAC (2,2,6,6-
tetramethyl-N-oxyl-4-amino-4-carboxylic acid) has been shown to be useful for PRE NMR 
studies of protein-peptide interactions.
143
 One of the advantages of TOAC over side chain 
attached spin labels is that TOAC can be directly incorporated into the peptide backbone in 
automated peptide synthesis. There has been growing interests in using TOAC in peptide-
protein and peptide-nucleic acid interactions and in combination with other physical 
techniques, such as electron paramagnetic resonance (EPR), circular dichroism (CD), 




In this study, the transient complexes formed by tetralysine peptides and three different 
plastocyanins have been studied using chemical shift perturbation (CSP) analysis, PRE NMR, 
ensemble docking and Monte Carlo (MC) simulations. The CSP data corresponded well with 
the electrostatic MC docking calculations, clearly showing that the binding is dominated by 
charge interactions. The PRE data indicated that within the electrostatic ensemble, the 
peptides assume multiple orientations in a dynamic fashion. The PRE data also provide 
evidence for the presence of orientations that are slightly more favored than expected from 
pure electrostatic interactions, perhaps due to transient hydrogen bond formation with TOAC 
or weak hydrophobic interactions. Overall, the experimental and simulation results provide 












and 2Q5B). The surfaces are colored according to the electrostatic potential calculated by the 
program APBS
211
 at an ionic strength of 10 mM, pH 6.5, 300 K to match the experimental 
conditions. The electrostatic potentials are colored and contoured from -8 (intense red) to + 8 
kT/e (intense blue). Hydrophobic residues (A, V, I, L, F, P, Y and M) are colored in green. 
Several relevant residues are labeled. For PhPc (C) two additional acidic residues are labeled 




5.2 Materials and Methods 
Peptide synthesis and preparation 
Fmoc-TOAC-OH was purchased from Iris Biotech (Germany). Synthetic peptides AKKKK, 
KKKKA, TOAC-KKKK (XKKKK) and KKKK-TOAC (KKKKX) were prepared as 
described,
143
 with N-terminal acetylation and C-terminal amidation. Peptides were checked 
on purity using rpHPLC and on integrity using MALDI-TOF mass spectrometry. The 
peptides were dissolved in 10 mM NaPi, pH 6.5. The fraction of paramagnetic peptide was 
checked by EPR and found to be close to 100%. The quantity of trifluoroacetic acid (TFA) 
in the sample was confirmed by 
19
F-NMR with trifluorotoluene as the internal reference. The 
molar ratio of 5:1 for TFA: peptide was used to calculate the peptide concentration. The 
peptides were kindly provided by Dr. Jan Wouter Drijfhout (Leiden University Medical 
Center). Martin van Son (Leiden University) is acknowledged for the EPR measurements. 
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Protein expression and purification    
General procedure: 
15
N-enriched M9 minimal media was prepared as described previously.
212
 For PoPc and 
PhPc, copper was excluded during bacterial growth. For additional 
13
C labeling the minimal 
medium was supplemented with 2 g/L 
13
C-Glucose. Cells were harvested by centrifugation 
and lyzed with a French pressure cell (Stansted Fluid Power Ltd.) in the presence of 1 mg 
lysozyme, 3.75 mg DNase, 1 mM PMSF and ZnCl2 (100 μM for PoPc and DPc, 5 mM for 
PhPc). For PoPc and DPc, an additional 250 μM ZnCl2 was added after passing through the 
French press. Cell debris was removed by centrifugation at 7,000× g for 25 min and 
membranes were removed by ultracentrifugation at 25,000× g for 1 h. All columns used for 
purification were purchased from GE Healthcare Biosciences. PoPc and DPc concentrations 
were determined using the Bradford assay (Bio-Rad) with bovine serum albumin as the 
standard. Pc was considered pure when the protein migrated as a single band on SDS-PAGE. 
PoPc: The PoPc gene from plasmid pETPc
47
 was subcloned to pET28 with an additional 
glycine residue at the N-terminus. 
15
N-labeled PoPc was essentially produced as described
47
 
with the following modification: the protein was expressed in E. coli (Rosetta 2) in M9 
minimal medium. Protein production was induced by adding IPTG to a final of 0.5 mM 
IPTG. Incubation was continued at 16 °C overnight. The protein was purified using 3× 5 mL 
HiTrap-DEAE FF ion-exchange column chromatography in 20 mM sodium phosphate, pH 
7.0. The protein was eluted with a gradient of 0-500 mM NaCl. Fractions containing PoPc 
were concentrated and purified by a Superdex G-75 size exclusion chromatography in 20 
mM sodium phosphate, pH 6.8, 100 mM NaCl. The yield of pure protein was 1.5 mg/L of 
culture for 
15




C-PoPc. Anneloes Blok is 











C-labelled recombinant DPc containing zinc was produced in E. coli 
BL21(DE3) and purified as described before,
46
 with the following modifications: All copper 
salts were replaced by ZnCl2 during purification. The protein was purified using 3× 5 mL 
HiTrap-Q HP ion-exchange column chromatography in 10 mM sodium phosphate, pH 5.8 at 
4 
o
C. The impurities were eluted with a gradient of 0-100 mM NaCl at 4 mL/min and the Pc 
protein was eluted at 100 mM NaCl at 0.5 mL/min. Then, size exclusion chromatography 
with Superdex G-75 was performed in 10 mM sodium phosphate, pH 6.5, 100 mM NaCl. 
The yield of pure protein was 149 mg/L of culture for 
15










N-enriched PhPc was produced without the leader peptide and purified as 
described,
213
 with the following modifications: After cell lysis and ultracentrifugation, the 
supernatant was dialyzed against 0.5 mM ZnCl2, 5 mM Tris-HCl pH 7.5, overnight at 4 
o
C. 




. The yield of pure protein 
was 3.5 mg/L of culture for 
15




All Pcs were concentrated by ultra filtration (Amicon, MW-cutoff 3 kDa). The samples were 
in 10 mM sodium phosphate, pH 6.5, 6% D2O. For peptide titrations, the protein 
concentrations were 200 M for 
15
N-DPc(Zn), 200 M for 
15
N-PhPc(Zn) and 110 M for 
15
N-PoPc(Zn). The samples for fern Pc and poplar Pc backbone assignment consisted of 2.4 




N labeled protein, respectively. Peptide solutions were prepared in 
10 mM sodium phosphate, pH 6.5. All NMR spectra were recorded at 300 K on a Bruker 
AVIII600 spectrometer equipped with a triple-resonance TXI-Z-GRAD cryoprobe, or a 
Bruker 600MHz Avance DRX spectrometer equipped with a 5 mm TCI cryoprobe. Data 
were processed with TopSpin and analyzed in SPARKY. Resonances in the HSQC spectra 
of DPc and PoPc were assigned using a 3D HNCACB experiment. The side chain resonance 
assignments of PoPc were taken from PoPc(Cd).
47
 NMR assignments have been deposited to 
the BMRB, entry codes 19236 (DPc) and 19247 (PoPc), and are available in Appendices D 
and E. 
PRE analysis 







N]-HSQC spectra were recorded. Each paramagnetic peptide was added 
to Pc at a peptide/Pc molar ratio of 0.5 for DPc, and 1 for PoPc and PhPc. Under these 
conditions, the fractions of bound Pc were 14% for DPc, and 35% for PoPc. The diamagnetic 
spectra were recorded by reducing the peptides with 5 equivalents of sodium ascorbate. The 
PREs were determined according to the procedure of Battiste and Wagner.
214
 The intensity 
ratio Ipara/Idia of the Pc resonances in the presence of XKKKK or KKKKX was normalized 
by dividing them by the average value of the ten largest Ipara/Idia values. The scaling factors 
for each Pc-peptide are 0.92, 0.87, 0.93, 1.07, 0.94 and 0.95 for PoPc-KKKKX, PoPc-
XKKKK, DPc-KKKKX, DPc-XKKKK, PhPc-KKKX and PhPc-XKKKK, respectively. The 
PRE ( paraR2 ) values were calculated according to Equation 1.2. The transverse relaxation 
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rates in the diamagnetic sample ( diaR2 ) were calculated from the line width at half height 
obtained from a Lorentzian peak fit in the direct dimension, by using SPARKY.
164
 The 
symbol t denotes the time for transverse relaxation during the pulse sequence (9 ms). 
Calculations of dissociation constants and bound ligand fractions 





spectrum upon titration with the peptide. CSP analysis was carried out as described 
before.
215
 The dissociation constants (KD) for PoPc were determined using a two-parameter 
non-linear regression curve fitting based on a one-site binding model as described 
previously.
166
 The fraction of bound ligand was calculated using the dissociation constant. 
For DPc, resonance overlap was observed for T79/E25 and A23/F12 during the titrations. 
These four residues were excluded from the KD calculation. The peptide:DPc interaction was 
modeled with two independent binding sites (Scheme 5.1). 
 
Here P and L are the free protein and the free peptide, respectively. (PL)1 and (PL)2 are the 
1:1 complexes formed by peptide binding to sites 1 and 2 on DPc, respectively. PLL is the 
protein with two peptides bound. KD1 and KD2 are the dissociation constants for sites 1 and 2, 
respectively. The binding curves were simulated numerically with varying values for KD1, 
KD2 and the  at 100% bound Pc using Microsoft Excel.  
Ensemble docking  
For DPc, PhPc and PoPc the PDB entries 1KDI
43
, 2Q5B and 1TKW model 1
47
 were used, 
respectively. The PREs were converted into distances for structure calculations as described 
previously.
215
 c was taken to be 5.54 ns for DPc, 5.14 ns for PoPc, and 5.93 ns for PhPc, on 
the basis of the HYDRONMR
216
 prediction of the rotational correlation time for each Pc. For 
each peak, R2 was estimated from the width at half-height (∆ν1/2) of a Lorentzian fit in the 
proton dimension by using R2= π∆ν1/2. PRE values were calculated after normalization of the 





fractions (35% for PoPc and 14 % for DPc). Three classes of PRE restraints were included in 
the calculations.
143
 1) For the amides of which the resonances disappear in the paramagnetic 
spectrum, an upper limit for Ipara was estimated from the standard deviation of the noise level 
of the spectrum. The upper bound PRE ( paraR2 ) value was set to 500 s
-1 
and the distance to 9 
Å. 2) For residues with Ipara/Idia >0.85, the lower bound distance was set to 15 Å. 3) For 
residues with Ipara/Idia between 0.1 and 0.85, the distances (r) calculated according to a 
previously described  equation
215
 were used with upper and lower bounds of r ± 0.1 Å. 
Violations were defined as the absolute differences between the calculated distance and the 
experimental distance including the corresponding upper and lower bound margins for the 
three classes. An additional restraint ensures that the TOAC nitroxy oxygen atom and the Pc 
center of mass are at a distance between 10 and 30 Å. The structure calculations were done 
in XPLOR-NIH.
178
 The accessible surface area (ASA) of each amide proton was calculated 
with a Python-based implementation of the Shrake-Rupley algorithm.
217
 
Monte Carlo (MC) simulation 
The peptide coordinates of XKKKK and KKKKX were generated from PRODRG server
153
 
and the conformations were optimized in Swiss PDB-Viewer
218
 to separate the charges as far 
as possible. For DPc, PhPc and PoPc the PDB entries 1KDI
43
, 2Q5B and 1TKW model 1
47
 





 The electrostatic potential was calculated with APBS
211
 for an 
ionic strength of 0.01 M and a temperature of 300 K to match the experimental conditions. 
An ensemble of 2000 peptide orientations, randomly selected from the entire run of 2.2×10
6 
saved structures, was considered for the calculations. The averaged distances were derived 
from the ensemble and compared to the experimental distances. Johannes M. Foerster 
(University of Bayreuth, Germany) is acknowledged for performing the MC simulations. 
5.3 Results  
Backbone assignments 
In order to study the three Pcs with NMR, the proteins were isotopically labeled with 
15
N for 




C for the resonance assignments. To eliminate the 




Zn-substituted Pc was used. For DPc and PoPc, backbone 





proteins. The assignments of Cu(I)-DPc (BMRB code 7370)
46
 and Cu(I)-PoPc (BMRB code 
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4019) were used as the starting points. The data of backbone assignments (H, N, C,C) have 
been deposited to BMRB under the codes 19236 (DPc) and 19247 (PoPc) and are provided 
in Appendices D and E. The assignments of Zn-substituted PhPc were kindly provided by Dr. 
Sandra Scanu (Leiden University). For DPc, the resonance of S92 was not found in the 
spectra. For PoPc, some residues close to N-terminus have double peaks. The double 
resonances exist for I1, D2, V3, S20, I21, S22, P23, G24, E25, K26, I27, V28, K30, M57, 
T69, F70, E71, V72, L74 and G78. Similar observations were described for Cd-PoPc.
47
 The 
double signals have been attributed to partial processing of the N-terminus methionine in the 
bacterial cytoplasm, as these residues are located near the N-terminus in the three-
dimensional structure of the protein.
47
   
Chemical shift perturbations 
To study the interaction of Pc with lysine peptides, four types of peptides were used. For the 
PRE experiment described below, a TOAC residue (X) was introduced at the N or C 
terminus (XKKKK and KKKKX). As controls for the introduction of TOAC, AKKKK and 
KKKKA were also used. First, the interaction of these peptides with the three Pc variants 
was studied using chemical shift perturbation (CSP) analysis. 
Each 
15
N Pc was titrated with the four peptides individually in a low ionic strength buffer (I 




N]-HSQC spectra were acquired at each titration point. For these 
studies TOAC was reduced to eliminate its paramagnetic effects. Addition of the peptides 




N]-HSQC spectra of all Pcs, with maximum observed 
average shifts, |ave| of, 0.07 ppm for PoPc, 0.05 ppm for DPc, and 0.01 ppm for PhPc 
(Figure 5.2). Single, averaged resonances were observed for all amides, indicating fast 
exchange between the free and bound Pc on the NMR time scale. The binding maps, 
obtained by coloring the protein residues according to the size of CSP, show similar patterns 
for different peptides for the same Pc (Figure 5.2 for KKKKX and Figure F1 for the other 
peptides). The similar patterns observed for KKKKX and XKKKK indicate that the CSPs 
are dominated by interaction with the four lysines. The binding maps of AKKKK and 
KKKKA were also similar to those of XKKKK and KKKKX, indicating no significant effect 
of TOAC on the peptide binding (Figure F1). 
In PoPc and DPc, most CSPs occurred around the regions of the acidic patches, in agreement 
with the assumption that the positively charged peptides interact with the acidic residues of 
Pc.
145,147
 The largest CSPs for PoPc occurred for residues D44, S45, D51, I55, and Gln88. 




for residues V3 and E8. E8 is located at the acidic arc of the northern side. Although the 
observed CSPs are very small for PhPc, still similar effects are observed from both TOAC 
peptides (Figure 5.2C). The small perturbations of the copper ligand residues (H37, C84, 
H87 and M92 for PoPc; H37, C87, H90 and M95 for DPc; H39, C89, H92 and M97 for 
PhPc) indicate that the copper site is not the main binding site of the peptides. Similar 
magnitudes of perturbations and binding maps caused by a tetralysine peptide (without an 





Figure 5.2: (A-C) Plots of NMR chemical shift perturbations measured for Pc backbone amides in 
the presence of TOAC-containing peptides. Extrapolated values (to 100% bound) for PoPc and DPc, 
and observed values for PhPc are shown. (D-E) CSPs (extrapolated to 100% bound, bound fractions 
see Table 1) mapped on the protein surfaces from the binding of KKKKX to PoPc (panel D, PDB 
entry 1TKW
47
) and DPc (panel E, PDB entry 1KDI
43
). Color representations: red, ave ≥ 0.04 ppm; 
orange, 0.04 >ave ≥ 0.02 ppm; yellow, 0.02 >ave≥ 0.01 ppm; white,ave < 0.01 ppm; grey, no 
data or overlapping resonances. The binding maps for the other peptides are shown in Figure F1 in 
Appendix F. 
 
Binding constants were obtained by fitting the chemical shift perturbation curves for the 
most affected residues (Figure 5.3, Figures F2 and F3 and Table 5.1). For PhPc, the 
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Figure 5.3: Chemical shift changes 
of selected Pcs resonances as a 
function of increasing [peptide]/[Pc]. 
The dissociation constants of the 
corresponding peptides (Table) were 
obtained by simultaneous fitting to a 
1:1 binding model for PoPc (solid 
lines) and by simulation for 2-site 
binding for DPc. Error bars represent 
± 0.005 ppm. (A) KKKKX with 
PoPc; (B) KKKKX with DPc, strong-
binding residues; (C) KKKKX with 










The binding curves for PoPc fitted well to a single binding site model (Figure 5.3A). 
Interestingly, there are two types of dissociation constants observed in DPc titrations. The 
residues that show stronger binding (lower KD) are clustered on the northern side of DPc 
(Figure 5.2E and Figure F3B). This might be due to the unusual surface charge distribution 
of DPc compared with other plant Pcs. It is possible that there is internal competition 
between the two binding sites for the peptides. Clearly the 1:1 binding model is not 
appropriate to explain the observation. Therefore, a two-site binding model was used to 
obtain the KD values for DPc (Figure 5.3B and C, Figure F2B-F2C, Figure F3C-F3F). For 
most peptides the KD values for the same Pc are similar, indicating that the TOAC caused no 
significant changes in the affinity of the peptides for Pc. Only KKKKX has a somewhat 
lower KD for PoPc than KKKKA, but the difference is within the error margins. 






































































Table 5.1: Dissociation constants of the complexes formed between Pc(Zn) and tetralysine peptides 
and their calculated bound fractions (fr.) at the end point of the titrations. 
Pc 
KKKKA KKKKX AKKKK XKKKK 
KD (M) fr.
 KD (M) fr. KD (M) fr. KD(M) fr. 
PoPc 150±40 0.95 90±30 0.97 110±20 0.97 130±40 0.96 
DPc (strong) 110±20 0.97 110±20 0.97 110±20 0.98 110±20 0.96 
DPc (weak) 300±40 0.91 300±50 0.90 340±40 0.94 300±100 0.94 
 
Paramagnetic relaxation enhancements  
The paramagnetic TOAC was introduced to determine whether the bound peptide possesses 
a single, well-defined orientation or samples several orientations. If the peptide orientation is 
well-defined, the strong distance dependence of the PRE should result in highly localized 
effects. The position of the TOAC molecule was selected at the N- and C-terminal of the 
tetralysine peptide, in order to interfere minimally with binding.
143
 The attached spin labels 
were thus expected to yield PRE of nuclei on nearby Pc residues. If the peptides bind in a 
specific orientation, the N- and C-terminal TOAC should generate different PRE patterns. 
PREs were observed for some residues, as shown in Figure 5.4. Binding of these peptides to 
the three Pcs is in the fast-exchange regime, so the observed PRE is a weighted average of 
free Pc (no PRE) and bound Pc. By dividing the observed PRE by the bound fractions 
calculated from KD, the PRE for 100% bound Pc is obtained. For DPc, the weak-binding KD 
values were used, because most residues showed weak binding. 
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Figure 5.4: PRE effects in Pc-KKKKX complexes. The paramagnetic peptide was added to Pc at a 
peptide/Pc molar ratio of 0.5 for DPc, and 1 for PoPc and PhPc, resulting in fractions of bound Pc of 
14% for DPc and 35% for PoPc. The bound fraction for PhPc is unknown but expected to be very 
small. Left: PRE maps of PoPc (A, PDB entry 1TKW
47
), DPc (B, PDB entry 1KDI
43
) and PhPc (C, 
PDB entry 2Q5B) bound to KKKKX peptide, color-coded on surface models of Pc: red, Ipara/Idia < 0.1; 
orange, 0.1 ≤Ipara/Idia < 0.85; white, Ipara/Idia ≥ 0.85; grey, prolines, unassigned, and overlapping 




N]-HSQC intensities of backbone amide of PoPc (A, including side 
chains which are shown in blue squares), DPc(B) and PhPc(C) in the complex with TOAC-
containing peptides. The dashed horizontal lines indicate Ipara/Idia = 0.85 (orange lines) and 0.1 (red 
lines). The error bars denote 2× standard deviations, derived from spectral noise levels using standard 




For PoPc binding to KKKKX, the residues that were broadened beyond detection were G49, 
E59, and the side chain of Q88. For PoPc binding with XKKKK, an additional residue (E43) 
was completely broadened. These residues are located on the same side as the acidic patches, 
which include E43 and E59. Many residues located around the acidic patch also experience 
PRE in different magnitudes. This observation indicates that the binding site(s) of the 
peptides on Pc is not restricted on the acidic patch residues only, but also extends to other 
polar or charged residues around this region and even to the hydrophobic patch, including 
some positively residues such as K26, K54, K66 (Ipara/Idia ratio 0.6-0.84). This observation 
suggests that the peptides sample a large area of the protein surface, and it demonstrates the 
superior sensitivity of PRE for transient interactions.  
For DPc with KKKKX and XKKKK, three residues disappeared from the spectra: G33, G36 
and E68. Two other acidic residues (E34, D69) are broadened but still visible in the spectra 
(Ipara/Idia ratio 0.59-0.82). These five residues are close together on the acidic arc at the 
northern side of DPc, indicating the cluster of negative charges on the protein attracted the 
peptides by electrostatic interactions.  
For PhPc, only one residue (T75) had a clearly significant PRE (Ipara/Idia ratio 0.5) under the 
experimental conditions (peptide:protein ratio 1:1). The Ipara/Idia ratios of V48, L55, H61 
were and Q63 and 0.84, 0.83, 0.84 and 0.83. These values are close to the defined threshold 
for unaffected residues (Ipara/Idia ratio 0.85). 
The PRE effects of tetralysine peptides on DPc are smaller than on PoPc in general. This is 
due to a smaller bound fraction. The PRE maps of DPc showed much less effects than the 
CSP maps of DPc. The residues with largest CSP are not those with largest PRE, probably 
because CSP monitors the effects from all atoms within the peptides, whereas PRE indicates 
the effects from the paramagnetic center only.  
It is interesting to note that strongly affected residues have unaffected neighbors. One 
example is A73 of PoPc, which is affected by PRE, while the neighboring V72 and L74 are 
not. Similarly, A75 of DPc, located in between the residues with PREs, K74 and K76, 
remains unaffected. Another example is seen for D61 and E62 of DPc, both located on the 
acidic arc. D61 is affected but E62 unaffected. These findings suggest highly localized 
effects and will be discussed in more detail later.  
Ensemble docking  
Visualization of the encounter state on the basis of PRE data can be carried out 
quantitatively using the ensemble docking approach.
112
 Calculations were performed using 1 
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to 15 copies of a pseudoatom that represents the paramagnetic center. The experimental 
PREs were converted into distances for ensemble docking. For DPc, the KD values used here 
are the low affinity ones, as most residues belong to the low-affinity group. The high-affinity 
residues were completely broadened and therefore their target distance ranges is the same 
using either KD values. Violations were defined as the absolute differences between the 
distance back-calculated from the entire ensemble (using r
-6
 averaging) and the experimental 
distance. Figure 5.5 shows the results of ensemble docking for KKKKX binding to PoPc and 
DPc with increasing ensemble size. Large distance violations occurred when using a single 
representation of the paramagnetic center (Figure 5.5, N=1), indicating that multiple 
orientations are required to describe the data. As a result of increasing degrees of freedom, 
the distance violations are reduced with increasingly larger ensembles. For PoPc (Figure 
5.5A), no significant reduction of violation occurred at N≥8. For DPc, the violation curve 
flattened at N=5 (Figure 5.5B).  
 
Figure 5.5: Averaged distance violations against number of paramagnetic pseudoatoms (N=1-
6,8,10,15) in the ensemble docking. (A) KKKKX-PoPc, (B) KKKKX-DPc. The dashed horizontal 
lines indicate the average violations calculated from MC dock. 
 
The resulting ensembles for N=6 are shown in Figure 5.6. Most of the paramagnetic centers 
are located in well-defined positions and not in a ‘cloud’ of orientations. This correlates with 
the observation that some amides of Pc are strongly affected by PRE whereas others that are 
nearby are not. That can be explained by assuming that the paramagnetic center spends a 
short time very close to the affected amide. Most of the affected amides have a considerable 
accessible surface area (ASA), enabling a close contact with the TOAC. In general, no major 





Figure 5.6: Ensemble docking. (A-B) Correlation of experimental distances (black dots) and back-
calculated average distances (green dots with green connecting lines) from the ensemble docking 
(N=6) of KKKKX bound to PoPc (A) and DPc (B). The average distances from the 20 lowest-energy 
solutions of the PRE driven ensemble docking are shown as green circles connected by green lines 
with error bars representing the standard deviation. Right y axes indicate the accessible surface area 
(ASA) of each amide proton, shown in blue dots with blue connecting lines. Grey areas indicate the 
error margins of the experimental distances. (C-D) PRE-based ensemble docking results (N=6) of 
PoPc (C, 396 solutions for KKKKX and 594 for XKKKK) and DPc (D, 630 solutions for KKKKX 
and 360 for XKKKK). The paramagnetic centers from TOAC are shown as spheres, with KKKKX in 
green and XKKKK in blue. Protein surfaces are colored the same as in PRE maps (Figure 5.4). 
 
Monte Carlo simulations 
Previous studies have shown that many encounter complexes are predominantly driven by 
electrostatic forces,
196
 although in some cases short-range hydrophobic interactions may also 
contribute.
220
 Visualization of the encounter complex of Cyt c and Cyt c peroxidase was 
successfully achieved using PRE data and rigid-body MC simulations.
180
  The results 
showed that this encounter complex is driven by electrostatic interactions. In MC 
simulations, one protein is docked to the other, guided by an electrostatic field and MC 




 In this way, charge−charge interactions represent the only force that brings 
together the binding partners. MC simulations were performed for Pc-peptide complex, and 
the Boltzmann distribution of orientations of the peptide in complex with Pc was obtained. 
The paramagnetic centers of the peptides are shown as green (KKKKX) and blue (XKKKK) 
spheres around Pc in Figure 5.7. 
The results for PoPc (Figure 5.7A) and DPc (Figure 5.7B) show that the peptides are located 
close to the acidic patches. For PhPc, the population is more randomly distributed, with a 
relatively higher density at the side of PhPc that is farthest from the hydrophobic patch 
(Figure 5.7C). Johannes M. Foester (University of Bayreuth, Germany) is acknowledged for 
performing the MC simulations. 
 
Figure 5.7: MC dock 
results showing 2000 
solutions of KKKKX and 
XKKKK bound to PoPc 
(A), DPc (B) and PhPc 
(C). The paramagnetic 
centers of the peptides are 
shown as green (KKKKX) 
and blue (XKKKK) 
spheres. Protein surfaces 
are colored according to 
the PRE maps (Figure 
5.4). The 2000 
orientations in each 
ensemble were selected 
randomly for the entire 











The distances from the nitroxy oxygen of the TOAC to the Pc amide hydrogens were 
measured and averaged (using r
-6
 averaging) for the 2000 MC ensemble, and the obtained 
distances were compared with the experimental values. The violations calculated for the MC 
dock ensemble are 2.08, 1.70, 0.68 and 0.56 for PoPc-KKKKX, PoPc-XKKKK, DPc-
KKKKX and DPc-XKKKK, respectively. All violations are in the middle of the range of 
values shown in Figure 5.5 and Figure F5 (A and B). Thus, the MC dock ensemble does not 
fully agree with the PRE data. Figure 5.8 shows the back-calculated average distances for 
each Pc residue in comparison with the PRE derived distances. Although the MC dock 
clearly places the paramagnetic center close to the affected residues, the simulation 
underestimates the PRE for these residues. 
 
Figure 5.8: Comparison of experimental distances (dots) and back-calculated average distances 
(circles with connecting lines) between Pc amides and the 2000 ensembles of peptide paramagnetic 
oxygen atoms from MC simulations. (A) PoPc-KKKKX; (B) DPc-KKKKX. 
 
Figure 5.9 shows the plots of electrostatic energy population distribution for all Pc-KKKKX 
complexes. PoPc (Figure 5.9A) and DPc (Figure 5.9B) have similar patterns. The highest 
population in DPc is at -6 kcal/mol, where as in PoPc is at -7 kcal/mol. For PhPc (Figure 
5.9C), it is clear that electrostatic interaction is much weaker (highest population at -2 
kcal/mol), indicating the electrostatic interaction is much weaker for PhPc. The histograms 
for Pc-XKKKK complexes are shown in Figure F5 in Appendix F. The highest population 
appears at -8, -7 and -2 kcal/mol for PoPc, DPc and PhPc, respectively. 
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Figure 5.9: Histograms showing the electrostatic interaction energy distribution of 2000 structures 
randomly selected from the MC simulations. (A) PoPc-KKKKX, (B) DPc-KKKKX, (C) PhPc-
KKKKX. 
5.4 Discussion 
The aim of the present work was to experimentally characterize the dynamics in encounter 
complexes. The rationale was to create a pure encounter complex by ensuring that 
electrostatics dominate the interactions. For this purpose the complexes formed by charged 
tetralysine peptides and three Pcs with distinct surface charge properties were studied. At pH 
6.5, the net charge of PoPc, DPc and PhPc is -7, -5 and -1, respectively and the charge 
distributions differ markedly between these Pcs.  
Previously, the interaction between the seed plant Silene pratensis Pc and lysine peptides of 
varying lengths was studied using circular dichroism, UV-Vis absorption, resonance Raman 
spectroscopy, and cyclic voltammetry. Minor changes in the geometry of the copper site 
were observed upon peptide binding.
44,147
 The peptides also competitively inhibited electron 
transfer within Pc-Cyt f
207
 and Pc-Cyt c.
147
 Mutagenesis of Pc showed that the interaction 
and electron-transfer inhibition by lysine peptides decreased significantly as the net charge 
of the Pc negative patch decreased,
147
 showing that charge interaction contributed to the 
binding. The authors proposed a specific and effective interaction between the positively 
charged peptides and the negative patches of Pc.
147
 These studies monitored spectroscopic 
changes caused by peptide binding but could not directly observe the binding interface and 
the dynamics of the interaction.  
Electrostatic interactions 
To establish whether electrostatic interactions were the dominating interaction force, the 
interaction surface was mapped using CSPs and compared with electrostatically driven 
docking calculations. In PoPc and DPc, CSPs were largest in the acidic regions. The KD 




In PhPc, peptide binding resulted in very small CSPs, suggesting a low affinity. No 
dissociation constant could be determined. These results are in good agreement with the MC 
simulations. The electrostatic ensembles match well with the CSP-derived binding maps for 
PoPc and DPc. The electrostatic interaction energies indicated that these two Pcs have a 
strong interaction, whereas for PhPc the affinity is quite weak. The data indicate that charge-
driven binding is a good first description of the complexes. 
Paramagnetic relaxation effects 
To determine whether the peptides assume a single, well-defined orientation or sample 
multiple orientations, the paramagnetic amino acid TOAC was incorporated at the N- and C- 
terminus of tetralysine peptides. Control peptides with Ala instead of TOAC were used to 
assess the effect of TOAC incorporation on peptide binding to Pc. No significant difference 
between the binding affinities of TOAC- and Ala- tetralysine peptides was observed, 
indicating that TOAC has little influence on the thermodynamics of peptide binding.  
In PoPc, the presence of TOAC caused PREs mainly in the neighborhood of the acidic 
patches as well as for some of the hydrophobic patch residues. CSPs were almost not 
observed in the hydrophobic patch, which suggests that the PREs for those residues represent 
peptide orientations that are sparsely populated. The PRE is highly sensitive for minor states 
in which the paramagnetic center is brought close to the nucleus. Apparently, transiently 
peptide-protein interactions that are not dominated by electrostatic forces are present. In DPc, 
the area affected by PREs is smaller and more localized than in PoPc. The largest PREs were 
detected around the top of the acidic arc, close to the copper site. The PRE and CSP maps 
are similar in this case. For PhPc, few PREs and CSPs were observed, in accord with the 
weak affinity for tetralysine peptides. 
Dynamics in the complexes 
It is believed that the overall size of the CSP is a measure for the degree of dynamics in a 
protein complex. Large CSPs are caused by a single, well-defined orientation in the complex, 
in which desolvation of the interface and multiple short-range interactions occur. Small 
CSPs indicate averaging of multiple orientations in the encounter state, with minimal 
desolvation. Small CSPs have been observed in several complexes of redox proteins that are 







 and Cyt c-Cyt b5.
225
 In this study, similarly small CSPs were observed in all Pc-
peptide complexes. Small CSP can be caused by a dynamic interaction or simply low affinity, 
Electrostatic protein-peptide complexes characterized by NMR 
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such as a small fraction of bound peptide. In the case of PoPc and DPc, the CSP could be 
extrapolated to 100% on the basis of the KD, demonstrating that the CSP are indeed small for 
the fully bound Pc. For PhPc the CSP were even too small to derive a reliable KD. To 
support the hypothesis that small overall CSP values correlate with dynamic interactions, we 
used PRE mapping. The observed PREs are scattered over the Pc surface, and both for PoPc 
and DPc they cannot be satisfied by a single orientation of the peptides. Furthermore, the N- 
and C-terminal TOAC containing peptides gave very similar PRE maps, which is not to be 
expected for peptides binding in well-defined orientations. Thus, qualitatively the PRE 
results strongly support a dynamic binding model, in which the peptide assumes many 
orientations relative to Pc and interconverts between these orientations faster than the NMR 
timescale defined by the maximum CSP (exchange rate >> 250 s
-1
).  
Back-calculated distances using the ensemble docking approach with multiple orientations 
showed a good correlation with the experimental PREs for ensemble sizes much larger than 
1, which is in line with dynamics within the complex. Also the average distances between 
TOAC and Pc amides of the MC dock ensembles matched the experimental distances 
qualitatively, but not quantitatively; the TOAC molecules were on average not close enough 
to the affected Pc amide groups to explain the observed PREs. This observation could be a 
consequence of the limitations of the docking method, such as the use of an exclusion grid to 
avoid steric hindrance. Alternatively, it could indicate small contributions of interactions 
other than electrostatics, perhaps very transient hydrogen bond formation between the 
exposed amide protons and the oxygen of TOAC. Evidence for the latter explanation comes 
from the PRE pattern. It is remarkable that the NMR resonances of several residues are 
broadened out beyond detection due to a PRE, whereas those of neighboring amides are 
(almost) unaffected. The distance between neighboring amides is about 4 Å, so the PRE ratio 




, where r is the distance between 
the nitroxy radical and the nearest amide proton. It can be shown that at least for some 
amides this must imply that the TOAC nitroxy group gets very close, within several 
Ångström for a short fraction of the time, which suggests that the sensitivity of PRE for 
minor states provides evidence for weak and transient short-range interactions. In 
physiological systems of protein-protein complexes such interactions must occur in the 
encounter complex next to the dominant charge-charge interactions for the complex to 





The binding of tetralysine peptides to Pcs with different surface charge properties has been 
characterized by a combination of CSP, PRE NMR and MC simulations. The high similarity 
of CSP maps for the different peptides used in the study, as well as the small magnitudes of 
CSPs strongly suggests a high degree of dynamics. Also the scattered distribution of PREs 
indicates the presence of multiple orientations. The peculiar distribution of peptide positions 
obtained from ensemble docking with high densities in small areas only qualitatively 
matches the electrostatic docking simulations, suggesting that the PRE approach picks up 
very transient, short-range interactions between the peptide and the protein, in which the 





6 Concluding remarks 
NMR in protein-ligand interactions 
NMR is a powerful tool at various steps of drug discovery and development. From ligand 
screening, hit validation to structural characterization, NMR is commonly used to 
characterize the structure and dynamics of the protein target and the ligand.  
Throughout this work, NMR spectroscopy has been extensively used to study molecular 
interactions. 1D 
1
H-NMR was used in Chapters 2 and 4 in various ways, such as TINS 
(target-immobilized NMR screening) fragment screening, characterizing ligand binding with 
a T2 relaxation filter, as well as paramagnetic pseudocontact shifts (PCSs). Isotope 
filtered/edited NOESY type experiments were used in Chapter 3. Chemical shift perturbation 




N]-HSQC titrations were used in Chapters 3 and 5 to determine 
binding constants of protein-small molecule and protein-peptide complexes. In addition, 
paramagnetic NMR spectroscopy was used to obtain PCS restraints in Chapter 4 (1D 
1
H-




N]-HSQC for protein PCSs) and paramagnetic relaxation 




N]-HSQC). This demonstrated the 
robustness of classical NMR approaches and the never-ending evolution of new NMR 
techniques that complement the conventional NMR approaches in structural studies. 
Similarity and difference between CPMG and PRE: relaxation, and relaxation 
A T2 relaxation filter can be used to filter out the sharp NMR signals of ligands from those of 
macromolecules, such as proteins. The filter can be applied using a Carr-Purcell-Meiboom-
Gill (CPMG) or a spin-lock pulse sequence. When the ligand is bound to the protein, it 
becomes slow-tumbling, and consequently the signal intensity of the ligand is reduced. With 
a reasonable fraction of bound ligand, changes in chemical shifts induced by ligand binding 
can also be observed, if no extensive line-broadening is used in spectra processing. By 
observing the differences in chemical shifts as well as the intensities between the free and 




should be noted that, in contrast to PRE (discussed below), the broadening effect is global on 
the bound ligand, i.e. there is no distance dependence between the bound ligand nuclei and 
the protein nuclei. For molecules with labile protons, the exchange process can also have 
significant broadening effects on the labile protons, but not on the non-labile ones. 
PRE NMR spectroscopy has proved to be a powerful technique for studying transient 
complexes.
120,121
 PRE arises from the unpaired electrons, which have very strong magnetic 
moments. These unpaired electrons may enhance relaxation rates of nearby nuclei because of 
the dipolar interaction between the unpaired electron and the nucleus as well as the fast 
longitudinal relaxation of the electron spin. The paramagnetic center can be an intrinsic 
metal binding site, or an engineered external tag on the protein surface. For synthetic 
peptides, the paramagnetic amino acid TOAC can be incorporated in peptides via a peptide 
bond, making it very convenient in automated peptide synthesis. Like for the NOE, the 
magnitude of PRE is strongly dependent on the distance between the paramagnetic center 
and the observed nucleus (r
-6
). Even lowly populated states which only exist shortly in the 
vicinity of the spin label can be observed. Therefore, similar to NOE in a certain extent, PRE 
is very sensitive to changes in distance. In contrast to NOE (effective range ~5 Å), PRE 
detects long range (10-35 Å) interaction with high sensitivity. Compared with the T2 
relaxation filter which simply removes broad signals based on the molecular size, PRE 
induces resonance broadening depending on the distance.  
Comparison of protein-ligand structures determined by NOE and by PCS 
The experimental data from NOESY experiments can be used as proton-proton distances 
between protein-ligand (intermolecular NOE) and within the protein residues (intramolecular 
NOE). With the use of filtered NOESY experiments, one can be used to distinguish protein-
protein and protein-ligand NOE. In Chapter 3, this strategy was successfully applied to 
determine the ligand binding mode using 43 intermolecular NOE restraints. Given the large 
number of restraints with a nature of short-range interaction, the ligand binding mode can be 
determined with high resolution. Although robust, however, the requirement of nearly 
complete backbone and side chain assignments for the bound protein is time-consuming and 




N-labeled proteins must be produced in relatively 
large quantity compared with the small quantity used in other NMR techniques. This can be 
costly if many ligand bound complexes need to be studied. 
Pseudocontact shifts (PCSs) are one of the most well-known paramagnetic effects. PCSs are 
distance and orientation dependent, and the effect is predictable. Significant PCSs can be 
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measured up to 60 Å away from the paramagnetic center with strong lanthanides, thus being 
an important source of long-range restraints, particularly for large proteins or complexes. In 
Chapter 4, we demonstrated that it is possible to determine the ligand binding site and obtain 
a low-resolution structure using only restraints from simple 1D-
1
H NMR spectra. This 
requires attachment of two-armed paramagnetic lanthanide tags (CLaNP-5) on three 
positions of the protein via disulfide bond linkage, one tag at a time. Besides, the ligand has 
to be in fast exchange on the NMR time scale. The ligand position is determined relative to 
the different paramagnetic tensor frames. Lanthanide positions can be modeled and tensor 
magnitudes (axial and rhombic components) estimated with sufficient accuracy if the protein 
structure is available. In Chapter 4, a low-resolution structure of the ligand binding mode has 
been determined using 21 ligand PCSs from three sets of para- and diamagnetic 1D-
1
H NMR 
spectra. The final structure is similar to the structure derived from NOE restraints (Chapter 
3). The quality of the structure can be improved if the tensor positions are optimized using 
experimental protein PCSs. Nevertheless, the structure information obtained with the 
predicted tensors is sufficient for the early stage of drug discovery. The advantage of this 
approach is that protein isotope labeling and protein backbone assignments are not 
compulsory. Most important are the ligand assignments, which are typically much easier to 
obtain. The resolution can further be improved by increasing the number of restraints. This 
can be achieved by using more than three tagging sites, using a tag with different tensor 
frames (such as CLaNP-7
188







P-NMR spectra (if the ligand has fluorine or phosphorous atoms). Sometimes 
introducing two additional cysteines on the protein can affect the stability and structure of 
the protein. Therefore, it is advised to prepare more mutants than actually needed, and select 
the ones which are least affected by the extra cysteines and by the lanthanide tags. 
Chemical shift perturbation analysis in protein-ligand complexes 
CSP analysis has been frequently used to study protein-protein and protein-ligand 
interactions. The interaction is accompanied by changes in the chemical environment of the 
observed nuclei at the binding interface as well as at a remote region. This information is 
subsequently converted into binding affinities (KD), and used to qualitatively estimate the 
degree of dynamics. CSPs are averaged over all orientations. The absolute size of CSPs has 
also been reported to correlate with the degree of dynamics: smaller chemical shift changes 
indicates higher mobility.
165,222,225,226
 Observation of distant conformational changes 




small molecule (Chapter 3). In Chapter 5, the overall small size of chemical shift 
perturbations strongly suggests that the Pc-tetralysine peptide complexes are highly dynamic. 
Therefore CSP analysis can be used as a tool to study protein-small molecule and protein-
peptide dynamics. Further developments in the quantitative analysis of CSP may be needed 
to draw a clear line between the encounter complex and the specific complex. 
Dynamics in transient protein-peptide complexes 
To study interactions in transient complexes, the traditional NOE method is difficult to apply. 
The sensitivity of PRE to lowly populated states makes it a versatile technique to study 
dynamics in complex formation.
120
 On the spectroscopy side, the interactions can be detected 
by simply acquiring standard HSQC spectra. On the sample preparation side, if the molecule 
(a protein or a ligand) is diamagnetic, an additional attachment step is required to introduce 
the paramagnetic source. It is also possible to replace the metal ion in metalloproteins with a 
suitable ion, to suppress or introduce paramagnetism to the system. In chapter 5, the electron 
transfer protein, plastocyanin (Pc), naturally harbours to a copper ion. In our in vitro study, 
the copper was replaced by a zinc ion to suppress PRE caused by the copper (II). The 
paramagnetic amino acid, TOAC, was attached on the peptide as the source of PRE. PRE 
data represent all orientations of the partners in the complex, including the sparse states. For 
encounter complexes that are mainly driven by long range electrostatic interactions, multiple 
orientations can exist with the same energy, like ‘velcro’.
197
 By comparing CSP and PRE 
maps of the Pc-tetralysine peptide complexes with the results from Monte Carlo (MC) 
simulations, it was found that the results of CSP maps and those of MC simulations were in 
high agreement for Pc from Populus nigra and Dryopteris crassirhizoma, which have many 
negative charges on the protein surface. For complexes with weaker charge complementarity, 
such as tetralysine binding to Pc from Phormidium laminosum, the binding is weak as 
observed in CSP and PRE data. The PRE data provide indisputable evidence that the peptide 
binds in multiple orientations. 
Computational tools for studying molecular interactions 
Modeling the positions of the lanthanide binding tag CLaNP-5 was first introduced in 
pseudoazurin and showed high accuracy.
144
 The modeling approach is simple and can be 
valuable for proteins that cannot be produced with isotope labels. If the secondary structure 
of the tagging site is flexible, fluctuations due to the mobility of the residues should be 
considered. In Chapter 4, the binding mode of the small-molecule ligand bound to FKBP12 
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was calculated relative to the positions of the lanthanides, which were derived from 
modeling and later optimized using experimental data.  
PCSdock (Chapter 4) provides a fast, rough estimate of the ligand binding site based on 
ligand PCSs. This simple procedure uses ligand PCSs as the input restraints, provided the 
tensor parameters and the protein structure are available. The ligand structure and 
assignments are not required. PCSdock simply shows the grid points that satisfy the input 
PCSs, which leads to a grid in which the ligand is likely to bind. 
An ensemble docking approach (Chapter 5) was used to visualize the PRE data of the 
complexes of Pc-charged peptides. For specific complexes, PRE should represent a single 
orientation of the binding partners. For encounter complexes that can exist in multiple 
orientations, interpretation of PRE data using an ensemble of orientations provides better 
visualization than using a single orientation. However, the ensemble docking approach still 
provides limited solutions. As MC simulations consider only electrostatic interactions, the 
results of experimental PRE of complexes that are purely driven by electrostatics are 
expected to correlate well with those of MC simulations. In our study, the results of 
theoretical MC simulations with experimental CSP and PRE analysis on the charged peptide 
and the three Pcs with different surface charge properties provided evidence for dominant 
non-specific electrostatic interactions as well as other transient short-range interactions, such 
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H NMR spectra of FKBP12 ligand titrations 
General description: The proton assignments correspond to the numbers on the ligand 
structures shown in each figure. Signal intensities were scaled non-linearly for ease of 
viewing the shapes of the resonances. Asterisks indicate the protein/buffer/solvent 
resonances. Table A1 summarizes the details of the titration experiments shown in Figures 
A1-A8. 
 
Table A1: Details of the titration experiments in Figures A1-A8.  





Bound [L] at 




A1 1 50 3.0 1.6 20 83 M 
A2 3 50 1.8 2.7 20 41 M 
A3 390 50 2.5 0.8 60 3.6 mM 
A4 429 100 1.0 2.9 60 2.4 mM 
A5 1051 100 1.0 n.d.
a)
 0.5 n.d. 
A6 1104 100 1.0 n.d. 60 n.d. 
A7 1406 100 1.0 n.d. 0.5 n.d. 
A8 1489 100 1.0 n.d. 20 n.d. 
.
a)  











































































































































H NMR spectra of ZB1104 titrated into wt FKBP12. The proton assignments were 

















H NMR spectra of ZB1406 titrated into wt FKBP12. The proton assignments were 























H NMR spectra of ZB1489 titrated into wt FKBP12. This compound showed 








Appendix B:  XPLOR-NIH script for NOE- and PCS-based structure 
calculations 
display $DATE $TIME 
! dock n ligand copies in FKBP12 using NOE restraints (pdb:1FKR14) 
! metal positions and tensor directions placed on PDB of protein 
! mutant 2 = 34-35 Cys 
! mutant 3 = 44-47 Cys 
! mutant 5 = 61-65 Cys, 22 Ala 
 
!-----------------DEFINE USER VARIABLES------------------ 
 eval ($frbound2 = 0.015)   ! fraction ligand bound to mutant 2 
 eval ($frbound3 = 0.009)   ! fraction ligand bound to mutant 3 
 eval ($frbound5 = 0.019)   ! fraction ligand bound to mutant 5 
 eval ($field = 600.13)   ! magnetic field in MHz 
 eval ($MUT2="Y")   ! data for mutant 2 Y/N 
 eval ($MUT3="Y")   ! data for mutant 3 Y/N 
 eval ($MUT5="Y")   ! data for mutant 5 Y/N 
 eval ($metal2="Yb")   ! Ln in mutant 2: Yb or Tm 
 eval ($metal3="Yb")   ! Ln in mutant 3: Yb or Tm 
 eval ($metal5="Yb")   ! Ln in mutant 5: Yb or Tm 
eval ($chaxYbm2=8.7e-32)   ! chi axial in m^3 CLaNP-5 Yb mutant 2 
 eval ($chrhoYbm2=3.4e-32)  ! chi rhombic in m^3 CLaNP-5 Yb mutant 2 
 eval ($chaxYbm3=8.9e-32)   ! chi axial in m^3 CLaNP-5 Yb mutant 3 
 eval ($chrhoYbm3=3.3e-32)  ! chi rhombic in m^3 CLaNP-5 Yb mutant 3 
 eval ($chaxYbm5=7.8e-32)   ! chi axial in m^3 CLaNP-5 Yb mutant 5 
 eval ($chrhoYbm5=2.7e-32)  ! chi rhombic in m^3 CLaNP-5 Yb mutant 5 
 eval ($fres= 2)   ! first residue to be used  
 eval ($lres= 107)   ! last residue to be used 
 eval ($PRF= (1e30*1e6)/(12*3.14159)) ! factor in PCS equation 
 eval ($f01=6.0)   ! force constant xpcs 
 eval ($f02=6.0)   ! force constant xpcs 
 eval ($f03=6.0)   ! force constant xpcs 
 eval ($stdev1=0.04)   ! stdev for PCS 
 eval ($stdev2=0.04)   ! stdev for PCS 
 eval ($stdev3=0.04)   ! stdev for PCS 
 eval ($a20=50)    ! random distance max + 0 A 
 eval ($a20a=360)   ! random rotation max +/-0.5* 
 eval ($a05= 40000)    ! nr cycle 
 eval ($a53= 300)     ! nr of steps 
 eval ($a59= 10)    ! .pdb writing threshold 
 eval ($a55= 300.0)   ! TBATH (temperatuur) 
 eval ($rot_5ring="Y")   ! rorate ligand oxazole ring 
 eval ($intac="N")   ! interactions to BB (Y) or BB + side chain (N) 
 eval ($rigid="N")   ! dynamics mode = rigid (Y) or rigid+langevin" (N) 
 eval ($pcs_r="Y")   ! docking with ligand PCS restraints 
 eval ($noe_r="N")   ! docking with NOE restraints 
 eval ($vdw_r="Y")   ! switch on/off vdw 
 eval ($flex_noe="Y")         ! also docking with NOE from flexible loop 
 eval ($lig_noe=”Y”)          ! include ligand intramolecular (transferred) NOE 
 eval ($attraction_noe = "Y") ! switch on/off attraction noe 
 eval ($pcs_calc="Y")  ! back-calc PCS at end  
 eval ($noe_calc="Y")  ! back-calc NOE distance at end 
 eval ($opttens="N")   ! optimize tensor orienations iteratively 
 eval ($kick=100)    ! # cycles per approach !100 
 eval ($vdwmax=0.2)   ! starting rcon value, scaling of vdW energy  
 eval ($lignr = 1)   ! number of ligand copies to be used 
eval ($genscale = 0.1)  ! general scale for noe  
 eval ($noescale = 0.5)  ! scale real noes 
 eval ($g01 = 20)   ! nr of cycles to get to max vdw in rigid docking 
(should be 2<$g01< $kick) !20 
!------------------------------------------------------------------------ 
!-------------OTHER VARIABLES; DO NOT CHANGE----------------------------- 
!------------------------------------------------------------------------ 
 eval ($vleckaxYbm2=$chaxYbm2/3.77E-35) !chi axial in van Vleck units 
 eval ($vleckrhYbm2=$chrhoYbm2/3.77E-35) !chi rhombic in van Vleck units 
 eval ($vleckaxYbm3=$chaxYbm3/3.77E-35) !chi axial in van Vleck units 
 eval ($vleckrhYbm3=$chrhoYbm3/3.77E-35) !chi rhombic in van Vleck units 
 eval ($vleckaxYbm5=$chaxYbm5/3.77E-35) !chi axial in van Vleck units 
 eval ($vleckrhYbm5=$chrhoYbm5/3.77E-35) !chi rhombic in van Vleck units 
 eval ($a01=1)   !cycle counter 
 eval ($a02=$kick)  !counts cycles after last kick 
 eval ($a02a=1) !counts approach step in which min ener was reached 
 eval ($a02b=1)   !counts cycle number in current approach 
 eval ($c01=0)    !counts number of saved structures 
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 eval ($a58=30.0)    !fbeta, frictinal constant 30.0 
 eval ($a56=1.5)     !velocity factor! 1.5 
 eval ($a48=$cpu*1e4)    !($cpu*1e4) 
 set seed=$a48 end  !generate random number 
 eval ($a54 = 0.01)   !timestep in ps 
 eval ($f1 = 0)   ! van der waals scaling factor 
 eval ($kk2 = $kick/2) 
!--------------------------------------------------------------------------- 
!--------------------- READ STRUCTURE -------------------------------------- 
!--------------------------------------------------------------------------- 
set echo=off end 
set mess=off end 
structure  @1FKR14.opt_lig.h.psf end 
param  @1FKR14.opt_lig.h.par end 
coor  @1FKR14.opt_lig.h.pdb  
set echo=on end 
set mess=on end 
 
 parameter 
        nbonds 
                inhi=0.75 
                ctofnb=5.0 
                ctonnb=4.0 
                repel=0.8 
                rexp=2 
                irex=2 
                rcon=$f1 




    BOND   (segid "drg") (segid "drg") 400. TOKEN 
    ANGLE  (segid "drg") (segid "drg") (segid "drg") 60. TOKEN 




   nonb (name OO) 0.12  9.00     0.12  9.00  
   nonb (name X)       0.0498   2.2272      0.0498   2.2272  
   nonb (name Y)       0.0498   2.2272      0.0498   2.2272  
   nonb (name Z)       0.0498   2.2272      0.0498   2.2272  
  IMPR  OO  X  Z  Y 500.0 0 -54.7356 
 end 
!-----------------------------rotate ligand oxazole ring-------------------------- 
if ($rot_5ring="Y") then 
 vector show (x) (resn DRG and name CAC) 
 eval ($ix=$RESULT) 
 vector show (y) (resn DRG and name CAC) 
 eval ($iy=$RESULT) 
 vector show (z) (resn DRG and name CAC) 
 eval ($iz=$RESULT) 
 vector show (x) (resn DRG and name CAD) 
 eval ($jx=$RESULT) 
 vector show (y) (resn DRG and name CAD) 
 eval ($jy=$RESULT) 
 vector show (z) (resn DRG and name CAD) 
 eval ($jz=$RESULT) 
 
 eval ($kx=$jx-$ix) 
 eval ($ky=$jy-$iy) 
 eval ($kz=$jz-$iz) 
 
 coor rota SELE=(resn DRG and (name CAD or name OAE or name CAF or name HAG 
   or name HAF or name CAK or name NAJ or name CAO or name CAL or name  
   HAL or name HAM or name HAN or name HAR or name HAS or name HAQ))  
      CENT=($jx $jy $jz) axis=($kx $ky $kz) -90.0 end 
end if 
!--------------------------------------------------------------------------- 
!--------------------- DEFINE RESTRAINTS ----------------------------------- 
!--------------------------------------------------------------------------- 
!-----------------DEFINE PCS------------------------ 
    ! ---- mutant 2, pcs in Hz, as observed --- 
 vector do (store1=-2.5) (segid="drg" and name CAL)  
vector do (store1=-3.5) (segid="drg" and name CAO)  
 vector do (store1=-2.5) (segid="drg" and name HAF) 
 vector do (store1=-2.5) (segid="drg" and name HAG) 




 vector do (store1=-6.9) (segid="drg" and name HAA) 
 vector do (store1=-9.4) (segid="drg" and name HAH) 
 vector do (store1=-5.7) (segid="drg" and name HAI) 
     ! ---- mutant 3, pcs in Hz, as observed --- 
 vector do (store2=2.2) (segid="drg" and name CAL)  
vector do (store2=2.2) (segid="drg" and name CAO)  
 vector do (store2=1.3) (segid="drg" and name HAF) 
 vector do (store2=1.3) (segid="drg" and name HAG) 
 vector do (store2=0.9) (segid="drg" and name HAB) 
 vector do (store2=0.4) (segid="drg" and name HAA) 
 vector do (store2=0.9) (segid="drg" and name HAH) 
 vector do (store2=2.3) (segid="drg" and name HAI) 
    ! ---- mutant 5, pcs in Hz, as observed --- 
 vector do (store3=3.5) (segid="drg" and name CAL) 
 vector do (store3=2.9) (segid="drg" and name CAO)  
 vector do (store3=3.7) (segid="drg" and name HAF) 
 vector do (store3=3.7) (segid="drg" and name HAG)  
 vector do (store3=1.6) (segid="drg" and name HAB)  
 vector do (store3=1.5) (segid="drg" and name HAA)  
 vector do (store3=1.5) (segid="drg" and name HAH)  
 vector do (store3=1.3) (segid="drg" and name HAI) 
  
if ($pcs_r="Y") then 
!-----------------DEFINE CONDITIONS MUTANT 2------------------------ 
 xpcs reset end 
 xpcs nres 500 end 
  
 if ($MUT2="Y") then  
  xpcs 
   class 2 
   force $f01 
   if ($metal2="Yb") then  
     coeff $vleckaxYbm2 $vleckrhYbm2 
   elseif ($metal2="Tm") then 
     coeff $vleckaxTm $vleckrhTm 
   end if 
  end 
    
  for $id in ID (store1) 
  loop E 
   vector show elem (store1) (ID $id) 
   eval ($obs=$RESULT/($frbound2*$field)) 
   xpcs 
     assign (atom "tens" 1 OO) 
   (atom "tens" 1 Z)  
   (atom "tens" 1 X) 
   (atom "tens" 1 Y) 
  (ID $id) $obs $stdev1 
   end 
  end loop E 
 end if 
!-----------------DEFINE CONDITIONS MUTANT 3------------------------ 
 
 if ($MUT3="Y") then  
  xpcs 
   class 3 !B 
   force $f02 
   if ($metal3="Yb") then  
     coeff $vleckaxYbm3 $vleckrhYbm3 
   elseif ($metal3="Tm") then 
     coeff $vleckaxTm $vleckrhTm 
   end if 
  end 
   
  for $id in ID (store2) 
  loop A 
   vector show elem (store2) (ID $id) 
   eval ($obs=$RESULT/($frbound3*$field)) 
   xpcs 
     assign (atom "tens" 2 OO) 
  (atom "tens" 2 Z)  
  (atom "tens" 2 X) 
  (atom "tens" 2 Y) 
  (ID $id) $obs $stdev2 
   end 
  end loop A 




!-----------------DEFINE CONDITIONS MUTANT 5------------------------ 
 
 if ($MUT5="Y") then  
  xpcs 
   class 5 !B 
   force $f03 
   if ($metal5="Yb") then  
     coeff $vleckaxYbm5 $vleckrhYbm5 
   elseif ($metal5="Tm") then 
     coeff $vleckaxTm $vleckrhTm 
   end if 
  end 
   
 for $id in ID (store3) 
 loop G 
   vector show elem (store3) (ID $id) 
   eval ($obs=$RESULT/($frbound5*$field)) 
    xpcs 
     assign (atom "tens" 3 OO) 
  (atom "tens" 3 Z)  
  (atom "tens" 3 X) 
  (atom "tens" 3 Y) 
  (ID $id) $obs $stdev3 
   end 
  end loop G 
 end if 
end if 
!-----------------DEFINE REAL NOEs------------------------ 
set echo=off end 
set mess=off end 
if ($noe_r="Y") then 
@noe.xpl 
end if 
set echo=on end 
set mess=on end 
!-----------------DEFINE ATTRACTION NOE------------------------ 
if ($attraction_noe = "Y") then 
noe 
  class      attraction 
  scale      attraction 0.5     !0.3 0.1                       
  sqconstant  attraction $genscale 
  sqexponent  attraction 2 
end 
 
eval ($l1 = 1) 
while ($l1 LE $lignr) loop G1 
  noe 
    assign (segid = "drg" and resi $l1 and name CAD) (name C2 and resn CM2) 13.0 
13.0 5.0 
    assign (segid = "drg" and resi $l1 and name HAT) (segid = "drg" and resi $l1 
and name NAJ) 2.0  1.0  0.1  end 
eval ($l1 = $l1 +1) 





!---------------------DYNAMICS RUN & OUTPUT--------------------------------- 
!--------------------------------------------------------------------------- 
  
 vector show (x) (name C2) 
 eval ($xc2 = $RESULT) 
 vector show (y) (name C2) 
 eval ($yc2 = $RESULT) 
 vector show (z) (name C2) 
 eval ($zc2 = $RESULT) 
 
 while ($a01 LE $a05) loop calc 
 
  eval ($a02 = $a02 + 1) 
  if ($a02 > $kick) then ! -----------put ligand randomly away-------------- 
   coor init end  ! always use the same starting position of ligands 
   coor @@1FKR14.opt_lig.h.pdb 
  if ($rot_5ring="Y") then 
   coor rota SELE=(resn DRG and (name CAD or name OAE or name CAF or name HAG 




   HAL or name HAM or name HAN or name HAR or name HAS or name HAQ))  
      CENT=($jx $jy $jz) axis=($kx $ky $kz) -90.0 end 
  end if 
 
   eval ($l1 = 1) 
   while ($l1 LE $lignr) loop F2 
 
     vector show ave (x)(segid="drg" and resi $l1) 
     eval ($x1 = $RESULT) 
     vector show ave (y)(segid="drg" and resi $l1) 
     eval ($y1 = $RESULT) 
     vector show ave (z)(segid="drg" and resi $l1) 
     eval ($z1 = $RESULT) 
     eval ($xr1 = $xc2 - $x1) 
     eval ($yr1 = $yc2 - $y1)  ! move ligands to centre of protein 
     eval ($zr1 = $zc2 - $z1) 
     coor trans SELE=(segid="drg" and resi $l1) VECT=($xr1 $yr1 $zr1) end 
 
     eval ($ang1=(0.5-RANDOM())*$a20a) 
     eval ($vec1=(0.5-RANDOM())*3) 
     eval ($vec2=(0.5-RANDOM())*3) 
     eval ($vec3=(0.5-RANDOM())*3)  ! move and rotate ligands randomly away 
     coor trans SELE=(segid="drg" and resi $l1) VECT=($vec1 $vec2 $vec3) DIST=50.0 
end 
     vector show ave (x)(segid="drg" and resi $l1) 
     eval ($x1 = $RESULT) 
     vector show ave (y)(segid="drg" and resi $l1) 
     eval ($y1 = $RESULT) 
     vector show ave (z)(segid="drg" and resi $l1) 
     eval ($z1 = $RESULT) 
     coor rota SELE=(segid="drg" and resi $l1)  
             cent=($x1 $y1 $z1) axis ($vec3 $vec1 $vec2) $ang1 end     
     eval ($l1 = $l1 + 1) 
  end loop F2 
 
  vector do (fbeta=$a58) (segid="drg") 
  vector do (vx=$a56) (segid="drg") 
  vector do (vy=$a56) (segid="drg") 
  vector do (vz=$a56) (segid="drg") 
 
  eval ($a02=1)  
  eval ($miner=999999) 
  !write coor FROM=MAIN SELE=(all) OUTPUT= temp2.pdb end 
 end if 
 
! ---------------------dynamics run------------------------------ 
  if ($intac="Y") then 
   constraints interactions  
    (segid="drg")  
    (segid= "tens" or (segid "fkbp" and (name CA or name N or name C or name CB or 
name HN or name O)))  end 
  else  
   constraints interactions (segid="drg")(segid "tens" or segid "fkbp") end 
  end if 
   
  constraints FIX=(not segid "drg") end 
    
  if ($pcs_r="Y") then 
    if ($vdw_r="Y") then 
  if ($attraction_noe="Y") then 
      flag exclude * include noe vdw xpcs end 
  else 
      flag exclude * include vdw xpcs end 
  end if 
    else 
     flag exclude * include noe xpcs end 
    end if 
  else 
    if ($vdw_r="Y") then    
    flag exclude * include noe vdw end   
    else 
    flag exclude * include noe end   
    end if 
  end if 
 
  para nbond rcon = $f1 end end 
  if ($f1 < $vdwmax) then 
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    eval ($f1 = $f1 + $vdwmax/($g01-1))  !valid for next round 
  end if 
  display QQQQQ $f1 
      
  display cycle $a01  
  dynamics rigid 
 dt=$a54 
 group=(segid="drg" and resi 1) 




 NTRFRQ=0 !new for XPLOR vs 3.8 
  end 
 
if ($rigid="N") then 
 if ($a02b > $g01) then 
 !------------local langevin dynamics-------------- 
 constraints  
   interactions ((segid "fkbp" and not (name Ca or name C or name O or name N or 
name 
   HN or name C2)  and segid "drg" around 8.0) ) (segid "fkbp")  
   interactions (segid "drg") (all)  
 end 
 
  constraints  !fix protein Bb + sc outside 8A from ligand + tens; ligand free 
   FIX (not ((segid "fkbp" and not (name Ca or name C or name O or name N or name 
   HN or name C2) and segid "drg" around 8.0) or (segid="drg") ))  
  end 
   
 display cycle $a01  
   
 if ($pcs_r="Y") then  
 if ($vdw_r="Y") then 
  if ($attraction_noe="Y") then 
   flag exclude * include noe vdw  bond angle dihedral impro xpcs end  
  else 
   flag exclude * include vdw  bond angle dihedral impro xpcs end  
  
  end if 
    else 
   flag exclude * include noe bond angle dihedral impro xpcs end  
 end if 
 else 
 if ($vdw_r="Y") then 
    flag exclude * include noe vdw  bond angle dihedral impro end  
    else 
   flag exclude * include noe bond angle dihedral impro end   
    end if 
 end if 
 energy end  
 
 vector do ( fbeta = 6.657235 ) ((segid "fkbp" and not (name Ca or name C or name 
O or name N or name HN or name C2)  and segid "drg" around 8.0) or segid "drg" ) 
 
 dynamics langevin 
    timestep = 0.001  
    nstep = 2000  
    ilbfrq = 2000  
    nprint = 200  
    tbath = 300.  
    iasvel = maxwell   
    rbuf = 0.0  
    origin = ( 0. 0. 0. ) 
 end 
 
 minimize powell             
  drop=1              
  nprint=10              
  nstep=50              
 end 
 
 end if     
end if  !------------local langevin dynamics finished-------------- 
            
    !------------CALCULATE ENERGIES AFTER EACH CYCLE-------------- 




   interactions (segid "drg") (segid "fkbp")  
  end 
  if ($pcs_r="Y") then!!MAKE SURE THIS MATCHES THE FLAG DURING THE RUN 
 if ($vdw_r="Y") then 
      if ($attraction_noe="Y") then 
    flag exclude * include noe vdw xpcs end 
      else 
    flag exclude * include vdw xpcs end   
      end if 
 else 
    flag exclude * include noe xpcs end   
end if 
  else  
 if ($vdw_r="Y") then 
    flag exclude * include noe vdw end  !xpcs 
 else 
    flag exclude * include noe end  !xpcs 
 end if 
  end if 
  energy end 
 
  set disp=ener.dat end  !write energy values 
  if ($a01=1) then 
 display file: ener.dat $DATE $TIME 
    if ($pcs_r="Y") then 
  if ($vdw_r="Y") then 
   if ($attraction_noe="Y") then 
    display cycle appr. step Etot Evdw Enoe Epcs 
   else 
    display cycle appr. step Etot Evdw Epcs 
   end if 
  else 
   display cycle appr. step Etot Enoe Epcs 
  end if 
    else 
  if ($vdw_r="Y") then 
   display cycle appr. step Etot Evdw Enoe 
  else 
   display cycle appr. step Etot Enoe 
  end if 
    end if 
  end if 
 
  if ($pcs_r="Y") then  
 if ($vdw_r="Y") then 
  if($attraction_noe="Y") then 
     display $a01 $a02a $a02 $ENER $VDW $NOE  $XPCS 
  else 
   display $a01 $a02a $a02 $ENER $VDW $XPCS 
  end if 
 else 
    display $a01 $a02a $a02 $ENER $NOE  $XPCS 
 end if 
  else 
 if ($vdw_r="Y") then 
   display $a01 $a02a $a02 $ENER $VDW $NOE 
 else 
   display $a01 $a02a $a02 $ENER $NOE 
 end if 
  end if 
  set disp=OUTPUT end 
 
  if ($miner>$ENER) then 
  if ($a02b > $g01) then 
  coor copy end 
   eval ($miner = $ENER) 
   eval ($mincyc = $a01) 
   eval ($minstep = $a02) 
   if ($vdw_r="Y") then  
     eval ($minvdw = $VDW)  
   end if 
   if ($noe_r="Y") then  
   eval ($minnoe = $NOE) 
   end if 
   if ($pcs_r="Y") then 
    eval ($minpcs = $XPCS) 
       if ($attraction_noe="Y") then  
Appendix B 
118 
    eval ($minnoe = $NOE) 
       end if 
   end if 
  end if 
  end if 
   !------------END OF APPROACH REACHED -------------- 
  if ($a02 = $kick) then  
    if ($miner LE $a59) then 
 !---write structure---        
        eval ($c01 = $c01 + 1) 
        eval ($a52="cycle_"+encode($c01)+".pdb") 
 coor swap end 
        write coord output=$a52 end 
 !---write information about this cycle---- 
 set disp=coor.dat end !write details of step 
     if ($c01=1) then 
    display file: coor.dat $DATE $TIME 
          if ($pcs_r="Y") then 
  if ($vdw_r="Y") then 
   if($attraction_noe="Y") then 
   display file cycle approach app. step Etot Evwd Enoe Epcs 
   else 
   display file cycle approach app. step Etot Evwd Epcs 
   end if 
  else    
   display file cycle approach app. step Etot Enoe Epcs 
  end if 
          else 
   if ($vdw_r="Y") then 
     display file cycle approach app. step Etot Evwd Enoe  
   else 
     display file cycle approach app. step Etot Enoe  
   end if 
          end if 
        end if 
      if ($pcs_r="Y") then 
   if ($vdw_r="Y") then 
    if($attraction_noe="Y") then 
      display $c01 $mincyc $a02a $minstep $miner $minvdw $minnoe $minpcs 
    else 
      display $c01 $mincyc $a02a $minstep $miner $minvdw $minpcs  
end if 
  else 
    display $c01 $mincyc $a02a $minstep $miner $minnoe $minpcs 
  end if 
      else 
  if ($vdw_r="Y") then 
    display $c01 $mincyc $a02a $minstep $miner $minvdw $minnoe
   else 
    display $c01 $mincyc $a02a $minstep $miner $minnoe  
  end if 
      end if  
        set disp=OUTPUT end 
 !---write file with PCS violations for this cycle--- 
        if ($pcs_calc="Y") then 
         @pcs_calc.xpl 
        end if 
 !---write file with distances of atoms with NOEs--- 
  if ($noe_calc="Y") then 
  @noe_calc.xpl 
 end if  
 set echo=on end 
 set mess=on end 
     end if 
    eval ($a02a = $a02a + 1 ) !approach counter 
    eval ($f1 = 0)  !set vdw back to zero 
    eval ($a02b = 0) !cycle per approach 
  end if 
 
  eval ($a02b = $a02b + 1) !cycle per approach 
  eval ($a01 = $a01 + 1) !cycle counter 
 end loop calc 









Appendix C:  XPLOR-NIH script for PRE-based ensemble docking  
! Energy minimization of TOAC pseudoatom position using PRE restraints 
! Using Plastocyanin for docking TOAC on tetra-Lys peptide 
! M. Ubbink 15.2.2013 
! file: red_run.inp 
 
 set mess=off end 




 eval ($idi="plas")  ! SEGID of plastocyanin 
 eval ($d1= 0.1)  ! lower bound CL3, real PRE 
 eval ($d2= 0.1)  ! upper bound CL3, real PRE 
! eval ($d3= 10.0)  ! target distance CL1 
 eval ($d4= 7)   ! lower bound CL1, disappeared 
 eval ($d5= 0)   ! upper bound CL1, disappeared 
 eval ($d6= 15)  ! target distance CL2, unaffected 
 eval ($d7= 0)   ! lower bound CL2, unaffected 
 eval ($d8= 100.0)  ! upper bound CL2, unaffected 
 eval ($d9= 0.5)  ! general scaling 
 eval ($d10= 0.1)  ! scaling CL1 (disappeared) 1 
 eval ($d11= 0.1)  ! scaling CL2 (not affected) 0.1 
 eval ($d12= 0.1)  ! scaling CL3 (real PREs) 1 
 eval ($d13= 100)  ! nr steps Powell energy minimization  
 eval ($d15= 0.01)  ! scaling NOE to pull all the Toac to the protein 
 eval ($tau_c= 5.54E-9)! tau-c in s 
 eval ($fbeta=0.06)  !TC friction coefficient in psec−1  
 eval ($run_nr= 1) !cycle counter, $a01 in fkbp script 
 eval ($kick=20)   ! # cycles per approach  
 eval ($total_cycles= 11000) ! nr runs EM (nr cycles),  $a05 in fkbp script   
 eval ($a02=1)   !counts cycles after last kick 
 eval ($min_app=1) !counts approach step in which min ener  
      ! was reached, $a02a in fkbp script 
 eval ($min_cycle=1) !counts cycle number in current approach, $a01 in fkbp script 
 eval ($a20=40)   ! random distance max + 0 A 
 eval ($a20a=30)  ! random rotation max +/-0.5* 
 eval ($c01=0)    !counts number of saved structures, $c01 in fkbp script 
 eval ($threshold=  4.00944*1.25)  ! .pdb writing threshold, $a59 in fkbp script 
 
 eval ($frb=1)      ! fraction in which the peptide is bound to PoPc 
 eval ($frl=1)   ! fraction of spin labelled TOAC peptide 
 eval ($ens=6)   ! nr of TOAC molecules in ensemble 
 eval ($t3=1)   ! first residue number of TOAC 
 eval ($t4=$t3+$ens-1) 
 eval ($a48=$cpu*1e4)   !($cpu*1e4) 
 set seed=$a48 end  !generate random number 
 eval ($Crd="Y")      ! Control loop Crd (Y/N)to kick TOAC after each approach 
 eval ($ener_check="Y") ! switch on energy barrier (Y/N)  
 eval ($checkener=2.1*$threshold)  ! energy barrier to prevent coordinate 
explosion  
 eval ($attraction_noe="Y") ! switch on attraction noe (Y/N) 
 eval ($fix_CL2="Y")    ! fix experimental distance for CL2 (unaffected) 
!------------------------------------------------------------------------- 
















  @PoPc.cu.h.pdb 
 
 




    residue TOAC 
  atom TC type=C charge=0.000 mass 12.00 end 





    molecule 
    name=TOAC 
 number=$ens 
   end                                           
 end  
 
 para 
  nbon 
    repe = 0.65  
    rcon = 60 
     
  end 
 end 
 
 vector do (X=10.0) (resn TOAC and name TC)! 
 vector do (Y=10.0) (resn TOAC and name TC)!define initial TC coordinates 






 !DEFINE NMR DERIVED DISTANCES FOR TC-NH 
 @restraints_PoPc_KKKKX_Kd93uM.xpl 
 
 if ($attraction_noe="Y") then ! 
 NOE 
   class CL4 
   averaging CL4 cent 
   potential CL4 square 
   sqconstant CL4 0.01 
   sqoffset CL4 0.0 
   scale CL4 $d15 
   sqexponent CL4 2  
   ceil=10.0 !20 
  end 
 
 eval ($t1 = $t3) 
 while ($t1 LE $t4) loop D ! set random coordinates for TOAC atoms 
  noe 
    assign (name TC and resi $t1) (name C2 and resn CM2) 20.0 10.0 10.0 
  end 
 eval ($t1 = $t1 + 1) 
 end loop D 






 set echo=off end 
 set mess=off end 
  
 constraints fix (not name TC) end 
 constraints interactions (name TC) (not name TC and not name C2) end 
 flag exclude * include noe vdw end 
 
 while ($run_nr LE $total_cycles) loop RUNS 
   eval ($t1 = $t3) 
   !coor orient sele=(segid "plas") end 
   if ($Crd="Y") then 
    if ($a02 = 1) then 
     while ($t1 LE $t4) loop Crd ! set random coordinates for TOAC atoms 
     !------------put TC at origin----------------- 
     vector do (fbeta=0.025) (name TC and resi $t1) 
     vector do (vx=0.1)(name TC and resi $t1) 
     vector do (vy=0.1)(name TC and resi $t1) 
     vector do (vz=0.1)(name TC and resi $t1) 




     eval ($x2= $RESULT) 
     vector show ave (y) (name TC and resi $t1) 
     eval ($y2= $RESULT) 
     vector show ave (z) (name TC and resi $t1) 
     eval ($z2= $RESULT) 
     eval ($dist=sqrt($x2**2+$y2**2+$z2**2)) 
     coor trans SELE=(name TC and resi $t1) VECT=(-$x2 -$y2 -$z2) DIST=$dist end 
 
     !------------- move TOAC randomly away---------------------- 
 
     eval ($vec1=0.5-RANDOM()) 
     eval ($vec2=0.5-RANDOM()) 
     eval ($vec3=0.5-RANDOM())  
     coor trans SELE=(name TC and resi $t1) VECT=($vec1 $vec2 $vec3) DIST=$a20 end 
     eval ($t1 = $t1 +1) 
    end loop Crd 
 
    minimize powell 
      drop=10 
      nprint=50 
   nstep=$d13 
   tolgradient=0.0001 
    end 
 
   end if ! if ($a02 = 1) then 
   end if ! if($Crd="Y") then 
 
   dynamics internal 
     nstep = 500 
     depred = 1  
     etol = 1 
     maxenergy = 100 
     timestep = 0.002 
     friction = $fbeta 
     nsavc = 20 
     fix = (segid $idi) 
     group = (name TC and resi 1) 
     group = (name TC and resi 2) 
     group = (name TC and resi 3) 
     group = (name TC and resi 4) 
     group = (name TC and resi 5) 
     group = (name TC and resi 6) 
     tbath = 300 
     nprint = 50 
  NTRFRQ=0 !new for XPLOR vs 3.8 
   end   
 
   energy end 
 
!-------------write all energy info------------------------- 
 
  set disp=ener.dat end  !write energy values 
  if ($run_nr=1) then 
   display ener.dat $DATE $TIME 
   display cycle appr step Etot Enoe Evdw  
  end if 
  display $run_nr $min_app $a02 $ENER $NOE   $VDW  
  set disp=OUTPUT end 
 
!-------------check energy----------------------------------- 
  if ($ener_check="Y") then 
    if ( $a02 = 1 ) then  
     if ($ENER>$checkener) then 
      display -----------------------ENERGY TOO HIGH, GO TO NEXT CYCLE -----------
--------- 
      eval ($a02=0) 
      eval ($min_app = $min_app + 1 ) !approach counter 
     end if ! if ($ENER>$checkener) then 
    end if !if ( $a02 = 1 ) then  
 
    if ( $a02 = 2 ) then  
     if ($ENER>$miner) then 
      display -----------------------ENERGY TOO HIGH, GO TO NEXT CYCLE -----------
--------- 
      eval ($a02=0) 
      eval ($min_app = $min_app + 1 ) !approach counter 
     end if ! if ($ENER>$miner) then 
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    end if ! if ( $a02 = 2 ) then  
  end if !if ($ener_check="Y") then 
!------------save energy info for currently lowest energy structure-------------- 
 
  if ($a02 = 1) then 
    eval ($miner=999999) 
  end if  
 
  if ($miner>$ENER) then 
    coor copy end 
    eval ($miner = $ENER) 
    eval ($mincyc = $run_nr) 
    eval ($minstep = $a02) 
    eval ($minvdw = $VDW)   
    eval ($minnoe = $NOE) 
  end if 
 
 






!------------write the coordinates for lowest energy structure-------------- 
 
  if ($a02 = $kick) then  
 
    if ($miner LE $threshold) then 
     eval ($c01 = $c01 + 1) 
     eval ($a52="cycle_"+encode($c01)+".pdb") 
     coor swap end 
     write coord sele=(name TC) OUTPUT=$a52 end 
 
     !------------save the PRE info for lowest energy structure-------------- 
     @pre_calc.xpl 
 
     !------------write the energy info for lowest energy structure-------------- 
 
     set disp=coor.dat end !write details of step 
     if ($c01=1) then 
    display file: coor.dat $DATE $TIME 
          display file cycle approach app.step Etot Enoe Evwd violation 
        end if 
        display $c01 $mincyc $min_app $minstep $miner $minnoe $minvdw
 $viol 
     set disp=OUTPUT end 
 
 
    end if ! if ($miner LE $threshold) then 
 
    eval ($min_app = $min_app + 1 ) !approach counter 
    eval ($min_cycle = 0) !cycle per approach 
    eval ($a02 = 0)  
  end if !  if ($a02 = $kick) then 
  display ------------------------END OF RUN $run_nr----------------------- 
 
!----------------go to the next run------------------------------ 
  eval ($run_nr = $run_nr +1) ! run counter 
  eval ($a02 = $a02 + 1)  




end loop RUNS 
display $DATE $TIME   
set echo=off end 








Appendix D: Backbone and side chain assignments of Zn-substituted PoPc 
Residue C C H N  Residue C C H N 
I1 59.73  40.89  - -  H37 53.92  36.59  7.852  110.2  
I1 59.76  38.60  - -  N38 52.66  39.93  9.196  120.3  
D2 52.86  42.05  7.793  126.2   I39 61.92  40.27  6.082  112.6  
D2 53.10  41.58  8.310  111.2   V40 61.15  34.73  8.605  126.4  
V3 60.62  34.86  8.810  124.1   F41 57.89  39.58  8.529  123.0  
V3 60.64  35.08  8.773  124.0   D42 53.75  42.31  8.385  121.3  
L4 54.68  42.58  8.963  126.0   E43 59.06  29.61  8.748  125.7  
L5 53.18  41.42  8.626  119.4   D44 55.37  41.47  8.314  117.6  
G6 44.37  0.00  7.816  116.2   S45 56.75  64.33  8.125  116.5  
A7 50.76  20.87  7.995  125.1   I46 58.83  39.45  7.060  114.9  
D8 57.51  39.98  8.935  119.9   P47 59.77  31.97  - - 
D9 53.42  39.59  7.627  115.3   S48 59.76  63.32  8.235  115.5  
G10 44.71  0.00  8.189  108.7   G49 45.11  0.00  8.729  112.8  
S11 60.35  63.09  8.046  115.8   V50 62.26  32.42  7.372  121.1  
L12 53.16  39.11  8.682  125.9   D51 52.25  41.03  8.251  126.7  
A13 50.06  22.39  7.351  124.6   A52 54.95  18.47  9.348  130.0  
F14 58.35  40.45  9.077  121.2   S53 61.47  63.13  8.617  114.2  
V15 59.31  34.20  8.823  121.5   K54 56.76  32.96  7.314  118.8  
P16 63.63  35.03  - -  I55 61.15  38.30  6.984  109.6  
S17 59.21  64.62  8.160  107.7   S56 58.17  67.13  6.649  110.2  
E18 55.26  32.27  7.500  119.9   M57 56.75  33.54  8.213  122.5  
F19 56.00  39.07  7.632  119.0   M57 56.53  33.12  8.247  122.6  
S20 56.74  66.30  8.592  115.3   S58 58.50  63.50  8.548  115.8  
S20 56.67  66.27  8.626  115.3   E59 59.72  29.48  8.597  122.9  
I21 59.62  42.71  8.716  116.5   E60 56.38  29.80  8.047  113.4  
I21 59.70  43.03  8.716  116.5   D61 54.05  42.14  7.601  122.5  
S22 56.78  63.29  8.228  116.8   L62 53.52  46.62  7.723  118.3  
S22 56.99  63.17  8.406  117.4   L63 54.07  40.34  8.882  119.7  
P23 64.51  31.46  - -  N64 54.79  42.10  8.467  124.7  
P23 64.39  31.48  - -  A65 50.11  21.55  8.349  121.2  
G24 44.97  0.00  9.216  113.3   K66 58.67  32.49  8.538  125.0  
G24 44.95  0.00  9.095  113.9   G67 45.13  0.00  8.806  113.6  
E25 56.99  31.06  7.655  121.7   E68 58.18  32.33  7.183  119.9  
E25 56.60  30.65  7.801  123.1   T69 59.38  73.68  8.373  110.6  
K26 56.16  33.67  8.040  122.3   T69 59.48  73.63  8.382  110.8  
K26 56.19  33.98  7.981  120.4   F70 57.87  43.78  8.661  120.7  
I27 60.34  39.64  8.867  125.6   F70 57.88  43.72  8.632  120.8  
I27 60.65  39.11  8.858  125.0   E71 54.00  32.74  7.789  126.2  
V28 61.64  31.39  8.468  126.3   E71 54.01  32.75  7.826  126.2  
V28 61.63  31.14  8.437  126.8   V72 60.21  35.52  8.568  120.1  
F29 57.18  39.29  9.042  126.5   V72 60.24  35.50  8.509  119.9  
K30 54.83  35.19  9.173  122.8   A73 50.39  20.61  8.235  128.9  
K30 54.88  35.11  9.138  122.6   L74 53.46  43.46  7.595  120.3  
N31 54.46  38.45  9.229  126.8   L74 53.35  43.48  7.556  120.3  
N32 56.50  42.50  9.016  129.2   S75 59.70  64.97  8.685  115.2  
A33 52.28  22.05  8.647  119.8   N76 53.95  37.54  7.901  120.0  
G34 47.51  0.00  7.750  116.5   K77 58.09  33.51  8.726  124.5  
F35 52.80  36.98  5.720  114.5   G78 43.70  0.00  8.683  108.2  




Residue C C H N  Residue H(sc1) H(sc2) N(sc) 
E79 56.04  31.99  8.224  119.2   N38 7.043  6.242  107.2  
Y80 56.54  39.77  9.513  122.6   N64 7.631  6.865  113.5  
S81 58.36  64.76  8.268  118.7   Q88 6.731  6.189  110.8  
F82 55.10  41.15  7.978  119.8   N99 7.418  6.683  112.2  
Y83 56.12  41.21  9.183  115.4       
C84 56.22  29.46  7.804  121.2       
S85 64.80  61.34  10.230  126.5       
P86 65.14  30.36  - -      
H87 54.11  34.88  7.189  112.5       
Q88 60.88  28.55  7.982  115.1       
G89 46.30  0.00  8.964  108.5       
A90 51.44  19.11  7.296  121.3       
G91 45.35  0.00  7.829  110.4       
M92 56.89  30.37  7.758  121.5       
V93 58.74  35.98  8.016  121.5       
G94 45.22  0.00  8.258  112.2       
K95 55.78  36.67  8.394  119.7       
V96 56.90  33.50  9.022  122.2       
T97 61.77  70.28  8.244  124.4       
V98 60.94  31.57  9.236  128.7       





Appendix E: Backbone assignments of Zn-substituted DPc 
Residue C C H N  Residue C C H N 
A1 51.87  20.70  - -  A52 56.14  18.11  8.234  122.0  
K2 55.70  35.28  8.579  123.2   S53 61.86  63.17  8.185  111.9  
V3 61.23  35.98  8.568  125.4   E54 59.61  30.32  7.695  124.9  
E4 55.79  30.83  9.265  126.7   L55 57.47  41.49  8.406  119.8  
V5 61.75  31.83  9.060  125.4   K56 59.66  32.20  8.160  122.0  
G6 43.85  - 8.015  112.6   A57 54.16  17.97  7.772  120.9  
D7 52.58  43.17  6.938  109.9   A58 51.60  19.40  7.223  121.2  
E8 59.14  29.44  8.915  116.9   S59 58.12  66.67  7.159  108.3  
V9 62.03  31.73  7.415  113.5   M60 56.24  34.29  8.489  123.1  
G10 45.51  - 7.841  108.9   D61 55.08  42.98  8.567  120.2  
N11 54.45  39.01  9.108  119.1   E62 59.42  29.74  8.460  123.5  
F12 51.90  34.75  8.662  125.6   N63 53.28  39.44  8.655  115.4  
K13 54.33  38.05  6.459  117.4   D64 53.26  43.33  7.593  121.7  
F14 57.37  41.32  8.332  119.6   L65 54.30  47.17  8.001  117.4  
Y15 54.80  41.22  9.328  118.4   L66 55.37  44.15  8.308  121.3  
P16 63.69  35.15  - -  S67 56.81  67.73  8.003  115.1  
D17 53.10  40.29  7.859  111.0   E68 59.52  29.62  8.688  118.2  
S18 56.93  64.35  7.184  114.5   D69 55.86  41.60  7.757  115.1  
I19 59.99  42.59  8.649  125.1   E70 53.79  30.18  7.251  120.2  
T20 61.43  70.56  8.469  124.6   P71 65.22  33.45  - - 
V21 58.40  35.73  9.124  119.6   S72 56.90  66.60  7.904  114.3  
S22 58.03  64.49  8.138  116.4   F73 57.84  44.44  9.029  125.5  
A23 54.41  18.25  8.672  125.7   K74 54.81  34.76  7.569  127.5  
G24 45.16  - 8.738  113.1   A75 50.40  23.60  8.753  125.6  
E25 55.98  30.80  8.118  123.4   K76 55.85  34.50  8.355  122.0  
A26 51.72  19.64  8.497  127.6   V77 62.23  33.58  8.862  128.0  
V27 61.44  32.63  8.924  122.4   S78 59.58  64.54  9.329  123.0  
E28 54.95  30.76  8.439  126.7   T79 61.79  68.79  8.145  123.5  
F29 57.07  40.30  9.443  127.5   P80 63.84  32.46  - - 
T30 60.83  71.85  8.771  118.2   G81 44.78  - 8.537  110.4  
L31 56.23  43.71  9.455  130.6   T82 62.25  71.00  7.628  115.2  
V32 62.51  33.33  8.743  131.5   Y83 56.60  42.36  9.569  128.0  
G33 43.85  - 8.279  112.5   T84 61.67  71.15  9.610  119.2  
E34 57.38  31.12  8.006  114.3   F85 54.32  40.36  8.089  121.4  
T35 63.05  69.04  7.865  117.7   Y86 56.42  41.47  8.616  115.1  
G36 46.38  - 8.556  112.7   C87 57.18  29.85  7.105  120.1  
H37 55.24  36.53  6.585  116.3   T88 69.99  67.19  9.995  126.6  
N38 51.16  40.36  9.503  123.8   P89 65.03  31.09  - - 
I39 61.51  40.08  5.990  113.0   H90 57.96  32.67  7.459  114.7  
V40 61.34  35.83  8.706  125.3   K91 61.58  29.21  7.903  128.0  
F41 58.75  40.72  8.264  124.0   S92 60.28  62.36  - - 
D42 54.35  42.60  8.822  122.9   A93 51.33  18.54  7.202  123.7  
I43 58.10  37.75  8.469  125.2   N94 54.62  36.96  8.195  114.0  
P44 62.77  32.41  - -  M95 56.66  31.08  7.492  119.7  
A45 53.68  18.05  8.606  126.7   K96 54.22  37.51  7.369  125.5  
G46 45.31  - 8.774  110.3   G97 44.21  - 8.212  112.7  
A47 50.79  17.41  7.482  123.5   T98 61.09  71.56  8.074  112.9  
P48 62.40  32.67  - -  L99 53.01  46.81  9.640  128.8  
G49 47.82  - 8.887  110.9   T100 62.59  69.82  9.384  126.3  
T50 64.51  67.95  8.040  112.2   V101 60.99  33.30  9.301  128.9  
V51 65.49  32.34  6.966  124.0   K102 57.42  34.75  8.780  133.5  
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Appendix F: Supplementary figures for Chapter 5
 
Figure F1: CSPs (extrapolated to 100% bound) mapped onto the protein surfaces from the binding 
of KKKKX (panels A and B), KKKKA (panels C and D) and AKKKK (panels E and F) to PoPc (left, 
PDB entry 1TKW
47
) and DPc (right, PDB entry 1KDI
43
). Color representations: red, ave ≥ 0.04 
ppm; orange, 0.04 >ave ≥ 0.02 ppm; yellow, 0.02 >ave≥ 0.01 ppm; white,ave < 0.01 ppm; 






Figure F2: Chemical shift changes of Pcs resonances as a function of increasing [peptide]/[Pc] for 
peptides XKKKK and KKKKX. The dissociation constants of the corresponding peptides (Table 5.1) 
were obtained by simultaneous fitting to a 1:1 binding model for PoPc (solid lines) and by simulation 
for 2-site binding for DPc. (A) XKKKK with PoPc; (B) XKKKK with DPc, strong-binding residues; 
(C) XKKKK with DPc, weak-binding residues; (D) KKKKX with PhPc; (E) XKKKK with PhPc. 
The titration points for each residue in (D) and (E) are connected with dashed lines. Error bars 




Figure F3: Chemical shift changes of Pcs resonances as a function of increasing [peptide]/[Pc] for 
peptides KKKKA and AKKKK. The residues which showed largest perturbations are shown. The 
dissociation constants of the corresponding peptides (Table 5.1) were obtained by simultaneous 
fitting to a 1:1 binding model for PoPc (solid lines) and by simulation for 2-site binding for DPc. (A) 
KKKKA with PoPc; (B) AKKKK with PoPc; (C) KKKKA with DPc, strong-binding residues; (D) 
AKKKK with DPc, strong-binding residues; (E) KKKKA with DPc, weak-binding residues; (F) 
AKKKK with DPc, weak-binding residues; (G) KKKKA with PhPc; (B) AKKKK with PhPc. The 






Figure F4: PRE effects in Pc-XKKKK complexes. Left: PRE maps of PoPc (A, PDB entry 1TKW
47
), 
DPc (B, PDB entry 1KDI
43
) and PhPc (C, PDB entry 2Q5B) bound to XKKKK peptide, color-coded 
on surface models of Pc: red, Ipara/Idia < 0.1; orange, 0.1 ≤Ipara/Idia < 0.85; white, Ipara/Idia ≥ 0.85; grey, 




N]-HSQC intensities of 
amides PoPc (A), DPc(B) and PhPc(C) in the complex with TOAC-containing peptides. For PoPc, 
the side chains are also included (blue squares). The dashed horizontal lines indicate Ipara/Idia = 0.85 
(orange lines) and 0.1 (red lines). The error bars denote 2× standard deviations, derived from spectral 





Figure F5: (A-B) Averaged distance violations against number of XKKKK peptides (N=1-6,8,10,15) 
in the ensemble docking for PoPc (A) and DPc (B). (C-D) Correlation of experimental distances 
(black dots) and back-calculated average distances (green circles with connecting lines) from the 
ensemble docking (N=6) of XKKKK bound to PoPc (C) and DPc (D). The average distances from 
the 20 lowest-energy solutions of the PRE driven ensemble docking are shown as black circles 
connected by black lines with error bars representing the standard deviation. Right y axes show the 




experimental distances. (E-F) Comparison of experimental distances (black dots) and back-calculated 
average distances (green dots with connecting lines) between Pc amides and the 2000 ensembles of 
peptide paramagnetic oxygen atoms from MC simulations for PoPc (E) and DPc (F). Grey areas 
indicate the error margins of the experimental distances. (G-I) Histograms showing the energy 





The work described in this thesis focuses on the application of various NMR techniques to 
the study of interactions between proteins and small molecules and proteins and peptides, 
including the well-established classical NMR approaches, and the recently developed 
paramagnetic NMR methods. Computational tools have been used to complement and 
visualize the experimental data.  
Chapter 1 presents an overview of NMR techniques for studying protein-ligand interactions. 
Due to its superior sensitivity in detecting weak interactions, NMR is the most used 
technique for fragment-based drug screening and the power of NMR is not restricted to 
primary screening only.  
The work presented in Chapter 2 gives detailed information on the characterization of 
fragment hits binding to FKBP12 using 1D-
1
H NMR. Recent advances in paramagnetic 
NMR spectroscopy have evolved a wide range of applications in studying protein-protein 
complexes but few cases of protein-ligand complex studies have been reported. To look for 
suitable ligands used in a paramagnetic NMR study (Chapter 4), fifteen FKBP12 ligands 
with diverse binding affinities and chemical structures were selected for the pilot study. The 
suitabilities of the ligands were assessed based on their binding affinity, chemical structure, 
isomeric purity, and changes of chemical shifts upon binding to the target protein. Based on 
the characterization of the bound ligands, the general rules of an ideal ligand were 
established as: (1) the ligand must be in fast exchange on the NMR time scale; (2) must 
contain sufficient number of proton resonances that are well-separated in the 1D-
1
H NMR 
spectrum; (3) must be isomerically pure; (4) must show clear and measurable chemical shift 
changes upon binding to the protein. The binding pose of the most suitable ligand was 
subsequently characterized in detail in Chapters 3 and 4. 
Chapter 3 describes the determination of the binding pose of a small molecule bound to 
FKBP12 based on NOE restraints. Chemical shift perturbation (CSP) analysis indicated that 
a large region of the protein, spanning both binding sites 1 and 2 on FKBP12, was affected 
either directly or indirectly by ligand binding. The CSP map therefore presents a challenge to 
identify the actual binding site. Thus, intermolecular NOE restraints acquired from standard 
isotope filtered/edited NOESY experiments were used to determine the binding site and 
ligand binding mode. Although not all NOE restraints were satisfied in the final structure, 
due to dynamics in the complex, the results show a promising hydrogen bond network that 




Chapter 4 presents an orthogonal NMR methodology to determine the structure of the above-
mentioned complex based on paramagnetic NMR pseudocontact shifts (PCSs). The two-
armed lanthanide binding tag, CLaNP5, was attached on three different double cysteine 
variants of FKBP12. The results indicate that it is possible to identify the ligand binding site 
and obtain a low resolution structure using bound ligand PCSs from simple 1D-
1
H NMR 
spectra. Due to the rigid structure of CLaNP5, optimization of the tensor frame and the 
lanthanide position was not necessary but could improve the quality of the structure. 
Therefore, the methodology can be particularly valuable for studying proteins that are very 
large or difficult to be labeled isotopically. 
The weak interaction and dynamic behavior of transient encounter complexes is challenging 
to study using existing experimental tools. The binding partners in such complexes present in 
nature, mostly being proteins, have low specificity and can interact with multiple partners in 
cascades. Chapter 5 describes the characterization of dynamics in artificial encounter 
complexes formed by plastocyanins and short charged peptides. Using CSP and PRE NMR 
spectroscopy, the dynamics in the encounter complexes were visualized and compared with 
the results from electrostatic Monte Carlo (MC) simulations. The highly similar CSP maps 
and the small shifts among different complexes strongly suggest a high degree of dynamics. 
In addition, the scattered PREs indicate the presence of multiple orientations. The overall 
results suggest that the complexes have multiple orientations and are dominated by 







Het werk beschreven in dit proefschrift richt zich op de toepassing van diverse 
kernspinresonantie (Nuclear Magnetic Resonance, NMR) technieken voor het bestuderen van 
de interactie tussen eiwitten en kleine moleculen en tussen eiwitten en peptiden. Er is 
gebruik gemaakt van zowel klassieke NMR-technieken als recent ontwikkelde 
paramagnetische NMR methoden. Computeranalyses zijn gebruikt om de experimentele data 
aan te vullen en te visualiseren. 
In Hoofdstuk 1 wordt een overzicht van NMR-technieken gegeven die gebruikt worden voor 
het bestuderen van eiwit-ligand interacties. Vanwege zijn superieure gevoeligheid voor de 
detectie van zwakke bindingen, is NMR de meest gebruikte techniek voor 
fragmentgebaseerde geneesmiddelen ontwikkeling, maar de kracht van NMR is niet beperkt 
tot alleen dit soort onderzoek.  
Het werk gepresenteerd in Hoofdstuk 2 geeft gedetailleerde informatie over de karakterisatie 
van fragmenten die binden aan FKBP12, door gebruik te maken van 1D-
1
H NMR. Recente 
ontwikkelingen in paramagnetische NMR-spectroscopie hebben geleid tot een breed 
spectrum van toepassingen voor het bestuderen van eiwit-eiwit complexen, maar er zijn 
weinig studies van eiwit-ligand complexen gerapporteerd. Om geschikte liganden te vinden 
voor toepassing van paramagnetische NMR-methoden (Hoofdstuk 4), zijn 15 FKBP12 
liganden met verschillende bindingsaffiniteiten geselecteerd voor een eerste onderzoek. De 
geschiktheid van de liganden is bepaald op basis van bindingsaffiniteit, chemische structuur, 
isomere zuiverheid en veranderingen van chemische verschuivingen (chemical shifts) bij 
binding aan het eiwit. Op basis van de gevonden resultaten zijn de algemene regels voor een 
ideale ligand als volgt: (1) de ligand moet zich in snelle uitwisseling (fast exchange) 
bevinden op de NMR-tijdschaal; (2) de ligand moet een voldoende aantal goed gescheiden 
proton resonanties vertonen in het 1D-
1
H NMR spectrum; (3) de ligand moet isomeer-zuiver 
zijn; (4) de ligand moet een duidelijke en meetbare chemische verschuiving vertonen bij 
binding aan het eiwit. De bindingspositie van het meest geschikte ligand is vervolgens 
gedetailleerd gekarakteriseerd, zoals beschreven in Hoofdstukken 3 en 4. 
Hoofdstuk 3 beschrijft de bepaling van de bindingspositie van een klein molecuul gebonden 
aan FKBP12, gebaseerd op NOE (Nucleaire Overhauser Effect) gegevens. Analyse van de 
verstoringen in chemische verschuiving (Chemical shift perturbation, CSP) toonden aan dat 




indirect wordt beïnvloed door binding van ligand. De CSP ‘kaart’ geeft daarom geen inzicht 
in de daadwerkelijke bindingsplek. Derhalve zijn NOEs, verkregen uit standaard isotoop 
gefilterde/gekoppelde NOESY-experimenten, gebruikt om de bindingsplaats en 
bindingsoriëntatie van het ligand te bepalen. De uiteindelijke structuur is niet in 
overeenstemming met alle NOEs, wat vermoedelijk wordt veroorzaakt door dynamiek van 
het ligand in de bindingsplaats. Toch is het resultaat waarschijnlijk betrouwbaar, mede 
omdat een waterstofbrugnetwerk aanwezig is, welk ook is gevonden bij andere FKBP12 
liganden. 
Hoofdstuk 4 presenteert een orthogonale NMR methode om de structuur van het hierboven 
genoemde complex te bepalen, gebaseerd op paramagnetische NMR pseudocontact shifts 
(PCSs). CLaNP-5, een eiwitprobe met twee armen welke een lanthanide-ion kan binden, is 
bevestigd aan drie verschillende dubbel-cysteϊne mutanten van FKBP12. De resultaten tonen 
aan dat het mogelijk is de bindingsplaats van een ligand te identificeren en een structuur met 
lage resolutie te verkrijgen door gebruik te maken van ligand-PCSs verkregen uit simpele 
1D-
1
H NMR spectra. Door de rigide structuur van CLaNP5 was optimalisatie van het tensor 
frame en de positie van de lanthanide niet noodzakelijk, al leidde dit wel tot een hogere 
kwaliteit van de structuur. Om deze reden kan deze methode in het bijzonder waardevol zijn 
voor het bestuderen van grotere eiwitten of eiwitten die moeilijk te verrijken zijn met 
isotopen.  
De zwakke interactie en het dynamisch gedrag van kortstondige complexen zijn een 
uitdaging om te bestuderen met de huidige experimentele hulpmiddelen. De bindingspartners 
van deze in de natuur voorkomende complexen, meestal eiwitten, hebben een lage 
specificiteit en kunnen opeenvolgende interacties vertonen met meerdere partners. 
Hoofdstuk 5 beschrijft de karakterisatie van de dynamiek in een kunstmatig kortlevend 
complex gevormd door plastocyanine en korte, geladen peptides. Door gebruik te maken van 
CSP en PRE NMR spectroscopie is de dynamiek van de kortstondige complexen 
gevisualiseerd en vergeleken met de resultaten van elektrostatische Monte Carlo (MC) 
simulaties. De zeer vergelijkbare CSP ‘kaarten’ tussen verschillende complexen evenals de 
kleine verschuivingen, suggereren een hoge mate van dynamiek. Bovendien tonen de 
verspreidde PRE’s de aanwezigheid aan van meerdere oriëntaties. De algehele resultaten 
suggereren dat de complexen uit meerdere oriëntaties bestaan en door elektrostatische 
interacties worden gedomineerd. Tevens zijn er aanwijzingen voor zwakke korte-
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